
<html lang="en"     class="pb-page"  data-request-id="2e75559e-e40e-45f3-bb20-9a85b73631ba"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-2;article:article:10.1021/acs.jmedchem.6b01597;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode" /></meta><meta name="dc.Creator" content="Lisa M.  Miller" /></meta><meta name="dc.Creator" content="Willem-Jan  Keune" /></meta><meta name="dc.Creator" content="Diana  Castagna" /></meta><meta name="dc.Creator" content="Louise C.  Young" /></meta><meta name="dc.Creator" content="Emma L.  Duffy" /></meta><meta name="dc.Creator" content="Frances  Potjewyd" /></meta><meta name="dc.Creator" content="Fernando  Salgado-Polo" /></meta><meta name="dc.Creator" content="Paloma  Engel García" /></meta><meta name="dc.Creator" content="Dima  Semaan" /></meta><meta name="dc.Creator" content="John M.  Pritchard" /></meta><meta name="dc.Creator" content="Anastassis  Perrakis" /></meta><meta name="dc.Creator" content="Simon J. F.  Macdonald" /></meta><meta name="dc.Creator" content="Craig  Jamieson" /></meta><meta name="dc.Creator" content="Allan J. B.  Watson" /></meta><meta name="dc.Description" content="Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signaling pathway is impli..." /></meta><meta name="Description" content="Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signaling pathway is impli..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 5, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01597" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01597" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01597" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01597" /></link>
        
    
    

<title>Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01597" /></meta><meta property="og:title" content="Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0032.jpeg" /></meta><meta property="og:description" content="Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signaling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a number of diseases including fibrotic diseases, cancer, and inflammation, among others. Many of the developed synthetic inhibitors for ATX have resembled the lipid chemotype of the native ligand; however, a small number of inhibitors have been described that deviate from this common scaffold. Herein, we report the structure–activity relationships (SAR) of a previously reported small molecule ATX inhibitor. We show through enzyme kinetics studies that analogues of this chemotype are noncompetitive inhibitors, and by using a crystal structure with ATX we confirm the discrete binding mode." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01597"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01597">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01597&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01597&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01597&amp;href=/doi/10.1021/acs.jmedchem.6b01597" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 722-748</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01541" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01591" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+M.++Miller">Lisa M. Miller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Willem-Jan++Keune">Willem-Jan Keune</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Castagna">Diana Castagna</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise+C.++Young">Louise C. Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emma+L.++Duffy">Emma L. Duffy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frances++Potjewyd">Frances Potjewyd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Salgado-Polo">Fernando Salgado-Polo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paloma++Engel+Garc%C3%ADa">Paloma Engel García</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dima++Semaan">Dima Semaan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Pritchard">John M. Pritchard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anastassis++Perrakis">Anastassis Perrakis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+J.+F.++Macdonald">Simon J. F. Macdonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig++Jamieson">Craig Jamieson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6567-8272" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan+J.+B.++Watson">Allan J. B. Watson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1582-4286" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">WestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Biochemistry, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Strathclyde Institute of Pharmacy and Biomolecular Science, University of Strathclyde, John Arbuthnott Building (Hamnet Wing), 161 Cathedral Street, Glasgow G1 1XL, U.K.</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Fibrosis Discovery Performance Unit, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div><div class="corresp-info"><strong>*</strong>For C.J.: phone, +44 (0)141 548 4830; E-mail, <a href="/cdn-cgi/l/email-protection#452637242c226b2f24282c20362a2b0536313724312d6b24266b302e"><span class="__cf_email__" data-cfemail="0b68796a626c25616a66626e7864654b787f796a7f63256a68257e60">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For A.J.B.W.: phone, +44 (0)141 548 2439; fax, +44 (0)141 548 4822; E-mail, <a href="/cdn-cgi/l/email-protection#cfaea3a3aea1e1b8aebbbca0a1e1feffff8fbcbbbdaebba7e1aeace1baa4"><span class="__cf_email__" data-cfemail="86e7eaeae7e8a8f1e7f2f5e9e8a8b7b6b6c6f5f2f4e7f2eea8e7e5a8f3ed">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01597&amp;href=/doi/10.1021%2Facs.jmedchem.6b01597" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 722–748</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 16, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 November 2016</li><li><span class="item_label"><b>Published</b> online</span>5 January 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 January 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01597" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01597</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D722%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLisa%2BM.%2BMiller%252C%2BWillem-Jan%2BKeune%252C%2BDiana%2BCastagna%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D2%26contentID%3Dacs.jmedchem.6b01597%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BSmall%2BMolecule%2BAutotaxin%2BInhibitors%2Bwith%2Ba%2BDiscrete%2BBinding%2BMode%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D748%26publicationDate%3DJanuary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01597"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2272</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01597" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;M. Miller&quot;},{&quot;first_name&quot;:&quot;Willem-Jan&quot;,&quot;last_name&quot;:&quot;Keune&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Castagna&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;C. Young&quot;},{&quot;first_name&quot;:&quot;Emma&quot;,&quot;last_name&quot;:&quot;L. Duffy&quot;},{&quot;first_name&quot;:&quot;Frances&quot;,&quot;last_name&quot;:&quot;Potjewyd&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Salgado-Polo&quot;},{&quot;first_name&quot;:&quot;Paloma&quot;,&quot;last_name&quot;:&quot;Engel García&quot;},{&quot;first_name&quot;:&quot;Dima&quot;,&quot;last_name&quot;:&quot;Semaan&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Pritchard&quot;},{&quot;first_name&quot;:&quot;Anastassis&quot;,&quot;last_name&quot;:&quot;Perrakis&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;J. F. Macdonald&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;Jamieson&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;J. B. Watson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;722-748&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01597&quot;},&quot;abstract&quot;:&quot;Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signaling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a number of diseases including fibrotic diseases, cancer, and inflammation, among others. Many of the developed synthetic inhibitors for ATX have resembled the lipid chemotype of the native ligand; however, a small number of inhibitors have been described that deviate from this common scaffold. Herein, we report the structure–activity relationships (SAR) of a previously reported small molecule ATX inhibitor. We show through enzyme kinetics studies that analogues of this chemotype are noncompetitive inhibitors, and by using a crystal structure with ATX we confirm the discrete binding mode.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01597&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01597" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01597&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01597" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01597&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01597" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01597&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01597&amp;href=/doi/10.1021/acs.jmedchem.6b01597" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01597" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01597" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01597%26sid%3Dliteratum%253Aachs%26pmid%3D27982588%26genre%3Darticle%26aulast%3DMiller%26date%3D2017%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BSmall%2BMolecule%2BAutotaxin%2BInhibitors%2Bwith%2Ba%2BDiscrete%2BBinding%2BMode%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D2%26spage%3D722%26epage%3D748%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291337" title="Carbon">Carbon</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/jmcmar.2017.60.issue-2/20170126/jmcmar.2017.60.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signaling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a number of diseases including fibrotic diseases, cancer, and inflammation, among others. Many of the developed synthetic inhibitors for ATX have resembled the lipid chemotype of the native ligand; however, a small number of inhibitors have been described that deviate from this common scaffold. Herein, we report the structure–activity relationships (SAR) of a previously reported small molecule ATX inhibitor. We show through enzyme kinetics studies that analogues of this chemotype are noncompetitive inhibitors, and by using a crystal structure with ATX we confirm the discrete binding mode.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Autotaxin (ATX) is a secreted glycoprotein phosphodiesterase belonging to the ectonucleotide pyrophosphatase and phosphodiesterase family (ENPP).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> ATX mediates the hydrolysis of lysophosphatidylcholine (LPC) <b>1</b> to the ubiquitous bioactive lipid mediator lysophosphatidic acid (LPA) <b>2</b> and choline <b>3</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a><b>2</b> acts on the LPA receptors; a series of G-protein coupled receptors (GPCRs), of which six have been identified to date, termed LPA<sub>1–6</sub>, with an additional three pending the publication of evidence to verify their categorization (GPR87, P2Y10, and GPR35).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Upon binding, a series of intracellular signaling pathways are invoked which could result in a range of cellular functions including differentiation, migration, proliferation, and survival.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Deregulation of the ATX-LPA signaling pathway is implicated in a variety of disease states and could lead to the development of several diseases including vascularization diseases, autoimmune diseases, cancer, fibrotic diseases, inflammation, and neurodegeneration, among others.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10">(5-10)</a> Accordingly, the use of ATX inhibitors has been and continues to be an attractive strategy for therapeutic intervention (for a recent review see Castagna et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. ATX-Mediated Hydrolysis of LPC Releasing LPA: Disease States via LPA Action on the GPCRs LPA<sub>1-6</sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R group = fatty acid chain with varying degrees of unsaturation.</p></p></figure><div class="NLM_p">With respect to the endogenous ligand (<b>1</b>), it is perhaps unsurprising that many of the synthetic ligands developed for ATX have resembled the lipid chemotype: an acidic “head” group linked through a variety of “cores” to a lipophilic “tail” (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>: <b>4</b>, <b>5</b>, <b>6</b>, and <b>7</b>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, a comparatively smaller number of inhibitors have been described that deviate from this common scaffold, for example, PAT-347 (<b>8</b>), reported by PharmAkea Therapeutics.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Lipid-based inhibitors have been previously reported to bind within the catalytic site of ATX and thus compete for the same region that the natural ligand is known to bind;<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> however, a recent report from PharmAkea found the small molecule inhibitor <b>8</b> to be a potent noncompetitive inhibitor of ATX, with a distinct mode of binding remote to the catalytic site.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This compound was noted to have a scaffold similar to our compound of interest, the indole-derived inhibitor <b>9</b> originally reported by Amira Pharmaceuticals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The patent in which <b>8</b> and related analogues are claimed report the IC<sub>50</sub> values in ≤0.5 μM, >0.5 but ≤3 μM, or >3 μM categories;<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> similarly, the patents in which analogues of <b>9</b> are reported also categorize the activities (IC<sub>50</sub> < 300 nM, 0.3–1 μM, or >1 μM).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> From consideration of this data, very little detailed SAR of these nonlipid-like ATX inhibitors can be extracted. On the basis of this, we generated a focused set of 50 analogues to explore the SAR of <b>9</b> in greater detail and to determine the features which contribute to its potency.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lipid-based inhibitors and small molecule inhibitors of ATX: <b>4</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a><b>5</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>6</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><b>7</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>8</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and <b>9</b> (previously reported activity from patent literature).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> FS-3 assay (a); LPC choline release assay (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Herein, we report the design, synthesis, and biological evaluation of our compound collection and describe the main determinants of potency regarding these indole-based compounds. We show that this chemotype has only limited activity in a bis(<i>p</i>-nitrophenol) phosphate (bis-<i>p</i>NPP) based assay; however, by using an LPC choline release assay, a number of potent inhibitors were identified. Analysis of this data, combined with further kinetic studies into the mode of ATX inhibition, has furnished a new insight into the binding site of this chemotype. Furthermore, we report the crystal structure of ATX in complex with an analogue of <b>9</b>, confirming that this chemotype binds in the same discrete binding site identified by PharmAkea in the cocrystal of <b>8</b> with ATX.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> ATX Inhibition Assays</h3><div class="NLM_p">There are a number of in vitro assays that are currently used to evaluate ATX activity; these can be divided into two categories based on the type of substrate the assay utilizes (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The first category employs the natural ligand <b>1</b>, and the second uses unnatural ATX substrates. As depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, ATX hydrolyzes <b>1</b> into <b>2</b> and <b>3</b>, thus the enzyme activity can be determined by quantitative measurement of these products using liquid chromatography–tandem mass spectrometry (LCMS), radiometry, colorimetry, or fluorimetry.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of ATX Inhibition Assays</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">category</th><th class="colsep0 rowsep0" align="center">substrate</th><th class="colsep0 rowsep0" align="center">analysis</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">natural substrate</td><td class="colsep0 rowsep0" align="left">LPC</td><td class="colsep0 rowsep0" align="left">LCMS,<a onclick="showRef(event, 'cit19a'); return false;" href="javascript:void(0);" class="ref cit19a">(19a)</a> radiometry,<a onclick="showRef(event, 'cit19b'); return false;" href="javascript:void(0);" class="ref cit19b">(19b)</a> colorimetry,<a onclick="showRef(event, 'cit19c'); return false;" href="javascript:void(0);" class="ref cit19c">(19c)</a> fluorimetry<a onclick="showRef(event, 'cit19d'); return false;" href="javascript:void(0);" class="ref cit19d">(19d)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unnatural substrate</td><td class="colsep0 rowsep0" align="left"><i>p</i>NP-TMP<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></td><td class="colsep0 rowsep0" align="left">absorbance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">bis-<i>p</i>NPP<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></td><td class="colsep0 rowsep0" align="left">absorbance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CPF4<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></td><td class="colsep0 rowsep0" align="left">FRET</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">FS-3<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></td><td class="colsep0 rowsep0" align="left">fluorescence</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">TG-<i>m</i>TMP<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></td><td class="colsep0 rowsep0" align="left">fluorescence</td></tr></tbody></table></div></div><div class="NLM_p">Of assays based on <b>1</b>, a commonly used method measures the production of <b>3</b> using an enzyme-coupled colorimetric assay:<a onclick="showRef(event, 'cit19c'); return false;" href="javascript:void(0);" class="ref cit19c">(19c)</a> choline oxidase converts <b>3</b> into betaine <b>10</b> and hydrogen peroxide, and then horseradish peroxidase (HRP) utilizes the hydrogen peroxide to oxidize a coloring substrate into its chromophoric state (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). There is a risk of false positives associated with this assay as the molecules under analysis may inhibit the enzymes used in the coloring reactions;<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> however, control reactions can be employed to reveal any interference.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0016.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. ATX-Mediated Choline Release Colorimetric Assay for ATX Inhibition<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R group = fatty acid chain with varying degrees of unsaturation.</p></p></figure><div class="NLM_p">Accordingly, assays that employ synthetic substrates can appear to be advantageous over the LPC choline release assay as they do not require the use of these additional enzymes. There are a number of unnatural substrates widely used, including the nucleotide thymidine 5′monophosphate <i>p</i>-nitrophenyl ester (<i>p</i>NP-TMP),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> the Förster resonance energy transfer (FRET) ligand CPF4,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> the fluorogenic substrate 3 (FS-3),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and the fluorescence probe Tokyo Green <i>m</i>-thymidine monophosphate (TG-<i>m</i>TMP).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A particularly widely used method employs the unnatural substrate bis(<i>p</i>-nitrophenyl) phosphate (bis-<i>p</i>NPP) <b>11</b>. ATX catalyzes the hydrolysis of <b>11</b> to release 4-nitrophenol <b>12</b> which, with an absorbance of 405 nm, is readily detected using colorimetry (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The popularity of this assay can be attributed to the low cost of this substrate and the direct readout the assay provides.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0017.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. ATX-Mediated Hydrolysis of Bis-<i>p</i>NPP <b>11</b> Releasing 4-Nitrophenol <b>12</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The recent report from PharmAkea Therapeutics described four structurally distinct ATX inhibitors that showed good inhibition using the LPC choline release assay but significantly lower potency when tested using the bis-<i>p</i>NPP or FS-3 substrates.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The differences in data sets of the three assays used were found to be a result of alternative binding modes within ATX, which was confirmed by crystallographic data identifying proximal binding sites. As stated above, these compounds were noted to have a scaffold similar to our compound of interest, the indole-derived inhibitor <b>9</b> originally reported by Amira Pharmaceuticals. In the choline release assay employed by Amira Pharmaceuticals, <b>9</b> is claimed to show an IC<sub>50</sub> of <300 nM, however, no further detail was given.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In addition, <b>9</b> was reported to have activity in a mouse air pouch assay, collagen-induced arthritis, a rat model of neuropathic pain, and in lung melanoma metastasis, although the efficacy of <b>9</b> in these assays was not disclosed. Herein, we report that <b>9</b> and related analogues were found to display only limited activity in the bis-<i>p</i>NPP assay; however, by using the LPC choline release assay a number of efficient inhibitors were identified, with IC<sub>50</sub> values ranging from 4 nM to >30 μM for the complete series. The disconnect observed between the two assay data sets for this chemotype was hypothesized to be due to an alternative binding mode remote to the catalytic site. We report enzyme kinetic studies and a cocrystal structure of ATX with an analogue of <b>9</b> to support this alternative binding site. Furthermore, we also report the exploration of the SAR associated with this chemotype.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Molecule Design</h3><div class="NLM_p">Using the limited data available, the key structural motifs of <b>9</b> were suspected to be (i) the chloro substitution at the 6-position of the indole, (ii) the substitution of the indole nitrogen, and (iii) the thiopyridine carboxylic acid. From this analysis, we were able to infer the initial SAR shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. In the current study, we aimed to probe this emerging SAR further, to test our observations, and to more completely establish the contribution of each of these principal structural motifs toward potency through the synthesis and biological evaluation of a series of analogues.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of indole <b>9</b> extracted from data reported by Amira Pharmaceuticals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The first region of interest was the 6-Cl substitution of the indole ring. Analysis of the patent data had suggested this was an important region of the molecule, with changes to substituent or position on the ring having a direct effect on the activity observed. To explore this relationship in greater depth, a series of compounds were designed with alternative chloro regiochemistry as well as removal or exchange of the chloro for alternative functional groups. Three alternatives were chosen to determine the optimal size and nature of the substituent: fluoro, methoxy, and methyl. The second region to be modified was at the <i>N</i>-1 position of the indole ring. The <i>N</i>-methyl pyrazole was replaced with a phenyl ring, cyclopentyl, and methyl to explore the tolerance of this region for a less polar aromatic ring as well as aliphatic groups. Finally, the thiopyridine carboxylic acid was modified, with changes made to the linker and the nature of the aromatic ring. The previously reported data in the patent literature contained little SAR around the linker area of the compound and therefore we were interested in converting the thioether to an ether or methylene linker, as well as exploring the difference between pyridyl and phenyl analogues.</div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">The known ATX inhibitor indole <b>9</b> was prepared as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Starting from ketone <b>13</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> the indole was synthesized using a Fischer synthesis as previously reported, either according to or modified from literature procedures.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This reaction produced a mixture of the 4-Cl and 6-Cl substituted indoles, which were successfully separated on silica to isolate the desired 6-Cl regioisomer <b>16</b> as the major product. The 4-Cl analogue <b>14</b> was also carried through the synthesis as part of the SAR study around the indole substitution. Introduction of the 1-methyl-pyrazole substitution to the indole nitrogen proved to be challenging, requiring harsh conditions and long reaction times during which partial hydrolysis of the ester occurred. As a result, the substitution reaction was telescoped into the final step to fully hydrolyze the ester and produce the desired acid <b>9</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0018.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Amira Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>t</i>BuOH, 3-chlorophenylhydrazine hydrochloride, reflux, (ii) HCl, AcOH; (b) 2 M aq NaOH, THF, RT; (c) 4-iodo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C.</p></p></figure><div class="NLM_p">Initial syntheses followed the reported methods from the Amira Pharmaceuticals patents to produce the desired indole <b>16</b> in good yield (71%, see <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). However, in the exploration of this key step, it was discovered that a number of the Fischer indole reactions proceeded by refluxing the ketone with the respective hydrazine hydrochloride in EtOH without an additional acid catalyst (see <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>). The synthesis of analogues in which the chloro was exchanged for an alternative functionality (F, OMe, and Me) was achieved using the same synthetic strategy employed in the synthesis of compound <b>9</b>. Using this synthetic route, the analogues described in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> were accessed. Unfortunately, synthesis of the 7-Cl analogue with the 1-methyl-pyrazole <i>N</i>-substituent was not achieved, as efforts to introduce the 1-methyl-pyrazole were unsuccessful.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0003.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Substitution on the indole ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The next series was designed to investigate the SAR associated with the 1-methyl-pyrazole substituent on the indole nitrogen. In place of the 1-methyl-pyrazole, three alternative substituents were used: methyl, cyclopentyl, and phenyl. The aliphatic substituents were introduced by an alkylation reaction using the corresponding alkyl halide and NaH (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0019.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>t</i>BuOH, phenylhydrazine hydrochloride, reflux, (ii) HCl, AcOH; (b) NaH, MeI, THF, reflux; (c) 2 M aq NaOH, THF, RT.</p></p></figure><div class="NLM_p">Following the alkylation step, hydrolysis of the corresponding ester revealed the desired carboxylic acid. The phenyl substituent was introduced using an alternative Ullmann coupling, and the 1-methyl-pyrazole was introduced using the conditions described previously. Using these approaches, the analogues described in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> were successfully synthesized.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0004.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Substitution on the indole nitrogen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The benzoic acid compounds were synthesized in a similar way to the pyridyl series with an additional step to introduce the ester functionality using a methoxycarbonylation reaction (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). From this intermediate, the desired alkyl or aryl <i>N</i>-substituent was introduced, followed by hydrolysis to gain the desired acid <b>47</b> in the final step of the synthesis. The ester <b>46</b>, and its deschloro counterpart <b>92</b> (not shown, see <a class="ref internalNav" href="#sec3" aria-label="experimental section">experimental section</a>), then allowed access to the analogues described in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>.</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0020.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>45</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chloroacetone, DIPEA, MeCN, reflux; (b) 3-chlorophenylhydrazine hydrochloride, EtOH, reflux; (c) Herrmann’s catalyst, Mo(CO)<sub>6</sub>, [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub>, DBU, MeOH/MeCN (1:4), 70 °C; (d) NaH, MeI, THF, reflux; (e) 2 M aq NaOH, THF, RT.</p></p></figure><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0005.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Substitution on the indole nitrogen, benzoic acid analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The oxygen-linked benzoic acid subset (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) were synthesized using the Fischer indole reaction that was employed with previous analogues (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Efforts to synthesize the corresponding ether linked pyridyl compounds were unsuccessful (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0021.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>59</b>–<b>62</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chloroacetone, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) phenylhydrazine hydrochloride, EtOH, reflux; (c) 2 M aq NaOH, THF, RT; (d) 4-bromo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C.</p></p></figure><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0006.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ether linked analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To access the methylene linked compounds, an alternative synthetic strategy was required as efforts to employ a Fischer indole synthesis were unsuccessful. It was discovered that by reordering the synthetic steps to install the 1-methyl-pyrazole at an earlier stage, the <i>N</i>-substitution proceeded in a much improved yield than the late stage introduction used in previous syntheses (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). A two-step alkylation of <b>66</b> using 6-bromopicolinaldehyde afforded the desired methylene linker in good yield. From the bromo intermediate <b>97</b> (not shown), the ester functionality was introduced via a methoxycarbonylation reaction to give <b>67</b>, followed by hydrolysis to reveal the desired acid <b>68</b>. Thus, this strategy was used to access the remaining compounds in this series (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div><figure id="sch8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0022.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compounds <b>66</b>–<b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-bromo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C; (b) (i) 6-bromopicolinaldehyde, CH<sub>2</sub>Cl<sub>2</sub>, (ii) Et<sub>3</sub>SiH, TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) Herrmann’s catalyst, Mo(CO)<sub>6</sub>, [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub>, DBU, MeOH/MeCN (1:4), 70 °C; (d) 2 M aq NaOH, THF, RT.</p></p></figure><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0007.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Methylene linked analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the importance of the indole core, this motif was removed and compound <b>75</b> was prepared featuring a phenyl at its center but retaining the 1-methyl-pyrazole motif. This compound was obtained from the commercial carboxylic acid <b>72</b> in four steps (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>). This required an alternative strategy, using a Suzuki–Miyaura reaction to introduce the 1-methyl-pyrazole via the coupling of <b>74</b> with 1-methylpyrazole-4-boronic acid pinacol ester.</div><figure id="sch9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0023.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Analogue <b>75</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) conc H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux; (b) 4-bromothiophenol, DMF, 45 °C; (c) 1-methylpyrazole-4-boronic acid pinacol ester, K<sub>3</sub>PO<sub>4</sub>, Pd(OAc)<sub>2</sub>, SPhos, THF/H<sub>2</sub>O (7:1), 50 °C; (d) 2 M aq NaOH, THF, RT.</p></p></figure><div class="NLM_p">The final deletion analogue was designed to remove one of the aromatic rings from the compound and replace it with an aliphatic carboxylic acid (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>). Starting from 4-bromobutyric acid <b>76</b>, the thiol group was introduced by an <i>S</i>-alkylation of thiourea, which was subsequently hydrolyzed in situ to form the primary thiol <b>77</b>. This was then followed by a second alkylation using chloroacetone to access the Fischer indole precursor <b>78</b>. With <b>79</b> in hand, the 1-methyl-pyrazole was introduced at the indole nitrogen (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>). This route was also employed to access the 6-Cl analogue <b>81</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).</div><figure id="sch10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0024.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Aliphatic Carboxylic Acid Analogue <b>80</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thiourea, EtOH, reflux; (b) chloroacetone, DIPEA, THF, RT; (c) phenylhydrazine hydrochloride, EtOH, reflux; (d) 4-bromo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C.</p></p></figure><figure id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0008.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Aliphatic acid analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To evaluate our compound library, the first screen was performed using the bis-<i>p</i>NPP assay. This was selected based on its broad application throughout the ATX literature.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> An initial screen was carried out using 30 μM of inhibitor allowing a rapid evaluation of the compounds. The criteria of >60% inhibition was set for a compound to be termed active and therefore progressed to further testing. On the basis of this initial survey of the activity of Amira compound <b>9</b> along with the 49 analogues in the bis-<i>p</i>NPP assay, we identified 10 potential inhibitors, including the patent compound <b>9</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>). These 10 compounds were tested again in the bis-<i>p</i>NPP assay using a concentration range of 30 nM to 30 μM inhibitor to determine the IC<sub>50</sub> for each of these compounds. Using the bis-<i>p</i>NPP assay, the Amira ATX inhibitor <b>9</b> was found to have an IC<sub>50</sub> of 22 nM, which was consistent with the value of <300 nM claimed in the patent (LPC choline release assay);<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> however, the IC<sub>50</sub> values observed in this set ranged from 22 nM to >30 μM (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These results demonstrated that our first screen at an inhibitor concentration of 30 μM had not been a reliable indicator of activity. Importantly, on further inspection of the dose response curves (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), it was noted that when using the bis-<i>p</i>NPP assay, compound <b>9</b> showed only 66% maximal inhibition of ATX at 30 μM (34% hydrolysis of <b>11</b>), indicating that this analogue was not fully inhibiting the ATX hydrolysis of <b>11</b>, potentially implying a discrete binding mode compared to that of the artificial substrate.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Bis-<i>p</i>NPP and LPC Assay Results<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Bis-<i>p</i>NPP IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">LPC IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">22 ± 6.9</td><td class="colsep0 rowsep0" align="center">4 ± 0.5<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">604 ± 113</td><td class="colsep0 rowsep0" align="center">25 ± 13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">>20 μM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">>8000<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="center">5700 ± 2500</td><td class="colsep0 rowsep0" align="center">1700 ± 400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">258 ± 127</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">>3500<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="center">816 ± 564</td><td class="colsep0 rowsep0" align="center">349 ± 125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">>10 μM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="center">85 ± 22</td><td class="colsep0 rowsep0" align="center">25 ± 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="center">75 ± 37</td><td class="colsep0 rowsep0" align="center">124 ± 37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="center">>4000<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">31 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="center">2000 ± 785</td><td class="colsep0 rowsep0" align="center">>2800<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">100 ± 36</td><td class="colsep0 rowsep0" align="center">1200 ± 800<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">290 ± 35</td><td class="colsep0 rowsep0" align="center">747 ± 500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">>4000<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">>20 μM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">5 ± 2.5</td><td class="colsep0 rowsep0" align="center">81 ± 28<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">11 ± 7<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="center">>30 μM</td><td class="colsep0 rowsep0" align="center">>5000<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="center">204 ± 88</td><td class="colsep0 rowsep0" align="center">726 ± 155</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="center">89 ± 43</td><td class="colsep0 rowsep0" align="center">339 ± 190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="center">33 ± 16</td><td class="colsep0 rowsep0" align="center">660 ± 224</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">>10 μM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All tested from 0.3 nM – 10 μM, 10 point curves, <i>n</i> = 2.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Consistent with the value of <300 nM claimed in the patent, LPC assay.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Incomplete curve observed.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Unable to determine IC<sub>50</sub> due to solubility issues in the assay medium.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Consistent with the value of >1 uM claimed in the patent, LPC assay.</p></div></div></div><figure id="fig9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0009.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Testing of <b>9</b> in the bis-<i>p</i>NPP assay from 30 nM to 30 μM of inhibitor. Dashed line indicates 60% inhibition criteria of initial screen. Control reactions confirmed there was no hydrolysis of <b>11</b> in the absence of ATX (data not shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A further 20 analogues were tested in the bis-<i>p</i>NPP assay, confirming that partial inhibition was a consistent feature associated with this series (data not shown, see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>). Although the bis-<i>p</i>NPP assay has many advantages, there are risks associated with the use of unnatural substrates if the binding interactions with the target enzyme are dissimilar to those of the natural substrate. There are a number of reported examples where misleading results were observed when using ATX assays that employ the unnatural ligands FS-3, CPF4, and <i>p</i>NP-TMP.<a onclick="showRef(event, 'ref17 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref17 ref25 ref26">(17, 25, 26)</a> The authors concluded that the discrepancies in assay data sets were the result of the inhibitor compounds and assay substrates binding to different regions of ATX. It has been well documented that the active site of ATX features three key regions with which small molecule inhibitors can interact: the catalytic site, the hydrophobic pocket, and the tunnel.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> Comparing the likely binding of the unnatural substrate <b>11</b> with that of ATX in complex with <b>2</b>, it is noted that while both bind at the catalytic site, the acyl chain of <b>2</b> shows additional extensive interactions with the hydrophobic pocket (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). This suggests that it is possible for small molecules to bind outside the catalytic site without inhibiting, or only partially inhibiting, the hydrolysis of <b>11</b>, potentially resulting in false negative results in the bis-<i>p</i>NPP ATX assay.</div><figure id="fig10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0010.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Three binding sites of ATX: catalytic site, hydrophobic pocket, and tunnel. Complex of LPA 14:0 (red) in mouse ATX (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NKN">3NKN</a>) with the docked position of bis-<i>p</i>NPP <b>11</b> (green) overlaid. Docked using GOLD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and viewed using Discovery Studio Visualizer.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Indeed, the noncompetitive inhibitor <b>8</b> from PharmAkea, which shares a number of structural similarities to <b>9</b>, has been reported to bind an allosteric site within the tunnel.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The authors observed that <b>8</b> inhibited the hydrolysis of <b>1</b> but not of <b>11</b>, showing that an inhibitor binding within the tunnel may not be detected using the bis-<i>p</i>NPP assay. Moreover, selected steroid analogues have recently been shown to bind the same site, with the activity of ATX in hydrolyzing LPC allosterically inhibited but not its activity on <i>p</i>NP-TMP.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> These reports led us to employ the natural substrate <b>1</b> in the LPC choline release assay to further evaluate our inhibitors, gain a more complete understanding of the underlying SAR, and offer insight into potential binding modes. Prior to testing the inhibition of ATX, a control reaction was run using three exemplar compounds to ensure that there was no incompatibility with the two coupling enzymes used in the assay: choline oxidase and HRP. Using choline chloride as the substrate, no inhibition was observed for the latter two reactions of the LPC assay, as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>). Testing proceeded with an initial screen of all 50 compounds from 400 nM to 100 μM to identify active inhibitors. From this data set, compounds that exhibited an IC<sub>50</sub> < 1 μM were tested further across a concentration gradient of 0.3 nM to 10 μM, and the IC<sub>50</sub> values were determined (compounds with IC<sub>50</sub> > 30 μM not shown, see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>). This assay provided us with robust inhibition data, with the more potent compounds showing full inhibition of ATX. Of the 50 analogues described in the current study, only four had been previously reported by Amira Pharmaceuticals (<b>9</b>, <b>47</b>, <b>51</b>, and <b>52</b>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The IC<sub>50</sub> values determined in our LPC choline release assay were consistent with the values claimed in the patents (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). It is also important to note that substrate concentration can affect the IC<sub>50</sub> value observed in an assay; for competitive assays such as bis-<i>p</i>NPP and the LPC choline release assay, the substrate concentration should be less than, or equal to, the Michaelis–Menten constant (<i>K</i><sub>M</sub>) for the given substrate.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The biological evaluations detailed in this current study were carried out using substrate concentrations equal to the <i>K</i><sub>M</sub> values of <b>1</b> (∼150 μM) and <b>11</b> (∼1 mM) for ATX previously reported by van Meeteren et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div id="sec1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Structure–Activity Relationship</h3><div class="NLM_p">Using the results from the LPC assay, we were able to define the SAR around this chemotype and provide a better understanding of the features which contribute to its potency. During our examination of the patent data, it became apparent that the 6-Cl of compound <b>9</b> was of high importance to the potency. The deletion analogue <b>75</b>, in which the indole was removed with a phenyl ring used as the core, had resulted in a complete loss of activity (data not shown, see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>), thus confirming the importance of the indole core. To investigate the SAR of the 6-Cl substitution on the indole, a series of analogues were made by varying the position of the chloro around the benzenoid ring as well as removing the substituent (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). We also aimed to explore the significance of the chloro by exchanging this for alternative functionalities: F, OMe, and Me. The effect of this chloro on potency was apparent throughout our results, with its presence increasing the potency in every example. It was also identified that the 6-position of the indole ring was optimal for the chloro, with the other regioisomers resulting in lowered or a complete loss of activity (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). This can be noted in the comparison of compounds <b>9</b>, <b>18</b>, and <b>29</b>, with the movement of the chloro substituent around the indole ring.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Indole Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0025.gif" alt="" id="GRAPHIC-d398e1802-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (LPC)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1700 ± 400 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="center">258 ± 127 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="center">4 ± 0.5 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="center">>3 μM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="center">349 ± 125 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="center">>10 μM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">6-Me</td><td class="colsep0 rowsep0" align="center">25 ± 12 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="center">124 ± 37 nM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Incomplete curve observed.</p></div></div></div><div class="NLM_p">To rationalize the effect of the 6-Cl, docking studies were performed using the apo form of the ATX enzyme. From this work, it was proposed that the 6-Cl projects into a nearby hydrophobic cleft (Leu160, Ala164, Trp207, and Trp161), making a series of hydrophobic interactions (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>B). The 6-Cl substituent is a vital motif for potency throughout this chemotype, therefore we hypothesize that the hydrophobic interactions of this substituent with the hydrophobic cleft are key contributors to the potency. It was possible to exchange the 6-Cl for alternative substituents (F, <b>31</b>; Me, <b>33</b>; OMe, <b>35</b>) and retain the activity, although the chloro was optimal. On the basis of our in silico model, a conclusion was drawn that the 6-Cl substituent provides the optimal size to fit within the hydrophobic pocket with a larger (Me, <b>33</b>) or smaller (F, <b>31</b>) substituent, resulting in a loss of potency.</div><figure id="fig11" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0011.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. In silico studies created using cocrystal of ATX with <b>2</b> and <b>8</b> PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZG7">4ZG7</a>. (A) Model of <b>51</b> (yellow) overlaid with cocrystal of <b>8</b> (colored by atom type) and ATX, with <b>2</b> residing in the catalytic site and hydrophobic pocket. (B) Model of ATX with <b>9</b> highlighting possible interactions. (C) Shift observed when 4-Cl substituted <b>18</b> is docked (yellow) vs 6-Cl substituted <b>9</b> (colored by atom type). Docked using GOLD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and viewed using Discovery Studio Visualizer<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moving these alternative substituents from the 6- to the 4-position of the indole resulted in loss of activity, providing further support to the importance of the 6-position. It was noted that with no substituent on the indole some weak activity was observed with an IC<sub>50</sub> of 1700 nM for compound <b>28</b>; however, introduction of a substituent to the 4-position resulted in loss of activity (<b>18</b>, <b>32</b>, and <b>34</b>), with the exception of the 4-F which is tolerated (<b>30</b>), showing that substitution at this position prevents binding of these compounds. Using our in silico model, we suggest that a clash between the 4-position substituents and a nearby residue (Phe157) alters the binding of these analogues (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>B). This shift in the binding position caused by the clash with the protein could explain the loss in potency observed when a substituent is introduced to the 4-position.</div><div class="NLM_p">The next region to be explored was the substitution on the indole nitrogen. To establish whether the aromatic substituent was required for activity, and if the size of the substituent was important, three alternative substituents were used in place of the 1-methyl-pyrazole: methyl, cyclopentyl, and phenyl. Analogues with the unsubstituted indole were also synthesized to determine whether any substituent at this region was required for activity. On the basis of the patent data, the 1-methyl-pyrazole is important for activity and removal of this substituent did result in a reduction in potency; however, compound <b>17</b> with no decoration of the indole nitrogen was a potent compound with an IC<sub>50</sub> of 25 nM. Further analogues exploring the substitution of the indole nitrogen (methyl, cyclopentyl, phenyl) found that the 1-methyl-pyrazole remained the most active (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Unfortunately, we were unable to determine the IC<sub>50</sub> of compound <b>42</b> due to poor solubility in the assay medium observed during the screening of this analogue. Our binding model had indicated possible π–π interactions for the 1-methyl-pyrazole of <b>9</b> with nearby residues (Trp207, pyrazole face to indole edge; Phe221, face to face). By changing the 1-methyl-pyrazole to an aliphatic substituent these interactions are lost, thus resulting in a loss of activity. The methyl group of <b>40</b> was well tolerated, whereas the cyclopentyl substituent of <b>41</b> was found to cause a large drop in potency. These results suggest that the larger aliphatic substituent is detrimental, either through unfavorable interactions or by clashing with the protein; however, we did not observe either from consideration of our binding model.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Indole Nitrogen Substituent, with 6-Cl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0026.gif" alt="" id="GRAPHIC-d398e2043-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (LPC)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">1-methyl-pyrazole</td><td class="colsep0 rowsep0" align="center">4 ± 0.5 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">25 ± 13 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">31 ± 11 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="center">>2800 nM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1-methyl-pyrazole</td><td class="colsep0 rowsep0" align="center">1700 ± 400 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">1-methyl-pyrazole</td><td class="colsep0 rowsep0" align="center">11 ± 7 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">747 ± 500 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">1200 ± 800 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="center">>25 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="center">81 ± 28 nM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Unable to determine due to solubility issues in the assay medium.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Incomplete curve observed.</p></div></div></div><div class="NLM_p">The relationship between the 1-methyl-pyrazole and the 6-Cl was highlighted by altering the substitution of the indole nitrogen in a series of compounds that did not feature the 6-Cl substitution. In this series of analogues (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), only one compound exhibited weak activity, which was the 1-methyl-pyrazole <b>28</b>, thus showing that either the 6-Cl or the 1-methyl-pyrazole must be present for activity; however, the 6-Cl substituent has the most profound effect on activity.</div><div class="NLM_p">This series of compounds was explored further via the synthesis of the analogous series with the nitrogen removed from the pyridine ring, thus allowing for the SAR of the pyridyl acid and the phenyl to be determined. The benzoic acid analogues demonstrated the same SAR as the pyridyl subseries, with the 1-methyl-pyrazole (<b>52</b>) giving the best inhibition (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Fortunately, compound <b>51</b> showed good solubility in the assay medium, allowing for the IC<sub>50</sub> to be determined at 81 nM, unlike the pyridyl analogue <b>42</b> with which we had observed poor solubility during screening in the LPC assay. This set of analogues additionally supports our observation from the data in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>: that it is beneficial to have a substituent of aromatic nature on the indole nitrogen, and although a cyclopentyl is unfavorable (<b>50</b>), smaller aliphatic groups can be tolerated (<b>47</b>).</div><div class="NLM_p">The acidic group of this chemotype was also found to be vital for ATX activity, as shown by the two deletion analogues in which the thioether linked pyridine was removed (<b>66</b>) or exchanged for an aliphatic acid (<b>81</b>) which resulted in loss of activity (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). During our docking studies of <b>9</b>, it was noted that both the indole ring and the 1-methyl-pyrazole substituent could potentially contribute to binding through π–π interactions; however, with the pyridyl acid oriented toward the solvent it made no specific interactions with ATX, and only a potential H-bonding interaction with a crystallographic water molecule was identified. The loss of activity observed with <b>66</b> and <b>81</b> could indicate that the aromaticity is required for additional interactions not identified in our docking study or that the increased number of rotatable bonds was unfavorable in the binding of this compound within ATX. By comparing the benzoic acid compound <b>52</b> with the corresponding pyridyl analogue <b>9</b>, we observed no significant change in potency with removal of the pyridyl nitrogen; however, by comparing matched pair examples with <i>N</i>-substituents other than the 1-methyl-pyrazole, it can be noted that the pyridine in general improves potency (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of the Carboxylic Acid Region</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0027.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0028.gif" alt="" id="GRAPHIC-d398e2361-autogenerated" /></img><div></div></div><div class="NLM_p">The thioether linker was then explored through replacement with an ether or a methylene. Previous reports from the patent literature had disclosed no analogues with the methylene, and only five with an ether linker, thus we sought to fill the SAR gap with a set of analogues using an ether and methylene with both the pyridyl and benzoic acids. A large drop in potency was observed as a result of changing the thioether (<b>9</b>) to a methylene spacer (<b>68</b>). We also noted this trend in the benzoic acid analogues with the thioether (<b>52</b>) being superior to an ether (<b>64</b>) or methylene (<b>69</b>) linker, although both alternatives were tolerated (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Our docking model provided little insight into the effects of changing the linker (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>); thus we hypothesize that the longer bond lengths of the thioether are beneficial to the binding of this chemotype. Furthermore, this subset again demonstrates the importance of the 6-Cl for activity and the superiority of the pyridyl analogues over the corresponding phenyl analogues.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR of the Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0029.gif" alt="" id="GRAPHIC-d398e2393-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (LPC)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="center">1700 ± 400 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="center">4 ± 0.5 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="center">11 ± 7 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="center">726 ± 155 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="center">339 ± 190 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="center">>30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="center">660 ± 224 nM</td></tr></tbody></table></div></div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Mechanistic Studies</h3><div class="NLM_p">To explore the potential binding mode of this chemotype, enzyme kinetic studies were carried out in the presence of four representative inhibitors: compounds <b>9</b>, <b>17</b>, <b>47</b>, and <b>51</b>. ATX activity for varying substrate concentrations (<b>1</b>) was measured in concentrations of each inhibitor. A mixed inhibition mathematical model was fitted to the original data to determine the value of α; values of α close to 1 indicate noncompetitive inhibition.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To graphically demonstrate the inhibition mode, we also present Lineweaver–Burk double reciprocal plots (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). These studies show that as the inhibitor concentration was increased, the <i>V</i><sub>max</sub> reduced but the <i>K</i><sub>M</sub> remained unchanged, which is indicative of noncompetitive inhibition. Consistently, the values of α for each of the compounds ranged between 0.6 and 2.6, characteristic of noncompetitive inhibition. Thus, all four exemplar compounds are strongly noncompetitive inhibitors. This data, along with the differences observed between the two ATX inhibition assays used, suggests that this chemotype has a distinct binding mode remote to that of the catalytic site of ATX, similar to that reported for the three noncompetitive PharmAkea compounds.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig12" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0012.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Enzyme kinetic studies using compounds <b>9</b>, <b>28</b>, <b>47</b>, and <b>51</b>. Compound <b>9</b>: α = 0.8.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>28</b>: α = 0.6. Compound <b>47</b>: α = 2.6. Compound <b>51</b>: α = 2.2. The data were plotted and the best fit values generated using GraphPad Prism 6 from nonlinear regression analysis to an equation corresponding to the mixed inhibition model allowing the determination of α. The constant “α” defines the effect of an inhibitor binding has on the affinity of the enzyme for the substrate; a value close to 1 is indicative of noncompetitive inhibition.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Crystallographic Data</h3><div class="NLM_p">To confirm the binding mode of this chemotype, the cocrystallization of a number of the inhibitors described herein with ATX was undertaken. Unfortunately, efforts to obtain a crystal structure of the most potent inhibitor <b>9</b> with ATX were unsuccessful; however, the cocrysallization of <b>51</b> (IC<sub>50</sub> = 81 ± 28 nM) with ATX was successful and the structure of this complex determined to 2.4 Å resolution, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQQ">5LQQ</a>. After molecular replacement and model adjustment difference, electron density in the tunnel close to the hydrophobic pocket could be observed, and compound <b>51</b> could be modeled in the difference density map. The docked position of <b>51</b> in our previously described in silico model with ATX (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) was found to be consistent with the binding mode observed in the cocrystal of <b>51</b> and ATX (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>).</div><figure id="fig13" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0013.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQQ">5LQQ</a>) vs docking model of <b>51</b> with ATX. Cocrystal structure of <b>51</b> (colored by atom type) overlaid with docking model of <b>51</b> (yellow). Docked using GOLD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and viewed using Discovery Studio Visualizer<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The thioether, indole, and <i>N</i>-phenyl are very clear in the electron map; however, the benzoic acid is not well resolved, possibly due to disorder (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a> for density map). This structure allowed us to locate the binding mode of this chemotype and confirm a number of key binding interactions (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>).</div><figure id="fig14" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0014.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Crystallographic data of <b>51</b> with ATX. (A) <b>51</b> bound within the tunnel, remote from the catalytic site. (B) Stick and ball model of <b>51</b>. (C) Ligand display for interaction and analysis (LIDIA) graph of <b>51</b>. Model and LIDIA graph built using COOT.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Images created using CCP4MG.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>51</b> binds in a very similar pose compared to the PharmAkea inhibitor <b>8</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZG7">4ZG7</a>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> which shares a number of structural similarities to analogue <b>51</b>. The placement of the thioether and indole moieties is nearly identical in the two structures, while the phenyl of <b>51</b> overlaps well with the cyclopropyl-dihydroindole in <b>8</b>. The 6-Cl substituent, shown to be vital for potency in our SAR studies, resides in a hydrophobic cleft, resulting in a series of interactions to nearby residues (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>B). Both the indole ring and the <i>N</i>-phenyl substituent contribute to binding with a number of π–π interactions; however, the benzoic acid (<b>51</b>) appears to make few discernible interactions with ATX as it is orientated toward the solvent. In the case of compound <b>8</b>, however, the fluoro-benzoic acid makes interactions with the main chain amide of Val278, a well-ordered glycerol molecule, and a crystallographic water molecule (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>) and is thus very well-defined in a single conformation in the electron density map. This is in sharp contrast to the benzoic acid in <b>51</b> that is clearly disordered, which suggests that the fluoro substituent of the benzoic acid ring may help to order it in a defined position within the tunnel. Alternatively, the presence of the phospholipid (<b>2</b>) in the structure of <b>8</b> bound to ATX, but not present in our structure with <b>51</b>, may help order this ring system. Docking studies result in an excellent overlay of <b>51</b> with <b>8</b> as expected, but the benzoic acid moiety was able to rotate around the thioether and project in a number of different vectors (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>). The disorder observed of the benzoic acid in the cocrystal structure of <b>51</b> with ATX supports the hypothesis that the thioether has rotational freedom.</div></div><div id="sec1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Physicochemical Properties</h3><div class="NLM_p">ATX inhibitors that resemble the natural ligand have high molecular weight (MW) and high log <i>D</i>, resulting in poor drug discovery potential. We were interested in the Amira compound <b>9</b>, not only due to its unique nonlipid chemotype but also because of its lower MW and improved lipophilicity it is potentially a more druglike inhibitor. With this in mind, we evaluated some key physicochemical properties as well as potency for a selected number of the analogues synthesized. <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a> details the physicochemical properties of the analogues in which the indole nitrogen substituent was varied (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a> for further properties measured). Compounds <b>9</b>, <b>17</b>, and <b>40</b> all showed good ligand efficiency in terms of both ligand efficiency index (LEI) and lipophilic ligand efficiency (LLE); however, the introduction of the pyrazole in compound <b>9</b> improves both potency and LLE.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Physicochemical Properties of Indole Nitrogen Substituent Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0030.gif" alt="" id="GRAPHIC-d398e2827-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">MW</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">soln<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub><a class="ref internalNav" href="#t7fn3" aria-label="c">c</a> (nm s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">LEI<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">LLE<a class="ref internalNav" href="#t7fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">1-methyl-pyrazole</td><td class="colsep0 rowsep0" align="char" char=".">399</td><td class="colsep0 rowsep0" align="char" char=".">2.70</td><td class="colsep0 rowsep0" align="char" char=".">377</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="center">4 nM</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">319</td><td class="colsep0 rowsep0" align="char" char=".">2.19</td><td class="colsep0 rowsep0" align="char" char=".">≥395</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="center">25 nM</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">333</td><td class="colsep0 rowsep0" align="char" char=".">2.68</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="center">31 nM</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="char" char=".">386</td><td class="colsep0 rowsep0" align="char" char=".">4.05</td><td class="colsep0 rowsep0" align="char" char=".">336</td><td class="colsep0 rowsep0" align="char" char=".">290</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="center">>2800 nM</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">395</td><td class="colsep0 rowsep0" align="char" char=".">4.30</td><td class="colsep0 rowsep0" align="char" char=".">485</td><td class="colsep0 rowsep0" align="char" char=".">155</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t7fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">log <i>D</i>, Chrom log <i>D</i> at pH 7.4.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Chemiluminescent nitrogen detection (CLND) kinetic aqueous solubility assay.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last"><i>P</i><sub>app</sub> permeability pH 7.4 assay.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Topological polar surface area (PSA) determined using JChem for Office (Excel) 16.3.2100.656, 2008–2016, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">IC<sub>50</sub> in LPC choline release assay.</p></div><div class="footnote" id="t7fn6"><sup>f</sup><p class="last">Ligand efficiency index, LEI = pIC<sub>50</sub>/HA, where HA denotes the number of non-hydrogen atoms.</p></div><div class="footnote" id="t7fn7"><sup>g</sup><p class="last">Lipophilic ligand efficiency, LLE = pIC<sub>50</sub> – log <i>D</i>.</p></div><div class="footnote" id="t7fn8"><sup>h</sup><p class="last">Unable to determine due to solubility issues in the assay medium.</p></div></div></div><div class="NLM_p">As expected, the compounds with the more lipophilic <i>N</i>-substituents, cyclopentyl (<b>41</b>) and phenyl (<b>42</b>), had increased log <i>D</i><sub>7.4</sub>, lowered PSA, and increased permeability. All the analogues in this series had reasonable aqueous solubility when measured using a high throughput screening solubility assay, including compound <b>42</b>, with which we had observed poor solubility in the assay medium. By comparing compounds <b>9</b> and <b>52</b>, we were able to determine the effects that the pyridine ring has on the physicochemical properties of this chemotype (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Although the activities and the LEI values of these two analogues are comparable, the lower log <i>D</i><sub>7.4</sub> of <b>9</b> improves the LLE, giving it an excellent LLE value of 6. At first glance this can make <b>9</b> appear to be a more attractive molecule; however, the introduction of the pyridine increases the PSA and lowers permeability of <b>9</b>, and thus <b>52</b> is perhaps the more attractive analogue. In particular, <b>52</b> has significantly improved solubility and permeability compared to the progenitor pyridine system <b>9</b>. This is not associated with any significant reduction in potency against ATX, as evidenced by the essentially conserved ligand efficiency value.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Physicochemical Properties of Benzoic Acid vs Pyridyl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0031.gif" alt="" id="GRAPHIC-d398e3131-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">MW</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">soln<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a> (nm s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t8fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">LEI<a class="ref internalNav" href="#t8fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">LLE<a class="ref internalNav" href="#t8fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">399</td><td class="colsep0 rowsep0" align="char" char=".">2.70</td><td class="colsep0 rowsep0" align="char" char=".">377</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="center">4 nM</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">398</td><td class="colsep0 rowsep0" align="char" char=".">3.36</td><td class="colsep0 rowsep0" align="char" char=".">556</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="center">11 nM</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">log <i>D</i>, Chrom log <i>D</i> at pH 7.4.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Chemiluminescent nitrogen detection (CLND) kinetic aqueous solubility assay.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last"><i>P</i><sub>app</sub> permeability pH 7.4 assay.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Topological polar surface area (PSA) determined using JChem for Office (Excel) 16.3.2100.656, 2008–2016, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t8fn5"><sup>e</sup><p class="last">IC<sub>50</sub> in LPC choline release assay.</p></div><div class="footnote" id="t8fn6"><sup>f</sup><p class="last">Ligand efficiency index, LEI = pIC<sub>50</sub>/HA, where HA denotes the number of non-hydrogen atoms.</p></div><div class="footnote" id="t8fn7"><sup>g</sup><p class="last">Lipophilic ligand efficiency, LLE = pIC<sub>50</sub> – log <i>D</i>.</p></div></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We designed and synthesized a series of analogues to explore the atypical ATX inhibitor <b>9</b>, previously reported by Amira Pharmaceuticals. In the current study, we have developed a robust SAR through the biological assessment of our compound library using two different ATX assays. This survey has established that some compounds inhibit hydrolysis of the natural substrate (LPC) but only partially inhibit activity with an artificial substrate. On the basis of this, we can infer a binding mode outside of the orthosteric site and this was corroborated by kinetic studies, which identified this chemotype as a noncompetitive ATX inhibitor. In addition to this, a crystal structure of ATX bound to compound <b>51</b> confirmed that it binds within the tunnel, which is an underexploited and recently described allosteric binding site. We emphasize that cross screening with an assay using a natural substrate is important to determine the true inhibitory activity of compounds for this enzyme. Through the measurement of the physicochemical properties, we demonstrated that this chemotype had consistently good aqueous solubility, with the more potent analogues possessing excellent LLE. This combined biochemical, biostructural, and physicochemical work has provided a more detailed insight into the SAR and binding mode of these small molecule ATX inhibitors, which could aid the design of new novel ATX inhibitors with nonlipid-like scaffolds.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedures</h3><div class="NLM_p last">All reagents and solvents were obtained from commercial suppliers and were used without further purification unless otherwise stated. Purification was carried out according to standard laboratory methods.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> All solvents for dry reactions were distilled according to standard laboratory practice. These solvents were transferred to a septum-sealed oven-dried flask over previously activated 4 Å molecular sieves and purged with and stored under nitrogen. Dichloromethane, ethyl acetate, methanol, petroleum ether 40–60°, and cyclohexane for purification purposes were used as obtained from suppliers without further purification. Thin layer chromatography (TLC) was carried out using Merck silica plates coated with fluorescent indicator UV254. These were analyzed under 254 nm UV light or developed using potassium permanganate solution. Silica chromatography was carried out using ZEOprep 60 HYD 40–63 μm silica gel or IST Isolute Flash silica cartridges. Reverse-phase HPLC purification was carried out using a Gilson 151 preparative HPLC using an Agilent Zorbax SB-C18 column at room temperature. Purification was performed using a gradient method, eluting with 5–80% acetonitrile/water over 15 min at a flow rate of 10 mL/min. Fractions were collected automatically using a GX-271 liquid handler. Reverse-phase ultraperformance liquid chromatography (UPLC) purification was carried out using an Acquity UPLC CSH C18 column at 40 °C. Purification was performed using a gradient method, eluting with 5–97% acetonitrile/10 mM (NH<sub>4</sub>)HCO<sub>3</sub> in water. Mass-directed automatic purification (MDAP) was carried out using a ZQ MS using alternate-scan positive and negative electrospray and a summed UV wavelength of 210–350 nm and an Xbridge C18 column (100 mm × 19 mm, 5 μm packing diameter, 20 mL/min flow rate) or Xbridge C18 column (150 mm × 30 mm, 5 μm packing diameter, 40 mL/min flow rate). Purification was performed using a gradient method at room temperature with the mobile phases as (A) 10 mM aqueous ammonium bicarbonate solution, adjusted to pH 10 with 0.88 M aqueous ammonia, and (B) acetonitrile. All compounds for testing were purified to at least 95% purity, as verified by HPLC, <sup>1</sup>H NMR, and high-resolution mass spectrometry (HRMS). Fourier transformed infrared (FTIR) spectra were obtained on one of three machines: (i) Shimadzu IR Affinity-1 machine, (ii) A2 Technologies ATR spectrometer, or (iii) Agilent 5500a FTIR ATR. <sup>1</sup>H, <sup>13</sup>C, and <sup>19</sup>F NMR spectra were obtained on a one of four Bruker NMR spectrometers: (i) Advance III HD console, Ascend 500 MHz magnet, BBO smart probe; (ii) Advance III console, 400 MHz Ultrashield magnet, Prodigy BBO probe, BB-H&F-D-05 Z; (iii) Advance II console, 400 MHz 9.4 T Oxford unshielded magnet, BBFO-z-ATMA probe; and (iv) Advance III console, 600 MHz 14.1 T Bruker Ultrashield magnet, TBI-z probe. Chemical shifts are reported in ppm, and coupling constants are reported in Hz with CDCl<sub>3</sub> referenced at 7.26 (<sup>1</sup>H) and 77.16 ppm (<sup>13</sup>C), CO(CD<sub>3</sub>)<sub>2</sub> at 2.05 (<sup>1</sup>H) and 29.84 ppm (<sup>13</sup>C), MeOD at 3.31 (<sup>1</sup>H) and 49.00 ppm (<sup>13</sup>C), and DMSO-<i>d</i><sub>6</sub> at 2.50 (<sup>1</sup>H) and 39.52 ppm (<sup>13</sup>C), respectively. HRMS were obtained through analysis at the EPSRC National Mass Spectrometry Facility, University of Wales, Swansea, or on a Micromass Q-Tof Ultima hybrid quadrupole time-of-flight mass spectrometer, with analytes separated on an Agilent 1100 liquid chromatograph equipped with a Phenomenex Luna C18(2) reversed phase column (100 mm × 2.1 mm, 3 μm packing diameter). LC conditions were 0.5 mL/min flow rate, 35 °C, injection volume 2–5 μL. Gradient elution with (A) water containing 0.1% (v/v) formic acid and (B) acetonitrile containing 0.1% (v/v) formic acid. Gradient conditions were initially 5% B, increasing linearly to 100% B over 6 min, remaining at 100% B for 2.5 min, and then decreasing linearly to 5% B over 1 min followed by an equilibration period of 2.5 min prior to the next injection.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Materials</h3><div class="NLM_p">Ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) was obtained from GVK Biosciences Private Limited (ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>). Bromocyclopentane was distilled over anhydrous calcium carbonate under reduced pressure prior to use.</div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Procedure 1: Fischer Indole Synthesis, For Example, Ethyl 6-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>16</b>)</h4><div class="NLM_p last">Prepared according to a modified version of the procedure described by Amira Pharmaceuticals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> To a round bottomed flask, ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (512 mg, 2.09 mmol, 1 equiv) and (3-chlorophenyl)hydrazine hydrochloride (374 mg, 2.09 mmol, 1 equiv) were added and dissolved in <i>t</i>BuOH (25 mL, 0.08 M) and stirred at 80 °C for 16 h. Following this, 1 M HCl in Et<sub>2</sub>O (0.3 mL) was added to the reaction mixture and stirred for a further 2 h before adding AcOH (0.3 mL) and stirred for a further 1 h. The reaction mixture was then allowed to return to room temperature and concentrated under vacuum to a residue that was purified by reverse-phase UPLC to afford the title compound as a brown solid (517 mg, 71%).</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Procedure 2: Ullmann Coupling, For Example, 6-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>9</b>)</h4><div class="NLM_p last">Prepared according to a modified version of a literature procedure for an Ullmann coupling.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> To a microwave vial was added 1,10-phenanthroline (56 mg, 0.311 mmol, 1 equiv), CuI (30 mg, 0.156 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (203 mg, 0.622 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (129 mg, 0.622 mmol, 2 equiv), and ethyl 6-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>16</b>) (108 mg, 0.311 mmol, 1 equiv). The reaction vessel was then sealed and purged with N<sub>2</sub> before addition of DMF (1 mL, 0.3 M). The reaction was then heated to 110 °C for 48 h. The reaction mixture was then diluted with water (15 mL) and extracted with EtOAc (3 × 10 mL). The combined organics were dried (hydrophobic frit) and concentrated under vacuum to a residue that was purified using MDAP to afford the title compound as a pale-yellow solid (10 mg, 8%).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure 3: Ester Hydrolysis, For Example, 6-((2-Methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>19</b>)</h4><div class="NLM_p last">To a round bottomed flask was added a solution of ethyl 6-((2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>36</b>) (56 mg, 0.179 mmol, 1 equiv) and 2 M aq NaOH (0.5 mL) in THF (0.5 mL, 0.4 M), and the reaction stirred at room temperature until complete by TLC. The reaction mixture was then concentrated under vacuum to a residue that was purified using MDAP to afford the title compound as a brown amorphous solid (27 mg, 53%).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> General Procedure 4: <i>N</i>-Arylation, For Example, 6-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>28</b>)</h4><div class="NLM_p last">Prepared according to a modified version of the procedure described by Amira Pharmaceuticals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> To a microwave vial was added ethyl 6-((2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>36</b>) (198 mg, 0.635 mmol, 1 equiv), 4-bromo-1-methyl-1<i>H</i>-pyrazole (198 μL, 1.90 mmol, 3 equiv), K<sub>2</sub>CO<sub>3</sub> (114 mg, 0.826 mmol, 1.3 equiv), and CuO (102 mg, 1.27 mmol, 2 equiv). The vial was then sealed and purged with N<sub>2</sub> before the addition of pyridine (2 mL, 0.3 M). The reaction mixture was then heated to 170 °C for 16 h. The reaction mixture was then allowed to return to room temperature, diluted with EtOAc (15 mL), and washed with water (3 × 10 mL). The organic layer was collected, dried (hydrophobic frit), concentrated under vacuum, and the residue purified using reverse-phase HPLC to afford the title compound as a yellow amorphous solid (15 mg, 6%).</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> General Procedure 5: Alternative Fischer Indole Synthesis, For Example, Ethyl 6-((5-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>82</b>)</h4><div class="NLM_p last">A solution of ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (1 g, 4.18 mmol, 1 equiv) and (4-chlorophenyl)hydrazine hydrochloride (749 mg, 4.18 mmol, 1 equiv) in EtOH (25 mL, 0.2 M) was refluxed until the reaction was complete by TLC. The reaction mixture was then allowed to return to room temperature, concentrated under vacuum, and the residue purified using silica chromatography, eluting with 0–50% EtOAc/cyclohexane, to afford the title compound as a brown amorphous solid (460 mg, 32%).</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> General Procedure 6: <i>N</i>-Alkylation of the Indole, For Example, Methyl 3-((1,2-dimethyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>93</b>)</h4><div class="NLM_p last">A solution of methyl 3-((2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>) (200 mg, 0.673 mmol, 1 equiv) and NaH 60% w/w (54 mg, 1.35 mmol, 2 equiv) in THF (3 mL, 0.2 M) was heated to 60 °C for 1 h before adding MeI (84 μL, 1.35 mmol, 2 equiv). The reaction mixture was heated to 60 °C for 16 h then allowed to return to room temperature, concentrated under vacuum, and the residue purified using silica chromatography, eluting with 10% EtOAc/petroleum ether, to afford the title compound as a pale-yellow amorphous solid (71 mg, 34%).</div></div><div id="sec3_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> General Procedure 7: Methoxycarbonylation, For Example, Methyl 3-((2-Methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>)</h4><div class="NLM_p last"><i>trans</i>-Bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl] dipalladium(II) (184 mg, 0.196 mmol, 5 mol %) was added to a solution of 3-((3-bromophenyl)thio)-2-methyl-1<i>H</i>-indole (<b>91</b>) (1.24 g, 3.91 mmol, 1 equiv), Mo(CO)<sub>6</sub> (1 g, 3.91 mmol, 1 equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (227 mg, 0.782 mmol, 20 mol %), and DBU (875 μL, 5.86 mmol, 1.5 equiv) in MeCN/MeOH (20 mL, 1:4, 0.2 M). The reaction mixture was heated to 70 °C for 16 h then allowed to return to room temperature, concentrated under vacuum, and the residue purified using silica chromatography, eluting with 20% EtOAc/petroleum ether, to afford the title compound as a brown solid (1 g, 88%).</div></div><div id="sec3_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Procedure 8: Two-Step Alkylation, For Example, 3-(3-Bromobenzyl)-6-chloro-2-methyl-1<i>H</i>-indole (<b>101</b>)</h4><div class="NLM_p last">6-Bromopyridine-2-carbaldehyde (91 mg, 0.488 mmol, 1.03 equiv) was added to a solution of 2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H-</i>indole (<b>98</b>) (100 mg, 0.474 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL, 0.2 M) at 0 °C and stirred for 20 min. Et<sub>3</sub>SiH (84 μL, 0.529 mmol, 1.1 equiv) and TFA (47 μL, 0.610 mmol, 1.3 equiv) were then added to the reaction mixture and stirred for a further 1 h, during which the reaction mixture was allowed to return to room temperature. The resulting solution was then quenched with satd aq NaHCO<sub>3</sub> and extracted using CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The organic layer was collected, dried (hydrophobic frit), concentrated under vacuum, and the residue purified using silica chromatography, eluting with 20–60% EtOAc/petroleum ether, to afford the title compound as a yellow gum (158 mg, 87%).</div></div><div id="sec3_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 6-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H-</i>indol-3-yl)thio)picolinic Acid (<b>9</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (56 mg, 0.311 mmol, 1 equiv), CuI (30 mg, 0.156 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (203 mg, 0.622 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H-</i>pyrazole (129 mg, 0.622 mmol, 2 equiv), and ethyl 6-((6-chloro-2-methyl-1<i>H-</i>indol-3-yl)thio)picolinate (<b>16</b>) (108 mg, 0.311 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford the title compound as a pale-yellow solid (10 mg, 8%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.06 (s, 1H), 7.90–7.79 (m, 1H), 7.78 (s, 1H), 7.73–7.61 (m, 1H), 7.46 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (d, <i>J</i> = 1.7 Hz, 1H), 7.16 (d, <i>J</i> = 7.1 Hz, 1H), 6.97–6.84 (m, 1H), 4.07 (s, 3H), 2.43 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 163.7, 161.5, 145.9, 144.9, 139.1, 138.6, 129.0, 127.9, 127.6, 127.5, 126.8, 124.0, 122.3, 119.4, 110.7, 97.8, 39.9, 11.6. One carbon not observed/coincident. υ<sub>max</sub> (neat): 2947, 2924, 1712, 1577 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>16</sub>ClN<sub>4</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 401.0646, <i>m</i>/<i>z</i> found 401.0646.</div></div><div id="sec3_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Ethyl 6-((4-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>14</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (512 mg, 2.09 mmol, 1 equiv) and (3-chlorophenyl)hydrazine hydrochloride (374 mg, 2.09 mmol, 1 equiv) in <i>t</i>BuOH (25 mL, 0.1 M) with additional 1 M HCl in Et<sub>2</sub>O (0.3 mL) and AcOH (0.3 mL). Purified using reverse-phase UPLC to afford ethyl 6-((4-chloro-2-methyl-1<i>H-</i>indol-3-yl)thio)picolinate (<b>14</b>) as a white amorphous solid (125 mg, 17%). Ethyl 6-((4-chloro-2-methyl-1<i>H-</i>indol-3-yl)thio)picolinate (<b>14</b>). <sup>1</sup>H NMR (600 MHz, MeOD): δ 7.75–7.71 (m, 1H), 7.58 (app t, <i>J</i> = 7.9 Hz, 1H), 7.33 (dd, <i>J</i> = 8.0, 0.5 Hz, 1H), 7.07 (app t, <i>J</i> = 7.9 Hz, 1H), 7.00 (dd, <i>J</i> = 7.6, 0.5 Hz, 1H), 6.82 (dd, <i>J</i> = 8.2, 0.6 Hz, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 2H), 2.49 (s, 3H), 1.41 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 165.8, 164.8, 147.2, 144.1, 137.7, 137.5, 125.4, 124.8, 122.7, 122.0, 121.2, 120.0, 109.9, 95.2, 61.6, 13.1, 10.4. υ<sub>max</sub> (neat): 3267, 2980, 1720, 1572, 1537 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>16</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 349.0585, <i>m</i>/<i>z</i> found 349.05885.</div></div><div id="sec3_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-((4-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>15</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((4-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>14</b>) (50 mg, 0.144 mmol, 1 equiv) and 2 M aq NaOH (1 mL) in THF (1 mL, 0.1 M). Purified using MDAP to afford the desired product as a brown amorphous solid (40 mg, 87%). <sup>1</sup>H NMR (400 MHz, MeOD): 7.78 (d, <i>J</i> = 7.6 Hz, 1H), 7.63 (app t, <i>J</i> = 7.9 Hz, 1H), 7.36 (dd, <i>J</i> = 7.9, 0.7 Hz, 1H), 7.10 (app t, <i>J</i> = 7.8 Hz, 1H), 7.03 (d, <i>J</i> = 7.6 Hz, 1H), 6.85 (dd, <i>J</i> = 8.1, 0.7 Hz, 1H), 2.51 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 166.0, 165.5, 147.1, 144.1, 137.7, 125.4, 124.8, 122.8, 122.0, 121.2, 119.9, 109.9, 95.1, 10.4. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3250, 3020, 2924, 1708, 1573, 1558, 1535 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 319.0303, <i>m</i>/<i>z</i> found 319.0300.</div></div><div id="sec3_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Ethyl 6-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>16</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (512 mg, 2.09 mmol, 1 equiv) and (3-chlorophenyl)hydrazine hydrochloride (374 mg, 2.09 mmol, 1 equiv) in <i>t</i>BuOH (25 mL, 0.1 M) with additional 1 M HCl in Et<sub>2</sub>O (0.3 mL) and AcOH (0.3 mL). Purified using reverse-phase UPLC to afford ethyl 6-((6-chloro-2-methyl-1<i>H-</i>indol-3-yl)thio)picolinate (<b>16</b>) as a brown amorphous solid (517 mg, 71%). <sup>1</sup>H NMR (600 MHz, MeOD): δ 7.73 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.59–7.54 (m, 1H), 7.39 (d, <i>J</i> = 1.8 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.02 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 6.74 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 2H), 2.48 (s, 3H), 1.41 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 164.7, 163.9, 147.5, 143.3, 137.7, 136. 6, 128.3, 127.4, 122.4, 120.5, 120.3, 118.5, 110.8, 95.9, 61.6, 13.1, 10.4. υ<sub>max</sub> (neat): 3250, 2975, 1720, 1574 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>16</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 349.0585, <i>m</i>/<i>z</i> found 349.0587.</div></div><div id="sec3_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 6-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>17</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>16</b>) (100 mg, 0.289 mmol, 1 equiv) and 2 M aq NaOH (1 mL) in THF (1 mL, 0.3 M). Purified using MDAP to afford the desired product as a yellow amorphous solid (79 mg, 86%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.77 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.58 (app t, <i>J</i> = 7.9 Hz, 1H), 7.40 (d, <i>J</i> = 1.9 Hz, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.04 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 6.74 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 2.49 (s, 3H). CO<sub>2</sub>H and NH protons not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 165.9, 163.6, 147.5, 143.3, 137.8, 136.5, 128.3, 127.4, 122.4, 120.5, 120.2, 118.5, 110.8, 95.9, 10.4. υ<sub>max</sub> (neat): 3302, 1734, 1685 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 319.0303, <i>m</i>/<i>z</i> found 319.0307.</div></div><div id="sec3_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-((4-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>18</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (54 mg, 0.300 mmol, 1 equiv), CuI (28 mg, 0.150 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (196 mg, 0.600 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (125 mg, 0.600 mmol, 2 equiv), and ethyl 6-((7-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>83</b>) (104 mg, 0.300 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford the desired product as an off-white solid (32 mg, 27%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.84 (d, <i>J</i> = 7.5 Hz, 1H), 7.65–7.61 (m, 3H), 7.19–7.03 (m, 4H), 4.04 (s, 3H), 2.37 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 160.1, 159.2, 142.0, 141.8, 136.2, 134.4, 133.2, 123.8, 121.7, 121.2, 120.6, 119.1, 119.0, 115.2, 115.0, 105.5, 93.2, 35.9, 7.7. υ<sub>max</sub> (neat):1735, 1510, 1500 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>16</sub>ClN<sub>4</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 399.0677, <i>m</i>/<i>z</i> found 399.0680.</div></div><div id="sec3_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 6-((2-Methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>19</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>36</b>) (56 mg, 0.179 mmol, 1 equiv) and 2 M aq NaOH (0.5 mL) in THF (0.5 mL, 0.4 M). Purified using MDAP to afford the title compound as a brown amorphous solid (27 mg, 53%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.75 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.56 (app t, <i>J</i> = 7.9 Hz, 1H), 7.42–7.34 (m, 2H), 7.18–7.10 (m, 1H), 7.10–7.01 (m, 1H), 6.75 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 2.49 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 166.2, 164.1, 163.2, 147.6, 142.1, 137.6, 136.2, 129.6, 122.4, 121.6, 120.0, 117.4, 110.9, 95.4, 10.4. υ<sub>max</sub> (neat): 3281, 1749, 1716, 1575, 1558 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 285.0692, <i>m</i>/<i>z</i> found 285.0693.</div></div><div id="sec3_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 6-((5-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>20</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((5-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>82</b>) (46 mg, 0.133 mmol, 1 equiv) and 2 M aq NaOH (0.5 mL) in THF (0.5 mL, 0.3 M). Purified using reverse-phase HPLC to afford the title compound as a pale-brown amorphous solid (37 mg, 87%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.79 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.63–7.58 (m, 1H), 7.37 (d, <i>J</i> = 8.6 Hz, 1H), 7.35 (d, <i>J</i> = 1.9 Hz, 1H), 7.13 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.77 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 2.51 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 166.0, 163.6, 147.7, 144.1, 137.8, 134.6, 130.9, 126.0, 122.3, 121.8, 120.2, 116.8, 112.2, 95.4, 10.4. υ<sub>max</sub> (neat): 3304, 2960, 2975 1751, 1705, 1656, 1577 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 319.0303, <i>m</i>/<i>z</i> found 319.0307.</div></div><div id="sec3_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 6-((7-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>21</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (1 g, 4.18 mmol, 1 equiv) and (2-chlorophenyl)hydrazine hydrochloride (748 mg, 4.18 mmol, 1 equiv) in EtOH (25 mL, 0.2 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 2 M aq NaOH (6 mL) in THF (6 mL, 0.7 M). Purified using MDAP to afford the title compound as a pale-yellow amorphous solid (289 mg, 22% over 2 steps). <sup>1</sup>H NMR (600 MHz, MeOD): δ 7.63 (dd, <i>J</i> = 7.5, 0.7 Hz, 1H), 7.47 (app t, <i>J</i> = 7.8 Hz, 1H), 7.38 (dd, <i>J</i> = 7.9, 0.7 Hz, 1H), 7.18 (dd, <i>J</i> = 7.6, 0.7 Hz, 1H), 7.05 (app t, <i>J</i> = 7.8 Hz, 1H), 6.56 (dd, <i>J</i> = 8.1, 0.7 Hz, 1H), 2.56 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 171.4, 162.1, 154.9, 143.4, 137.0, 133.1, 131.6, 121.0, 120.7, 119.6, 119.0, 116.5, 116.2, 97.8, 10.3. υ<sub>max</sub> (neat): 3130, 1591, 1556 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 319.0303, <i>m</i>/<i>z</i> found 319.0306.</div></div><div id="sec3_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-((4-Fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>22</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((4-fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>85</b>) (51 mg, 0.154 mmol, 1 equiv) and 2 M aq NaOH solution (0.5 mL) in THF (0.5 mL, 0.3 M). Purified using MDAP to afford the title compound as a yellow amorphous solid (46 mg, 99%). <sup>1</sup>H NMR (600 MHz, MeOD): δ 7.75 (dd, <i>J</i> = 7.5, 0.7 Hz, 1H), 7.58 (app t, <i>J</i> = 7.9 Hz, 1H), 7.18 (d, <i>J</i> = 8.2 Hz, 1H), 7.07–7.03 (m, 1H), 6.86 (d, <i>J</i> = 8.2 Hz, 1H), 6.68 (dd, <i>J</i> = 11.1, 7.9 Hz, 1H), 2.46 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 166.1, 164.7, 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 246.5 Hz), 147.3, 142.8, 139.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 10.3 Hz), 137.7, 122.5, 121.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.7 Hz), 120.0, 117.7 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 17.3 Hz), 107.2 (d, <i>J</i><sub>C–F</sub> = 3.8 Hz), 105.3 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 19.2 Hz), 93.2 (d, <i>J</i><sub>C–F</sub> = 1.6 Hz), 10.1. <sup>19</sup>F NMR (376 MHz, MeOD): δ −129.6. υ<sub>max</sub> (neat): 3300, 2600, 1687, 1573 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>12</sub>FN<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 303.0598, found <i>m</i>/<i>z</i> 303.0596.</div></div><div id="sec3_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 6-((6-Fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>23</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((6-fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>84</b>) (50 mg, 0.152 mmol, 1 equiv) and 2 M aq NaOH (0.5 mL) in THF (0.5 mL, 0.3 M). Purified using MDAP to afford the title compound as a brown amorphous solid (3 mg, 6%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.62 (d, <i>J</i> = 7.5 Hz, 1H), 7.46 (app t, <i>J</i> = 7.8 Hz, 1H), 7.33 (dd, <i>J</i> = 8.6, 5.3 Hz, 1H), 7.09 (dd, <i>J</i> = 9.6, 2.2 Hz, 1H), 6.85–6.79 (m, 1H), 6.57 (d, <i>J</i> = 8.0 Hz, 1H), 2.46 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 169.1, 163.0, 160.0 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 235.9 Hz), 151.6, 142.7 (d, <i>J</i><sub>C–F</sub> = 0.4 Hz), 137.3, 136.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 12.6 Hz), 126.1, 120.9, 119.5, 118.4 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 10 Hz), 108.1 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 24.7 Hz), 97.2 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 26.4 Hz), 96.1, 10.4. <sup>19</sup>F NMR (376 MHz, MeOD): δ −123.86. υ<sub>max</sub> (neat): 3338, 1732, 1608, 1583, 1556 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>12</sub>FN<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 303.0598, found <i>m</i>/<i>z</i> 303.0596.</div></div><div id="sec3_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-((2,4-Dimethyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>24</b>) and 6-((2,4-Dimethyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>32</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (49 mg, 0.270 mmol, 1 equiv), CuI (26 mg, 0.135 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (176 mg, 0.540 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (112 mg, 0.540 mmol, 2 equiv), and ethyl 6-((2,4-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>87</b>) (88 mg, 0.270 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford the desired 6-((2,4-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinic acid (<b>24</b>) as a an off-white amorphous solid (31 mg, 38%) and 6-((2,4-dimethyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-<i>1H</i>-indol-3-yl)thio)picolinic acid (<b>32</b>) as a white solid (24 mg, 24%). 6-((2,4-Dimethyl-1<i>H</i>-indol-3-yl)thio)picolinic acid (<b>24</b>): <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.76 (dd, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.63–7.55 (m, 1H), 7.23 (d, <i>J</i> = 8.1 Hz, 1H), 7.05–6.97 (m, 1H), 6.84–6.75 (m, 2H), 2.56 (s, 3H), 2.47 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 166.1, 165.9, 147.4, 142.3, 137.8, 136.4, 129.5, 127.1, 122.5, 121.8, 121.4, 119.9, 108.9, 95.2, 17.5, 10.3. υ<sub>max</sub> (neat): 3302, 1690, 1580, 1558 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 299.0849, found <i>m</i>/<i>z</i> 299.0849. 6-((2,4-Dimethyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic acid (<b>32</b>): <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.16 (s, 1H), 6.94 (d, <i>J</i> = 7.5 Hz, 1H), 6.88 (s, 1H), 6.80 (app t, <i>J</i> = 7.8 Hz, 1H), 6.30–6.18 (m, 2H), 6.13–5.98 (m, 2H), 4.01 (s, 3H), 1.78 (s, 3H), 1.56 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.8, 163.9, 148.9, 143.5, 138.3, 137.0, 135.8, 129.2, 127.9, 125.7, 122.1, 121.3, 121.0, 119.0, 118.6, 107.3, 96.8, 37.5, 16.8, 9.2. υ<sub>max</sub> (neat): 2943, 2921, 1720, 1686, 1619, 1574, 1561 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 379.1223, found <i>m</i>/<i>z</i> 379.1220.</div></div><div id="sec3_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 6-((2,6-Dimethyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>25</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (49 mg, 0.270 mmol, 1 equiv), CuI (26 mg, 0.135 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (176 mg, 0.540 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (112 mg, 0.540 mmol, 2 equiv), and ethyl 6-((2,6-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>86</b>) (88 mg, 0.270 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford 6-((2,6-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinic acid (<b>25</b>) as a yellow amorphous solid (8 mg, 10%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.64 (d, <i>J</i> = 7.5 Hz, 1H), 7.46 (app t, <i>J</i> = 7.8 Hz, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 1H), 7.18 (d, <i>J</i> = 0.5 Hz, 1H), 6.88 (dd, <i>J</i> = 8.0, 0.9 Hz, 1H), 6.63 (d, <i>J</i> = 8.0 Hz, 1H), 2.45 (s, 3H), 2.42 (s, 3H). NH and CO<sub>2</sub>H not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 169.2, 163.5, 151.7, 141.2, 137.1, 136.6, 131.4, 127.5, 121.5, 120.9, 119.2, 117.2, 110.8, 95.6, 20.3, 10.3. υ<sub>max</sub> (neat): 3280, 3249, 2900, 1722, 1578, 1560, 1441 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 299.0849, found <i>m</i>/<i>z</i> 299.0849.</div></div><div id="sec3_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 6-((4-Methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>26</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((4-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>89</b>) (47 mg 0.137 mmol, 1 equiv) and 2 M aq NaOH (0.5 mL) in THF (0.5 mL, 0.3 M). Purified using MDAP to afford the title compound as a yellow amorphous solid (42 mg, 98%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72 (d, <i>J</i> = 7.5 Hz, 1H), 7.55 (app t, <i>J</i> = 7.9 Hz, 1H), 7.06–6.93 (m, 2H), 6.89 (d, <i>J</i> = 8.2 Hz, 1H), 6.49 (d, <i>J</i> = 7.5 Hz, 1H), 3.59 (s, 3H), 2.43 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 165.9, 165.8, 153.5, 146.7, 140.7, 137.8, 137.5, 123.1, 122.4, 119.7, 118.6, 104.4, 101.0, 94.2, 54.4, 10.2. υ<sub>max</sub> (neat): 3273, 2950, 1716, 1583, 1539 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub>S) requires <i>m</i>/<i>z</i> 315.0798, found <i>m</i>/<i>z</i> 315.0798.</div></div><div id="sec3_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-((6-Methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>27</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 6-((6-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>88</b>) (46 mg, 0.134 mmol, 1 equiv) and 2 M aq NaOH (0.5 mL) in THF (0.5 mL, 0.3 M). Purified using MDAP to afford the title compound as a brown amorphous solid (36 mg, 86%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.75 (dd, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.58–7.51 (m, 1H), 7.21 (d, <i>J</i> = 8.6 Hz, 1H), 6.93 (d, <i>J</i> = 2.1 Hz, 1H), 6.78 (dd, <i>J</i> = 8.1, 0.9 Hz, 1H), 6.70 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 3.80 (s, 3H), 2.44 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 165.8, 164.2, 156.7, 147.1, 140.9, 137.9, 136.9, 123.5, 122.7, 120.1, 118.0, 109.7, 94.8, 94.7, 54.7, 10.4. υ<sub>max</sub> (neat): 3286, 2995, 1724, 1627, 1581, 1500 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>16</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub>S) requires <i>m</i>/<i>z</i> 315.0798, found <i>m</i>/<i>z</i> 315.0798.</div></div><div id="sec3_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>28</b>)</h4><div class="NLM_p last">Prepared according general procedure 4 using ethyl 6-((2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>36</b>) (198 mg, 0.635 mmol, 1 equiv), 4-bromo-1-methyl-1<i>H</i>-pyrazole (198 μL, 1.90 mmol, 3 equiv), K<sub>2</sub>CO<sub>3</sub> (114 mg, 0.826 mmol, 1.3 equiv), and CuO (102 mg, 1.27 mmol, 2 equiv) in pyridine (2 mL, 0.3 M). Purified using reverse-phase HPLC to afford the title compound as a yellow amorphous solid (15 mg, 6%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ 11.03 (br s, 1H), 8.08 (s, 1H), 7.81 (d, <i>J</i> = 7.4 Hz, 1H), 7.76–7.61 (m, <i>J</i> = 7.8 Hz, 2H), 7.48 (d, <i>J</i> = 7.4 Hz, 1H), 7.30–7.11 (m, 3H), 6.99 (d, <i>J</i> = 7.9 Hz, 1H), 4.05 (s, 3H), 2.43 (s, 3H). <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ 165.2, 163.3, 148.1, 145.4, 139.7, 139.4, 137.2, 129.9, 129.1, 123.8, 123.5, 122.2, 120.7, 118.8, 111.5, 98.0, 55.3, 39.8, 11.6. υ<sub>max</sub> (neat): 2924, 2852, 1708, 1693, 1573 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 365.1067, <i>m</i>/<i>z</i> found 365.1070.</div></div><div id="sec3_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-((5-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>29</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (57 mg, 0.318 mmol, 1 equiv), CuI (30 mg, 0.159 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (207 mg, 0.636 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (132 mg, 0.636 mmol, 2 equiv), and ethyl 6-((5-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>82</b>) (110 g, 0.318 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford the title compound as a white amorphous solid (28 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.88 (d, <i>J</i> = 7.5 Hz, 1H), 7.65–7.61 (m, 3H), 7.50 (d, <i>J</i> = 1.7 Hz, 1H), 7.19–7.05 (m, 3H), 4.05 (s, 3H), 2.38 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 163.6, 161.3, 145.9, 145.6, 138.6, 137.1, 137.0, 130.2, 127.7, 127.5, 124.0, 123.2, 119.4, 118.0, 111.7, 97.2, 39.9, 11.7. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3025, 1730, 1577, 1558, 1531 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>16</sub>ClN<sub>4</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 399.0677, <i>m</i>/<i>z</i> found 399.0680.</div></div><div id="sec3_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 6-((4-Fluoro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-3-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>30</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (80 mg, 0.442 mmol, 1 equiv), CuI (42 mg, 0.221 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (288 mg, 0.884 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (184 mg, 0.884 mmol, 2 equiv), and ethyl 6-((7-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>83</b>) (146 mg, 0.442 mmol, 1 equiv) in DMF (1.5 mL, 0.3 M). Purified using MDAP to afford the title compound as a red amorphous solid (6 mg, 3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.87 (d, <i>J</i> = 7.3 Hz, 1H), 7.67 (d, <i>J</i> = 7.4 Hz, 1H), 7.63 (s, 1H), 7.61 (s, 1H), 7.22 (s, 1H), 7.11 (dd, <i>J</i> = 12.8, 8.0 Hz, 1H), 7.00 (d, <i>J</i> = 8.2 Hz, 1H), 6.88–6.75 (m, 1H), 4.05 (s, 3H), 2.37 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 162.1, 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 249.1 Hz), 144.5, 142.2, 141.3 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.4 Hz), 138.5, 137.1, 127.6, 124.2, 123.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.5 Hz), 119.2, 117.5 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 17.9 Hz), 107.3 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 18.8 Hz), 106.8 (d, <i>J</i><sub>C–F</sub> = 3.3 Hz), 95.1, 39.9, 11.4. Two carbons not observed/coincident. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>): δ −126.82. υ<sub>max</sub> (neat): 2800, 2500, 1735, 1577, 1558 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>16</sub>FN<sub>4</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 383.0973, found <i>m</i>/<i>z</i> 383.0975.</div></div><div id="sec3_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-((6-Fluoro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-3-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>31</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (55 mg, 0.304 mmol, 1 equiv), CuI (29 mg, 0.152 mmol 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (198 mg, 0.608 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (126 mg, 0.608 mmol, 2 equiv), and ethyl 6-((6-fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>84</b>) (100 mg, 0.304 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford the title compound as a yellow amorphous solid (25 mg, 22%). <sup>1</sup>H NMR (600 MHz, MeOD): δ 8.01 (s, 1H), 7.73 (s, 1H), 7.71 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (app t, <i>J</i> = 7.8 Hz, 1H), 7.42 (dd, <i>J</i> = 8.1, 5.2 Hz, 1H), 6.93 (d, <i>J</i> = 9.4 Hz, 1H), 6.90–6.86 (m, 2H), 4.03 (s, 3H), 2.39 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 162.1, 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 249.1 Hz), 144.5, 142.2, 141.3 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.4 Hz), 138.5, 137.1, 127.6, 124.2, 123.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.5 Hz), 119.2, 117.5 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 17.9 Hz), 107.3 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 18.8 Hz), 106.8 (d, <i>J</i><sub>C–F</sub> = 3.3 Hz), 95.1, 39.9, 11.4. Two carbons not observed/coincident. υ<sub>max</sub> (neat): 2900, 1725, 1618, 1575, 1558 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>16</sub>FN<sub>4</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 383.0973, found <i>m</i>/<i>z</i> 383.0979.</div></div><div id="sec3_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 6-((2,6-Dimethyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>33</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (49 mg, 0.270 mmol, 1 equiv), CuI (26 mg, 0.135 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (176 mg, 0.540 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (112 mg, 0.540 mmol, 2 equiv), and ethyl 6-((2,6-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>86</b>) (88 mg, 0.270 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford 6-((2,6-dimethyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic acid (<b>33</b>) as a yellow amorphous solid (28 mg, 27%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.99 (s, 1H), 7.72 (d, <i>J</i> = 0.6 Hz, 1H), 7.68 (d, <i>J</i> = 7.4 Hz, 1H), 7.51 (app t, <i>J</i> = 7.8 Hz, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 7.01 (s, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 1H), 6.72 (d, <i>J</i> = 8.0 Hz, 1H), 4.03 (s, 3H), 2.40 (s, 3H), 2.38 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 147.1, 143.1, 141.2, 140.5, 136.4, 132.6, 130.8, 126.5, 125.0, 124.8, 123.4, 121.6, 113.9, 42.2, 24.2, 14.0. Four carbons not observed/coincident. υ<sub>max</sub> (neat): 2921, 2852, 1680, 1615, 1558, 1573 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 379.1223, found <i>m</i>/<i>z</i> 379.1220.</div></div><div id="sec3_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6-((4-Methoxy-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>34</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (53 mg, 0.292 mmol, 1 equiv), CuI (28 mg, 0.146 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (190 mg, 0.584 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (121 mg, 0.584 mmol, 2 equiv), and ethyl 6-((4-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>89</b>) (100 mg, 0.292 mmol, 1 equiv) in DMF (2 mL, 0.1 M). Purified using MDAP to afford the title compound as an off-white amorphous solid (21 mg, 18%). <sup>1</sup>H NMR (600 MHz, MeOD): δ 7.96 (s, 1H), 7.68 (s, 1H), 7.60 (d, <i>J</i> = 7.3 Hz, 1H), 7.47 (app t, <i>J</i> = 7.8 Hz, 1H), 7.07 (app t, <i>J</i> = 8.1 Hz, 1H), 6.79 (d, <i>J</i> = 8.2 Hz, 1H), 6.75 (d, <i>J</i> = 7.8 Hz, 1H), 6.59 (d, <i>J</i> = 7.8 Hz, 1H), 4.02 (s, 3H), 3.64 (s, 3H), 2.35 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 163.9, 153.8, 142.3, 140.4, 136.6, 136.6, 128.7, 123.0, 120.5, 119.6, 118.6, 118.2, 110.0, 103.3, 102.0, 97.5, 54.5, 38.2, 9.9. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3150, 2900, 2800, 1602, 1556 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>S) requires <i>m</i>/<i>z</i> 395.1172, found <i>m</i>/<i>z</i> 395.1174.</div></div><div id="sec3_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 6-((6-Methoxy-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>35</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (56 mg, 0.311 mmol, 1 equiv), CuI (30 mg, 0.156 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (203 mg, 0.622 mmol, 2 equiv), 4-iodo-1-methyl-1<i>H</i>-pyrazole (129 mg, 0.622 mmol, 2 equiv), and ethyl 6-((6-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>88</b>) (106 mg, 0.311 mmol, 1 equiv) in DMF (1 mL, 0.3 M). Purified using MDAP to afford the title compound as a pink amorphous solid (32 mg, 26%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.85 (d, <i>J</i> = 7.4 Hz, 1H), 7.65 (s, 1H), 7.63–7.58 (m, 2H), 7.38 (d, <i>J</i> = 8.6 Hz, 1H), 7.09 (d, <i>J</i> = 8.1 Hz, 1H), 6.83 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 6.70 (d, <i>J</i> = 2.2 Hz, 1H), 4.05 (s, 3H), 3.79 (s, 3H), 2.35 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.8, 162.1, 157.3, 145.8, 142.8, 139.5, 138.5, 137.1, 127.6, 124.0, 122.9, 119.5, 119.2, 119.1, 111.0, 97.2, 94.6, 55.8, 39.8, 11.6. υ<sub>max</sub> (neat): 3300, 1755, 1616, 1583, 1556 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>S) requires <i>m</i>/<i>z</i> 395.1172, found <i>m</i>/<i>z</i> 395.1173.</div></div><div id="sec3_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Ethyl 6-((2-Methyl-1<i>H-</i>indol-3-yl)thio)picolinate (<b>36</b>)</h4><div class="NLM_p last">Prepared according to the general procedure 1 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (1 g, 4.24 mmol, 1 equiv) and phenylhydrazine hydrochloride (615 mg, 4.24 mmol, 1 equiv) in <i>t</i>BuOH (50 mL, 0.1 M), with additional 1 M HCl in Et<sub>2</sub>O (0.6 mL) and AcOH (0.6 mL). Purified using silica chromatography, eluting with 10–80% EtOAc/petroleum ether, to afford the title compound as a brown amorphous solid (1.23 g, 93%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.59 (br s, 1H), 7.74 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.51 (d, <i>J</i> = 7.9 Hz, 1H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.37 (d, <i>J</i> = 8.7 Hz, 1H), 7.24–7.19 (m, 1H), 7.13 (td, <i>J</i> = 7.7, 1.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.1 Hz, 1H), 4.47 (q, <i>J</i> = 7.1 Hz, 2H), 2.53 (s, 3H), 1.43 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 165.1, 164.1, 148.0, 141.6, 137.2, 135.7, 129.8, 122.5, 122.4, 120.9, 120.5, 118.8, 110.9, 97.8, 61.9, 14.3, 12.2. υ<sub>max</sub> (neat): 3281, 1732, 1716, 1573 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 313.1005, <i>m</i>/<i>z</i> found 313.1005.</div></div><div id="sec3_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6-((1,2-Dimethyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>37</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using methyl ethyl 6-((2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>36</b>) (301 mg, 0.965 mmol, 1 equiv), NaH 95% w/w (73 mg, 2.89 mmol, 3 equiv), and MeI (120 μL, 1.93 mmol, 2 equiv) in DMF (3 mL, 0.3 M). The crude material was then used in general procedure C using 2 M aq NaOH (0.25 mL). Purified by reverse-phase HPLC to afford the title compound as a dark-red amorphous solid (35 mg, 12% over 2 steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 7.5 Hz, 1H), 7.57 (dd, <i>J</i> = 9.7, 5.9 Hz, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.39 (d, <i>J</i> = 8.1 Hz, 1H), 7.29 (d, <i>J</i> = 7.3 Hz, 1H), 7.17 (app t, <i>J</i> = 7.4 Hz, 1H), 6.98 (d, <i>J</i> = 8.1 Hz, 1H), 3.81 (s, 3H), 2.53 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 145.2, 138.0, 137.9, 123.5, 123.4, 122.2, 121.8, 120.7, 120.5, 118.6, 118.5, 118.0, 110.5, 108.9, 29.2, 10.4. υ<sub>max</sub> (neat): 2992, 2852, 1693, 1571, 1550 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 299.0854, found <i>m</i>/<i>z</i> 299.0853</div></div><div id="sec3_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 6-((1-Cyclopentyl-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>38</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using ethyl 6-((2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>36</b>) (300 mg, 0.962 mmol, 1 equiv), NaH 60% w/w (116 mg, 2.89 mmol, 3 equiv), and bromocyclopentane (309 μL, 2.89 mmol, 3 equiv) in DMF (3 mL, 0.3 M). Purified by reverse-phase HPLC to afford the title compound as a yellow amorphous solid (36 mg, 11%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.10 (s, 1H), 7.70 (d, <i>J</i> = 7.6 Hz, 1H), 7.49 (d, <i>J</i> = 7.8 Hz, 1H), 7.41–7.37 (m, 2H), 7.24–7.19 (m, 1H), 7.16–7.11 (m, 1H), 6.79 (d, <i>J</i> = 8.7 Hz, 1H), 5.49–5.44 (m, 1H), 2.53 (s, 3H), 2.07–1.96 (m, 2H), 1.93–1.75 (m, 4H), 1.67–1.62 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 164.3, 163.7, 147.7, 141.4, 136.7, 135.3, 129.3, 121.9, 121.8, 120.3, 119.9, 118.1, 110.6, 96.9, 78.3, 32.2, 23.3, 11.7. υ<sub>max</sub> (neat): 3275, 2918, 1714, 1570 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>20</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 351.1173, found <i>m</i>/<i>z</i> 351.1170.</div></div><div id="sec3_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 6-((2-Methyl-1-phenyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>39</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using ethyl 6-((2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>36</b>) (200 mg, 0.641 mmol, 1 equiv), bromobenzene (204 μL, 1.92 mmol, 3 equiv), CuO (102 mg, 1.28 mmol, 2 equiv), and K<sub>2</sub>CO<sub>3</sub> (115 mg, 0.833 mmol, 1.3 equiv) in pyridine (2 mL, 0.3 M). Purified by reverse-phase HPLC to afford the title compound as a brown amorphous solid (12 mg, 5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (d, <i>J</i> = 7.4 Hz, 1H), 7.67–7.49 (m, 5H), 7.41–7.39 (m, 2H), 7.23–7.14 (m, 3H), 7.12 (d, <i>J</i> = 8.0 Hz, 1H), 2.39 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 163.2, 161.6, 145.3, 142.9, 138.0, 137.7, 136.7, 129.3, 128.2, 127.4, 123.6, 122.3, 121.1, 118.7, 118.0, 110.3, 96.9, 11.2. υ<sub>max</sub> (neat): 2920, 2850, 1693, 1573, 1550 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>21</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 361.1010, found <i>m</i>/<i>z</i> 361.1010.</div></div><div id="sec3_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 6-((6-Chloro-1,2-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>40</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using ethyl 6-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>16</b>) (138 mg, 0.399 mmol, 1 equiv), NaH 60% w/w (64 mg, 1.60 mmol, 4 equiv), and MeI (74 μL, 1.19 mmol, 3 equiv) in DMF (2 mL, 0.2 M). Purified using reverse-phase HPLC to afford the title compound as a yellow amorphous solid (28 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.84 (d, <i>J</i> = 7.3 Hz, 1H), 7.58 (app t, <i>J</i> = 7.8 Hz, 1H), 7.43–7.36 (m, 2H), 7.12 (d, <i>J</i> = 8.3 Hz, 1H), 6.94 (d, <i>J</i> = 7.9 Hz, 1H), 3.76 (s, 3H), 2.51 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 161.6, 143.5, 138.0, 137.2, 127.8, 127.7, 127.1, 123.3, 121.1, 118.9, 118.8, 109.2, 95.4, 30.2, 29.2, 10.6. υ<sub>max</sub> (neat): 2916, 2848, 1703, 1573, 1556 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>14</sub>ClN<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 333.0462, found <i>m</i>/<i>z</i> 333.0463.</div></div><div id="sec3_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 6-((6-Chloro-1-cyclopentyl-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>41</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using ethyl 6-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>16</b>) (193 mg, 0.558 mmol, 1 equiv), NaH 60% w/w (178 mg 4.46 mmol, 8 equiv), and bromocyclopentane (359 μL, 3.35 mmol, 6 equiv) in DMF (3 mL, 0.2 M). Purified by reverse-phase HPLC to afford the title compound as an off-white solid (19 mg, 10%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.85 (dd, <i>J</i> = 7.5, 0.8 Hz, 1H), 7.65–7.57 (m, 1H), 7.48–7.43 (m, 2H), 7.42 (s, 1H), 7.11 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 6.96 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 4.85 (m, 1H), 2.54 (s, 3H), 2.33–2.20 (m, 2H), 2.20–2.04 (m, 4H), 1.90–1.77 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 163.6, 162.1, 145.7, 144.1, 138.5, 135.2, 128.6, 127.7, 123.9, 121.3, 119.7, 119.2, 111.6, 96.1, 57.5, 30.2, 25.2, 11.9. υ<sub>max</sub> (neat): 2958, 2872, 1699, 1570 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>20</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 385.0783, found <i>m</i>/<i>z</i> 385.0778.</div></div><div id="sec3_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 6-((6-Chloro-2-methyl-1-phenyl-1<i>H</i>-indol-3-yl)thio)picolinic Acid (<b>42</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 1,10-phenanthroline (104 mg, 0.578 mmol, 1 equiv), CuI (55 mg, 0.289 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (377 mg, 1.15 mmol, 2 equiv), iodobenzene (147 μL, 1.15 mmol, 2 equiv), and ethyl 6-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>16</b>) (200 mg, 0.578 mmol, 1 equiv) in DMF (2 mL, 0.1 M). Purified using MDAP to afford the title compound as a white amorphous solid (9 mg, 4%). <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.88 (d, <i>J</i> = 7.3 Hz, 1H), 7.66 (app t, <i>J</i> = 7.8 Hz, 1H), 7.61 (app t, <i>J</i> = 7.4 Hz, 2H), 7.55 (app t, <i>J</i> = 7.4, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.40–7.36 (m, 2H), 7.19–7.13 (m, 2H), 7.11 (d, <i>J</i> = 8.1 Hz, 1H), 2.37 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 162.6, 144.6, 138.6, 137.8, 136.8, 129.8, 128.8, 128.3, 127.8, 127.7, 122.1, 121.5, 120.2, 119.1, 110.1, 110.0, 98.3, 10.3. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3051, 1771, 1598, 1559, 1501 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>21</sub>H<sub>16</sub>ClN<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 395.0616, found <i>m</i>/<i>z</i> 395.0617.</div></div><div id="sec3_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-((3-Bromophenyl)thio)propan-2-one (<b>44</b>)</h4><div class="NLM_p last">A flask containing 3-bromothiophenol (<b>43</b>) (273 μL, 2.65 mmol, 1 equiv) in THF (15 mL, 0.2 M) was cooled to 0 °C. DIPEA (2.3 mL, 13.2 mmol, 5 equiv) was added portionwise and allowed to stir for 30 min before the addition of chloroacetone (2.3 mL, 29.0 mmol, 11 equiv). The reaction mixture was then allowed to warm to room temperature and stirred for 16 h. The reaction mixture was concentrated under vacuum, diluted with EtOAc (30 mL), and washed with H<sub>2</sub>O (30 mL). The organic layer was collected, dried (hydrophobic frit), and concentrated under vacuum. Purified using silica chromatography, eluting with 0–40% EtOAc/petroleum ether, to afford the title compound as a colorless oil (540 mg, 83%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45 (app t, <i>J</i> = 1.8 Hz, 1H), 7.33–7.29 (m, 1H), 7.24–7.20 (m, 1H), 7.13 (t, <i>J</i> = 7.9 Hz, 1H), 3.68 (s, 2H), 2.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 202.8, 137.2, 131.6, 130.4, 129.8, 127.6, 122.9, 44.3, 28.1. υ<sub>max</sub> (neat): 3050, 1571, 1559 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>9</sub>H<sub>10</sub>BrOS) requires <i>m</i>/<i>z</i> 246.9609, found <i>m</i>/<i>z</i> 246.9601.</div></div><div id="sec3_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 3-((3-Bromophenyl)thio)-6-chloro-2-methyl-1<i>H</i>-indole (<b>45</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using (3-chlorophenyl)hydrazine hydrochloride (1.5 g, 8.18 mmol, 1 equiv) and 1-((3-bromophenyl)thio)propan-2-one (<b>44</b>) (2 g, 8.18 mmol, 1 equiv) in EtOH (40 mL, 0.2 M). Purified by silica chromatography, eluting with 0–10% EtOAc/petroleum ether, to afford the title compound as a cream amorphous solid (639 mg, 22%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 10.97 (br s, 1H), 7.48 (d, <i>J</i> = 1.9 Hz, 1H), 7.38 (d, <i>J</i> = 8.4 Hz, 1H), 7.26–7.23 (m, 1H), 7.15 (app t, <i>J</i> = 7.9 Hz, 1H), 7.11 (app t, <i>J</i> = 1.8 Hz, 1H), 7.08 (dd, <i>J</i> = 8.4 Hz, 1H), 7.03–7.01 (m, 1H), 2.52 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 143.0, 142.8, 136.3, 132.2, 129.5, 127.3, 127.0, 125.4, 123.4, 122.4, 122.2, 121.8, 109.1, 97.8, 11.7. υ<sub>max</sub> (neat): 3409, 1573, 1557, 1536 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>12</sub>BrClNS) <i>m</i>/<i>z</i> requires 353.9534, <i>m</i>/<i>z</i> found 353.9529.</div></div><div id="sec3_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Methyl 3-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>46</b>)</h4><div class="NLM_p last">Prepared according to general procedure 7 using <i>trans</i>-bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl]dipalladium(II) (90 mg, 0.0959 mmol, 5 mol %), 3-((3-bromophenyl)thio)-6-chloro-2-methyl-1<i>H</i>-indole (<b>45</b>) (639 mg, 1.81 mmol, 1 equiv), Mo(CO)<sub>6</sub> (478 mg, 1.81 mmol, 1 equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (112 mg, 0.386 mmol, 20 mol %), and DBU (433 μL, 2.90 mmol, 1.6 equiv) in MeCN/MeOH (20 mL, 1:4, 0.3 M). Purified by column chromatography, eluting with 0–20% EtOAc/petroleum ether, to afford the title compound as a cream amorphous solid (463 mg, 77%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 10.92 (br s, 1H), 7.73–7.66 (m, 2H), 7.47 (d, <i>J</i> = 1.8 Hz, 1H), 7.38 (d, <i>J</i> = 8.4 Hz, 1H), 7.34–7.30 (m, 1H), 7.25–7.18 (m, 1H), 7.07 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 3.81 (s, 3H), 2.53 (s, 3H). <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 166.8, 144.4, 141.2, 137.4, 131.9, 130.6, 130.0, 129.7, 128.1, 126.9, 126.6, 121.6, 120.0, 112.1, 98.4, 52.4, 12.0. υ<sub>max</sub> (neat): 3405, 3321, 2950, 1699, 1621, 1591, 1575, 1539 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>15</sub>ClNO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 334.0476, <i>m</i>/<i>z</i> found 334.0474.</div></div><div id="sec3_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-((6-Chloro-1,2-dimethyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>47</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using methyl 3-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>46</b>) (200 mg, 0.604 mmol, 1 equiv), NaH 60% w/w (193 mg, 4.82 mmol, 8 equiv), and MeI (150 μL, 2.41 mmol, 4 equiv) in DMF (3 mL, 0.2 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 4 M aq NaOH (5 mL) in THF (3 mL, 0.2 <span class="smallcaps smallerCapital">m</span>). Purified by reverse-phase HPLC to afford the title compound as a cream amorphous solid (2 mg, 1% over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.82–7.73 (m, 2H), 7.43 (d, <i>J</i> = 8.4 Hz, 1H), 7.35 (d, <i>J</i> = 1.7 Hz, 1H), 7.23 (app t, <i>J</i> = 7.7 Hz, 1H), 7.19–7.13 (m, 1H), 7.09 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 3.75 (s, 3H), 2.51 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ: 170.1, 144.0, 140.6, 137.7, 130.6, 129.8, 129.0, 128.2, 128.1, 127.2, 126.6, 121.4, 119.8, 109.5, 98.0, 30.7, 11.1. υ<sub>max</sub> (neat): 3436, 2900, 2651, 2543, 1679, 1574 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>17</sub>H<sub>13</sub>ClNO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 332.0330, <i>m</i>/<i>z</i> found 332.0324.</div></div><div id="sec3_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 3-((4-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>48</b>) and 3-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic acid (<b>49</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using (3-chlorophenyl)hydrazine hydrochloride (3.3 g, 18.6 mmol, 1 equiv) and 1-((3-bromophenyl)thio)propan-2-one (<b>44</b>) (4.6 g, 18.6 mmol, 1 equiv) in EtOH (90 mL, 0.2 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 7 using <i>trans</i>-bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl]dipalladium(II) (200 mg, 0.213 mmol, 1 mol %), Mo(CO)<sub>6</sub> (4.9 g, 18.6 mmol, 1 equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (1.08 g, 3.72 mmol, 20 mol %), and DBU (4.2 mL, 27.9 mmol, 1.5 equiv) in MeCN/4 M aq NaOH (60 mL, 1:4, 0.3 M). One gram of crude material was purified by MDAP to afford 3-((4-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic acid (<b>48</b>) as a cream amorphous solid (100 mg, 2% over 2 steps) and 3-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic acid (<b>49</b>) as a cream amorphous solid (70 mg, 1% over 2 steps). 3-((4-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic acid (<b>48</b>): <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 11.04 (br s, 1H), 7.80–7.69 (m, 2H), 7.40 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.35–7.27 (m, 1H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 7.13–6.98 (m, 2H), 2.53 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 167.9, 145.3, 143.0, 138.5, 132.3, 130.2, 129.6, 126.9, 126.7, 126.5, 125.8, 123.1, 122.3, 111.2, 97.7, 12.0. υ<sub>max</sub> (neat): 3410, 2869, 2658, 2543, 1681, 1569, 1537 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>13</sub>ClNO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 318.0174, <i>m</i>/<i>z</i> found 318.0167. 3-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic acid (<b>49</b>): <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 10.84 (br s, 1H), 7.76–7.72 (m, 2H), 7.47 (d, <i>J</i> = 1.8 Hz, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.32 (app t, <i>J</i> = 7.5 Hz, 1H), 7.26–7.23 (m, 1H), 7.07 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 2.53 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 167.3, 144.3, 141.0, 137.4, 132.1, 130.5, 129.8, 129.7, 128.0, 127.2, 126.9, 121.5, 120.0, 112.1, 98.5, 12.0. υ<sub>max</sub> (neat): 3385, 2850, 2665, 2549, 1667, 1591, 1570, 1539 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>13</sub>ClNO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 318.0174, <i>m</i>/<i>z</i> found 318.0163.</div></div><div id="sec3_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 3-((6-Chloro-1-cyclopentyl-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>50</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using methyl 3-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>46</b>) (25 mg, 0.0755 mmol, 1 equiv), NaH 60% w/w (24 mg, 0.602 mmol, 8 equiv), and bromocyclopentane (32 μL, 0.301 mmol, 4 equiv) in DMF (1 mL, 0.1 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 4 M aq NaOH (1 mL) in THF (1 mL, 0.1 M). Purified using silica chromatography, eluting with 0–20% EtOAc/petroleum ether, to afford the title compound as a pale-yellow gum (2 mg, 7% over 2 steps). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 7.78–7.69 (m, 2H), 7.59 (d, <i>J</i> = 1.7 Hz, 1H), 7.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.32 (app t, <i>J</i> = 7.8 Hz, 1H), 7.21–7.18 (m, 1H), 7.09 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 5.20–5.04 (m, 1H), 2.62 (s, 3H), 2.28–2.19 (m, 4H), 2.16–2.06 (m, 2H), 1.91–1.78 (m, 2H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 145.9, 141.1, 136.4, 130.6, 130.2, 130.0, 127.9, 127.4, 127.1, 121.6, 120.7, 112.4, 98.8, 58.4, 30.8, 25.8, 12.1. Two carbons not observed/coincident. υ<sub>max</sub> (neat): 3406, 2924, 2872, 1716, 1608, 1593, 1577, 1534 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>21</sub>H<sub>21</sub>ClNO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 388.0945, <i>m</i>/<i>z</i> found 388.0948.</div></div><div id="sec3_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 3-((6-Chloro-2-methyl-1-phenyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>51</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using 3-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic acid (<b>49</b>) (65 mg, 0.205 mmol, 1 equiv), iodobenzene (46 μL, 0.409 mmol, 2 equiv), CuI (19 mg, 0.102 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (133 mg, 0.409 mmol, 2 equiv), and 1,10-phenanthroline (37 mg, 0.205 mmol, 1 equiv) in DMF (1 mL, 0.2 M). Purified by reverse-phase HPLC to afford the title compound as a white amorphous solid (11 mg, 14%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 7.81 (dd, <i>J</i> = 2.4, 1.1 Hz, 1H), 7.77 (dt, <i>J</i> = 7.3, 1.5 Hz, 1H), 7.73–7.66 (m, 2H), 7.66–7.59 (m, 1H), 7.59–7.54 (m, 2H), 7.51(d, <i>J</i> = 8.4 Hz, 1H), 7.40–7.27 (m, 2H), 7.16 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.13–7.08 (m, 1H), 2.41 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>) δ: 165.7, 144.1, 139.0, 138.0, 136.3, 130.9, 129.5, 129.3, 128.6, 128.5, 127.4, 126.0, 125.7, 121.0, 119.0, 109.8, 99.0, 10.4. Two carbons not observed/coincident. υ<sub>max</sub> (neat): 3058, 2978, 2924, 2658, 1690, 1593, 1577, 1536, 1502 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>22</sub>H<sub>15</sub>ClNO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 394.0487, <i>m</i>/<i>z</i> found 394.0480.</div></div><div id="sec3_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 3-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>52</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using methyl 3-((6-chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)benzoate (<b>90</b>) (68 mg, 0.165 mmol, 1 equiv) and 4 M aq NaOH (1 mL) in THF (1 mL, 0.2 M). Purified using silica chromatography, eluting with 10% MeOH/DCM, to afford the title compound as a cream amorphous solid (16 mg, 24%). <sup>1</sup>H NMR (500 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 11.29 (br s, 1H), 8.09 (s, 1H), 7.80 (s, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 1H), 7.72 (s, 1H), 7.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.35 (app t, <i>J</i> = 7.7 Hz, 1H), 7.29 (d, <i>J</i> = 7.9 Hz, 1H), 7.22 (s, 1H), 7.14 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 4.04 (s, 3H), 2.42 (s, 3H). <sup>13</sup>C NMR (126 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 146.4, 140.4, 140.0, 137.2, 132.3, 130.8, 130.0, 129.2, 129.0, 128.8, 127.5, 127.2, 122.4, 120.3, 119.3, 111.4, 100.0, 39.9, 11.7. One carbon not observed/coincident. υ<sub>max</sub> (neat): 2920, 2848, 1718, 1571, 1537 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>20</sub>H<sub>15</sub>ClN<sub>3</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 398.0548, <i>m</i>/<i>z</i> found 398.0539.</div></div><div id="sec3_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 3-((2-Methyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>53</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using methyl 3-((2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>) (100 mg, 0.337 mmol, 1 equiv) and 2 M aq NaOH (1 mL) in THF (1 mL, 0.3 M). Purified by reverse-phase HPLC to afford the title compound as a cream amorphous solid (71 mg, 74%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 10.71 (br s, 1H), 7.76 (app t, <i>J</i> = 1.5 Hz, 1H), 7.74–7.72 (m, 1H), 7.48–7.39 (m, 2H), 7.30 (app t, <i>J</i> = 7.7 Hz, 1H), 7.25–7.22 (m, 1H), 7.15–7.11 (m, 1H), 7.07–7.04 (m, 1H), 2.53 (s, 3H). One exchangeable proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 167.4, 143.1, 141.6, 137.0, 132.1, 131.0, 130.4, 129.7, 127.1, 126.7, 122.7, 121.1, 118.8, 112.1, 97.9, 12.0. υ<sub>max</sub> (neat): 3390, 3057, 2885, 2654, 2546, 1686, 1570, 1543 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>14</sub>NO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 284.0740, <i>m</i>/<i>z</i> found 284.0740.</div></div><div id="sec3_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 3-((1,2-Dimethyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>54</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using methyl 3-((1,2-dimethyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>93</b>) (54 mg, 0.174 mmol, 1 equiv) and 2 M aq NaOH (1 mL) in THF (1 mL, 0.2 M). Purified by reverse-phase HPLC to afford the title compound as a cream amorphous solid (31 mg, 60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.84 (app t, <i>J</i> = 1.5 Hz, 1H), 7.76–7.74 (m, 1H), 7.55 (d, <i>J</i> = 7.8 Hz, 1H), 7.36 (d, <i>J</i> = 8.2 Hz, 1H), 7.25–7.11 (m, 4H), 3.79 (s, 3H), 2.53 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 171.1, 143.2, 141.1, 137.3, 130.7, 129.8, 129.7, 128.9, 127.2, 126.4, 122.1, 120.8, 118.9, 109.3, 97.4, 30.6, 11.0. υ<sub>max</sub> (neat): 2922, 2546, 1680, 1572, 1521 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>16</sub>NO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 298.0896, <i>m</i>/<i>z</i> found 298.0893.</div></div><div id="sec3_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 3-((1-Cyclopentyl-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>55</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using methyl 3-((2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>) (200 mg, 0.673 mmol, 1 equiv), NaH 60% w/w (216 mg, 5.39 mmol, 8 equiv), and bromocyclopentane (288 μL, 2.69 mmol, 4 equiv) in DMF (3 mL, 0.2 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 4 M aq NaOH (5 mL) in THF (3 mL, 0.2 M). Purified by reverse-phase HPLC to afford the title compound as a white amorphous solid (15 mg, 6% over 2 steps). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 7.78–7.70 (m, 2H), 7.57 (d, <i>J</i> = 8.3 Hz, 1H), 7.49 (d, <i>J</i> = 7.5 Hz, 1H), 7.30 (app t, <i>J</i> = 7.7 Hz, 1H), 7.22–7.17 (m, 1H), 7.17–7.12 (m, 1H), 7.09–7.07 (m, 1H), 5.14–5.05 (m, 1H), 2.61 (s, 3H), 2.37–2.23 (m, 2H), 2.23–2.07 (m, 4H), 1.92–1.73 (m, 2H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 167.2, 144.5, 141.6, 135.9, 132.1, 131.4, 130.4, 129.8, 127.2, 126.8, 122.3, 121.0, 119.5, 112.5, 97.9, 58.2, 30.6, 25.8, 11.7. υ<sub>max</sub> (neat): 3388, 2976, 2954, 2870, 2660, 2539, 1668, 1591, 1571, 1530 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>21</sub>H<sub>20</sub>NO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 350.1220, <i>m</i>/<i>z</i> found 350.1216.</div></div><div id="sec3_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 3-((2-Methyl-1-phenyl-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>56</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 using methyl 3-((2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>) (127 mg, 0.428 mmol, 1 equiv), iodobenzene (95 μL, 0.856 mmol, 2 equiv), CuI (41 mg, 0.214 mmol, 0.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (279 mg, 0.856 mmol, 2 equiv), and 1,10-phenanthroline (77 mg, 0.428 mmol, 1 equiv) in DMF (1 mL, 0.4 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 4 M aq NaOH (1 mL) in THF (2 mL, 0.2 M). Purified by reverse-phase HPLC to afford the title compound as a cream amorphous solid (14 mg, 9% over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.95–7.89 (m, 1H), 7.82–7.76 (m, 1H), 7.63–7.55 (m, 3H), 7.54–7.48 (m, 1H), 7.41 (dd, <i>J</i> = 8.3, 1.3 Hz, 2H), 7.29–7.26 (m, 2H), 7.20–7.12 (m, 3H), 2.40 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 143.4, 140.6, 138.2, 137.6, 130.8, 129.8, 129.6, 129.0, 128.6, 128.1, 127.4, 126.6, 122.6, 121.4, 118.8, 110.6, 99.5, 11.9. Two carbons not observed/coincident. υ<sub>max</sub> (neat): 2917, 2852, 2651, 2536, 1679, 1597, 1571, 1530, 1501 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>22</sub>H<sub>16</sub>NO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 358.0907, <i>m</i>/<i>z</i> found 358.0900.</div></div><div id="sec3_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 3-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)benzoic Acid (<b>57</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using methyl 3-((2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>) (202 mg, 0.680 mmol, 1 equiv), 4-bromo-1-methyl-1<i>H</i>-pyrazole (209 μL, 2.02 mmol, 3 equiv), CuO (108 mg, 1.35 mmol, 2 equiv), and K<sub>2</sub>CO<sub>3</sub> (122 mg, 0.884 mmol, 1.3 equiv) in pyridine (2 mL, 0.3 M). Purified using reverse-phase HPLC to afford the title compound as a dark-red amorphous solid (22 mg, 9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.33 (s, 1H), 7.81 (app t, <i>J</i> = 1.7 Hz, 1H), 7.72–7.69 (m, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.33 (dd, <i>J</i> = 4.8, 3.9 Hz, 1H), 7.21–7.19 (m, 2H), 7.16–7.12 (m, 2H), 3.86 (s, 3H), 2.51 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 166.9, 141.3, 140.3, 135.5, 130.6, 130.1, 129.8, 128.7, 126.6, 125.8, 122.3, 120.8, 118.8, 110.8, 98.7, 52.2, 12.1. Three carbons not observed/coincident. υ<sub>max</sub> (neat): 3381, 3375, 1695, 1572, 1539 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>20</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 362.0969, <i>m</i>/<i>z</i> found 362.0967.</div></div><div id="sec3_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Ethyl 3-(2-Oxopropoxy)benzoate (<b>59</b>)</h4><div class="NLM_p last">Chloroacetone (2.4 mL, 30.1 mmol, 1 equiv) was added to a stirred suspension of ethyl 3-hydroxybenzoate (<b>58</b>) (5 g, 30.1 mmol, 1 equiv) and K<sub>2</sub>CO<sub>3</sub> (8.3 g, 60.2 mmol, 2 equiv) in acetone (150 mL, 0.2 M). The reaction mixture was heated to 60 °C for 16 h then allowed to return to room temperature and concentrated under vacuum. The residue was then dissolved in EtOAc (100 mL) and washed with water (100 mL), followed by 4 M aq NaOH (100 mL). The organic layer was collected, dried (hydrophobic frit), and concentrated under vacuum. Purified using silica chromatography, eluting with 10% EtOAc/petroleum ether, to afford the title compound as a yellow liquid (3.7 g, 55%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.70–7.68 (m, 1H), 7.53 (dd, <i>J</i> = 2.6, 1.4 Hz, 1H), 7.37 (app t, <i>J</i> = 8.0 Hz, 1H), 7.10 (dd, <i>J</i> = 8.2, 2.7, 1H), 4.60 (s, 2H), 4.37 (q, <i>J</i> = 7.1 Hz, 2H), 2.29 (s, 3H), 1.39 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 205.0, 166.3, 157.8, 132.3, 129.8, 123.1, 119.8, 115.0, 73.2, 61.3, 26.8, 14.4. υ<sub>max</sub> (neat): 2980, 2906, 1714, 1585 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>12</sub>H<sub>15</sub>O<sub>4</sub>) <i>m</i>/<i>z</i> requires 223.0965, <i>m</i>/<i>z</i> found 223.0966.</div></div><div id="sec3_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Ethyl 3-((2-Methyl-1<i>H</i>-indol-3-yl)oxy)benzoate (<b>60</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 using phenylhydrazine hydrochloride (653 mg, 4.50 mmol, 1 equiv) and ethyl 3-(2-oxopropoxy)benzoate (<b>59</b>) (1 g, 4.50 mmo, 1 equiv) in <i>t</i>BuOH (45 mL, 0.1 M) with additional 1 M HCl in Et<sub>2</sub>O (14 mL) and AcOH (14 mL). Purified by reverse-phase HPLC to afford the title compound as a pale-brown amorphous solid (167 mg, 12%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.91 (s, 1H), 7.79–7.71 (m, 2H), 7.34 (app t, <i>J</i> = 8.2 Hz, 1H), 7.28 (app t, <i>J</i> = 7.6 Hz, 2H), 7.20–7.12 (m, 2H), 7.06 (app t, <i>J</i> = 7.5 Hz, 1H), 4.39 (q, <i>J</i> = 7.1 Hz, 2H), 2.29 (s, 3H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 166.6, 159.4, 133.2, 132.0, 130.0, 129.5, 124.4, 122.9, 121.7, 121.5, 119.8, 119.7, 117.1, 116.6, 111.0, 61.2, 14.4, 10.1. υ<sub>max</sub> (neat): 3370, 2980, 1715, 1697, 1620, 1584 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>18</sub>NO<sub>3</sub>) <i>m</i>/<i>z</i> requires 296.1281, <i>m</i>/<i>z</i> found 296.1284.</div></div><div id="sec3_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 3-((2-Methyl-1<i>H</i>-indol-3-yl)oxy)benzoic Acid (<b>61</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 3-((2-methyl-1<i>H</i>-indol-3-yl)oxy)benzoate (<b>60</b>) (50 mg, 0.169 mmol, 1 equiv) and 1 M aq NaOH (1 mL) in THF (2 mL, 0.1 M). Purified by reverse-phase HPLC to afford the title compound as a brown oil (8 mg, 18%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.74–7.71 (m, 1H), 7.70–7.64 (m, 2H), 7.35 (app t, <i>J</i> = 7.9 Hz, 1H), 7.32–7.28 (m, 1H), 7.24–7.18 (m, 1H), 7.16–7.12 (m, 1H), 7.07–6.99 (m, 1H), 2.34 (s, 3H). NH and CO<sub>2</sub>H protons not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 170.9, 159.5, 133.3, 130.7, 130.1, 129.7, 124.3, 123.6, 122.0, 121.5, 120.9, 119.9, 117.2, 116.9, 111.0, 10.4. υ<sub>max</sub> (neat): 3404, 2920, 2558, 1690, 1584, 1572 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>14</sub>NO<sub>3</sub>) <i>m</i>/<i>z</i> requires 268.0968, <i>m</i>/<i>z</i> found 268.0971.</div></div><div id="sec3_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 3-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)oxy)benzoic Acid (<b>62</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using ethyl 3-((2-methyl-1<i>H</i>-indol-3-yl)oxy)benzoate (<b>60</b>) (94 mg, 0.319 mmol, 1 equiv), 4-bromo-1-methyl-1<i>H</i>-pyrazole (99 μL, 0.956 mmol, 3 equiv), CuO (51 mg, 0.638 mmol, 2 equiv), and K<sub>2</sub>CO<sub>3</sub> (57 mg, 0.415 mmol, 1.3 equiv) in pyridine (1 mL, 0.3 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 2 M aq NaOH (1 mL) in THF (1 mL, 0.3 M). Purified by reverse-phase HPLC to afford the title compound as a brown oil (4 mg, 4% over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.75–7.71 (m, 1H), 7.72–7.69 (m, 1H), 7.64 (s, 1H), 7.59 (s, 1H), 7.37 (app t, <i>J</i> = 7.9 Hz, 1H), 7.30–7.23 (m, 2H), 7.22–7.17 (m, 1H), 7.15–7.11 (m, 1H), 7.08–7.02 (m, 1H), 4.04 (s, 3H), 2.12 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 170.8, 159.4, 137.4, 136.0, 130.9, 130.8, 129.8, 127.7, 127.2, 123.7, 122.1, 121.0, 120.9, 120.3, 119.8, 117.2, 117.0, 110.3, 39.9, 9.6. υ<sub>max</sub> (neat): 3121, 3053, 2947, 1697, 1583 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub>) <i>m</i>/<i>z</i> requires 348.1343, <i>m</i>/<i>z</i> found 348.1344.</div></div><div id="sec3_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 3-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)oxy)benzoic Acid (<b>63</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using ethyl 3-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)oxy)benzoate (<b>94</b>) (150 mg, 0.454 mmol, 1 equiv) and 2 M aq NaOH (1 mL) in THF (1 mL, 0.4 M). Purified by reverse-phase HPLC to afford the title compound as an orange amorphous solid (30 mg, 22%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 9.95 (br s, 1H), 7.44–7.41 (m, 1H), 7.28 (dd, <i>J</i> = 2.5, 1.5 Hz, 1H), 7.16 (app t, <i>J</i> = 7.9 Hz, 1H), 7.13 (d, <i>J</i> = 1.7 Hz, 1H), 6.94 (dd, <i>J</i> = 8.2, 2.6 Hz, 1H), 6.87 (d, <i>J</i> = 8.4 Hz, 1H), 6.69 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 2.05 (s, 3H). One exchangeable proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 167.3, 160.4, 134.7, 133.2, 130.6, 130.4, 127.5, 126.9, 123.9, 120.7, 120.5, 118.4, 116.7, 112.0, 111.9, 10.1. υ<sub>max</sub> (neat): 3327, 3071, 1690, 1601, 1585, 1520 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>13</sub>ClNO<sub>3</sub>) <i>m</i>/<i>z</i> requires 304.0549, <i>m</i>/<i>z</i> found 304.0544.</div></div><div id="sec3_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 3-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)oxy)benzoic Acid (<b>64</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using (3-chlorophenyl)hydrazine hydrochloride (1.9 g, 10.8 mmol, 1 equiv) and ethyl 3-(2-oxopropoxy)benzoate (<b>59</b>) (2.4 g, 10.8 mmol, 1 equiv) in EtOH (50 mL, 0.2 M). One gram of the crude material was then used according to general procedure 4 using 4-bromo-1-methyl-1<i>H</i>-pyrazole (940 μL, 9.10 mmol, 3 equiv), CuO (1.4 g, 18.2 mmol, 6 equiv), and K<sub>2</sub>CO<sub>3</sub> (1.6 g, 11.8 mmol, 4 equiv) in pyridine (15 mL, 0.7 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 2 M aq NaOH (30 mL) in THF (15 mL, 0.7 M). Purified by reverse-phase HPLC to afford the title compound as a cream amorphous solid (36 mg, 1% over 3 steps). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 8.05 (s, 1H), 7.77–7.67 (m, 2H), 7.62 (dd, <i>J</i> = 2.6, 1.5 Hz, 1H), 7.45 (app t, <i>J</i> = 7.9 Hz, 1H), 7.26 (dd, <i>J</i> = 8.3, 2.7 Hz, 1H), 7.24–7.16 (m, 2H), 7.03 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 4.03 (s, 3H), 2.21 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 167.3, 160.0, 137.2, 137.0, 133.1, 131.1, 130.7, 129.4, 129.1, 128.3, 124.1, 121.3, 120.8, 120.4, 119.2, 118.6, 116.8, 111.0, 39.8, 9.5. υ<sub>max</sub> (neat): 3122, 2949, 2921, 1696, 1606, 1584 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>17</sub>ClN<sub>3</sub>O<sub>3</sub>) <i>m</i>/<i>z</i> requires 384.0924, <i>m</i>/<i>z</i> found 384.0926.</div></div><div id="sec3_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>66</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using 6-chloro-2-methyl-1<i>H</i>-indole (<b>65</b>) (300 mg, 1.81 mmol, 1 equiv), 4-bromo-1-methyl-1<i>H</i>-pyrazole (224 μL, 2.17 mmol, 1.2 equiv), CuO (290 mg, 3.62 mmol, 2 equiv), and K<sub>2</sub>CO<sub>3</sub> (325 mg, 2.36 mmol, 1.3 equiv) in pyridine (3.5 mL, 0.5 M). Purified using silica chromatography, eluting with 0–30% EtOAc/petroleum ether, to afford the title compound as a brown amorphous solid (351 mg, 79%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.56 (s, 1H), 7.50 (s, 1H), 7.42 (d, <i>J</i> = 8.3 Hz, 1H), 7.13–7.08 (m, 1H), 7.06 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 6.33 (s, 1H), 4.01 (s, 3H), 2.27 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 139.4, 138.6, 137.3, 127.5, 127.2, 126.8, 120.8, 120.5, 119.7, 110.1, 101.2, 39.8, 13.2. υ<sub>max</sub> (neat): 3119, 2943, 1715, 1676, 1607, 1580 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>13</sub>H<sub>13</sub>ClN<sub>3</sub>) <i>m</i>/<i>z</i> requires 248.0763, <i>m</i>/<i>z</i> found 248.0766.</div></div><div id="sec3_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Methyl 6-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)picolinate (<b>67</b>)</h4><div class="NLM_p last">Prepared according to general procedure 7 using <i>trans</i>-bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl]dipalladium(II) (9 mg, 0.00959 mmol, 5 mol %), 3-((6-bromopyridin-2-yl)methyl)-6-chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>97</b>) (84 mg, 0.202 mmol, 1 equiv), Mo(CO)<sub>6</sub> (53 mg, 0.202 mmol, 1 equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (12 mg, 0.0414 mmol, 20 mol %), and DBU (45 μL, 0.303 mmol, 1.5 equiv) in MeCN/MeOH (2.5 mL, 1:4, 0.1 M). Purified using silica chromatography, eluting with 50–70% EtOAc/petroleum ether, to afford the title compound as a cream amorphous solid (61 mg, 76%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 7.96 (s, 1H), 7.88 (dd, <i>J</i> = 7.7, 1.0 Hz, 1H), 7.80 (app t, <i>J</i> = 7.7 Hz, 1H), 7.60 (s, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.07 (d, <i>J</i> = 1.7 Hz, 1H), 7.00 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 4.32 (s, 2H), 4.01 (s, 3H), 3.93 (s, 3H), 2.36 (s, 3H). <sup>13</sup>C NMR (151 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 166.5, 162.6, 148.6, 139.5, 138.4, 137.3, 137.0, 128.9, 127.7, 127.6, 126.5, 123.2, 120.8, 120.4, 119.9, 110.7, 110.4, 52.6, 39.8, 34.0, 11.1. υ<sub>max</sub> (neat): 3086, 3057, 2950, 2917, 2855, 1712, 1610, 1593, 1584 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>21</sub>H<sub>20</sub>ClN<sub>4</sub>O<sub>2</sub>) <i>m</i>/<i>z</i> requires 397.1240, <i>m</i>/<i>z</i> found 397.1236.</div></div><div id="sec3_2_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 6-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)picolinic Acid (<b>68</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using methyl 6-((6-chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)picolinate (<b>67</b>) (50 mg, 0.126 mmol, 1 equiv) and 2 M aq NaOH (2 mL) in THF (2 mL, 0.1 M). Purified by reverse-phase HPLC to afford the title compound as a yellow oil (23 mg, 48%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 8.10–7.82 (m, 3H), 7.61 (s, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 7.6, 1.0 Hz, 1H), 7.08 (d, <i>J</i> = 1.8 Hz, 1H), 7.01 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 4.37 (s, 2H), 4.01 (s, 3H), 2.36 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 165.3, 161.9, 147.1, 139.7, 139.6, 137.3, 137.1, 128.9, 127.7, 127.7, 127.5, 122.2, 120.9, 120.2, 119.9, 110.5, 110.4, 39.8, 33.4, 11.1. υ<sub>max</sub> (neat): 3097, 2922, 1716, 1684, 1670, 1610, 1588 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>18</sub>ClN<sub>4</sub>O<sub>2</sub>) <i>m</i>/<i>z</i> requires 383.1084, <i>m</i>/<i>z</i> found 383.1084.</div></div><div id="sec3_2_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)benzoic Acid (<b>69</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using methyl 3-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)methyl)benzoate (<b>96</b>) (345 mg, 1.10 mmol, 1 equiv), 4-bromo-1-methyl-1<i>H</i>-pyrazole (227 μL, 2.20 mmol, 2 equiv), CuO (176 mg, 2.20 mmol, 2 equiv), and K<sub>2</sub>CO<sub>3</sub> (197 mg, 1.43 mmol, 1.3 equiv) in pyridine (3 mL, 0.4 M). Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 2 M aq NaOH (2 mL) in THF (2 mL, 0.5 M). Purified by reverse-phase HPLC to afford the title compound as a white amorphous solid (5 mg, 1% over 2 steps). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 8.00–7.94 (m, 2H), 7.85 (d, <i>J</i> = 7.6 Hz, 1H), 7.62 (s, 1H), 7.52 (dd, <i>J</i> = 7.7, 0.6 Hz, 1H), 7.45–7.36 (m, 2H), 7.08 (d, <i>J</i> = 1.7 Hz, 1H), 7.00 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 4.21 (s, 2H), 4.01 (s, 3H), 2.32 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 167.7, 143.0, 139.6, 137.3, 136.6, 133.7, 131.6, 130.3, 129.4, 128.9, 128.1, 127.7, 127.6, 120.8, 120.1, 119.9, 111.7, 110.5, 39.8, 30.6, 11.1. υ<sub>max</sub> (neat): 2922, 2554, 2361, 2153, 1693, 1606, 1585 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>21</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>2</sub>) <i>m</i>/<i>z</i> requires 382.1131, <i>m</i>/<i>z</i> found 382.1134.</div></div><div id="sec3_2_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 3-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)benzoic Acid (<b>70</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using methyl 3-((2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)benzoate (<b>100</b>) (100 mg, 0.278 mmol, 1 equiv) and 2 M aq NaOH (2 mL) in THF (2 mL, 0.1 M). Purified by reverse-phase HPLC to afford the title compound as cream amorphous solid (10 mg, 10%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 7.99 (s, 1H), 7.92 (s, 1H), 7.84 (d, <i>J</i> = 7.7 Hz, 1H), 7.59 (d, <i>J</i> = 0.6 Hz, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 7.44 (d, <i>J</i> = 7.2 Hz, 1H), 7.38 (app t, <i>J</i> = 7.7 Hz, 1H), 7.14–6.95 (m, 3H), 4.21 (s, 2H), 4.01 (s, 3H), 2.33 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (151 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 143.4, 139.1, 137.3, 135.2, 133.8, 131.5, 130.3, 129.3, 129.0, 128.6, 128.0, 122.0, 120.7, 120.5, 118.8, 111.5, 110.6, 39.7, 30.8, 11.0. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3113, 3051, 2918, 2467, 1699, 1605, 1584 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>21</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>) <i>m</i>/<i>z</i> requires 344.1405, <i>m</i>/<i>z</i> found 344.1403.</div></div><div id="sec3_2_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 6-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)picolinic Acid (<b>71</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 using methyl 6-((2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)picolinate (<b>102</b>) (50 mg, 0.139 mmol, 1 equiv) and 2 M aq NaOH (1 mL) in THF (1 mL, 0.1 M). Purified by reverse-phase HPLC to afford the title compound as a green gum (21 mg, 44%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.50 (br s, 1H), 8.15 (d, <i>J</i> = 7.6 Hz, 1H), 7.97 (app t, <i>J</i> = 7.8 Hz, 1H), 7.66 (s, 1H), 7.59 (s, 1H), 7.50 (d, <i>J</i> = 7.9 Hz, 1H), 7.39 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (d, <i>J</i> = 3.6 Hz, 2H), 7.11 (dd, <i>J</i> = 7.7, 4.1 Hz, 1H), 4.53 (s, 2H), 4.06 (s, 3H), 2.28 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 163.4, 159.8, 144.8, 142.1, 138.4, 137.0, 135.6, 128.3, 127.8, 127.7, 122.9, 122.3, 120.8, 120.2, 117.8, 110.2, 107.4, 39.7, 31.1, 11.0. υ<sub>max</sub> (neat): 3103, 2950, 1725, 1716, 1696, 1670, 1616, 1588 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>20</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub>) <i>m</i>/<i>z</i> requires 345.1357, <i>m</i>/<i>z</i> found 345.1355.</div></div><div id="sec3_2_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Methyl 6-Bromopicolinate (<b>73</b>)</h4><div class="NLM_p last">Concentrated H<sub>2</sub>SO<sub>4</sub> (0.35 mL) was added to a round bottomed flask containing 6-bromopicoline (<b>72</b>) (1 g, 4.95 mmol, 1 equiv) in MeOH (30 mL, 0.2 M). The reaction mixture was heated to reflux under N<sub>2</sub> for 16 h, then cooled to 0 °C and 35% aq NH<sub>4</sub>OH (1.6 mL) was added. The resulting solution was then concentrated under vacuum, dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), and washed with brine (50 mL). The organic layer was collected, dried (hydrophobic frit), and concentrated under vacuum to afford the title compound as a white amorphous solid (900 mg, 84%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.09 (dd, <i>J</i> = 7.0, 1.5 Hz, 1H), 7.73–7.66 (m, 2H), 4.00 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 164.4, 148.7, 142.1, 139.2, 131.8, 124.0, 53.1. υ<sub>max</sub> (neat): 3000, 1719, 1678, 1562 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>7</sub>H<sub>5</sub>BrNO<sub>2</sub>) <i>m</i>/<i>z</i> requires 217.9634, found 217.9632.</div></div><div id="sec3_2_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Methyl 6-((3-Bromophenyl)thio)picolinate (<b>74</b>)</h4><div class="NLM_p last">Methyl 6-bromopicolinate (<b>73</b>) (499 mg, 2.31 mmol, 1.1 equiv), Cs<sub>2</sub>CO<sub>3</sub> (1.4 g, 4.36 mmol, 2 equiv), and 3-bromothiophenol (218 μL, 2.12 mmol, 1 equiv) were dissolved in DMF (10 mL, 0.2 M) and stirred at 45 °C under N<sub>2</sub> for 16 h. The reaction mixture was diluted with H<sub>2</sub>O (30 mL) and extracted using EtOAc (3 × 30 mL). The organic layers were combined, dried (hydrophobic frit), and concentrated under vacuum. Purified using silica chromatography, eluting with 10–40% EtOAc/petroleum ether, to afford the title compound as a white amorphous solid (260 mg, 38%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.86 (d, <i>J</i> = 7.6 Hz, 1H), 7.83–7.79 (m, 1H), 7.63 (app t, <i>J</i> = 7.9 Hz, 1H), 7.57–7.53 (m, 2H), 7.32 (d, <i>J</i> = 7.9 Hz, 1H), 7.06 (d, <i>J</i> = 8.1 Hz, 1H), 3.98 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 165.0, 151.4, 143.9, 142.3, 140.7, 137.0, 136.2, 135.1, 128.8, 127.9, 126.7, 125.5, 55.9 υ<sub>max</sub> (neat): 2960, 1724, 1560 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>13</sub>H<sub>9</sub>BrNO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 325.9666, <i>m</i>/<i>z</i> found 325.9666.</div></div><div id="sec3_2_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 6-((3-(1-Methyl-1<i>H</i>-pyrazol-4-yl)phenyl)thio)picolinic Acid (<b>75</b>)</h4><div class="NLM_p last">Pd(OAc)<sub>2</sub> (2 mg, 0.00893 mmol, 1 mol %) was added to a solution of methyl 6-((3-bromophenyl)thio)picolinate (<b>74</b>) (280 mg, 0.864 mmol, 1 equiv), 1-methylpyrazole-4-boronic acid pinacol ester (269 mg, 1.29 mmol, 1.5 equiv), and S-Phos (707 mg, 1.72 mmol, 2 equiv) in THF:H<sub>2</sub>O (0.8 mL, 7:1, 1 M) then heated to 50 °C for 16 h under N<sub>2</sub>. Following aqueous workup, the reaction mixture was then used in the next step without further purification. The crude material was used according to general procedure 3 using 2 M aq NaOH (0.3 mL). Purified by reverse-phase HPLC to afford the title compound as a cream amorphous solid (37 mg, 14% over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.90 (d, <i>J</i> = 7.3 Hz, 1H), 7.77 (s, 1H), 7.75–7.67 (m, 2H), 7.64 (s, 1H), 7.62–7.55 (m, 1H), 7.51–7.42 (m, 2H), 7.24 (s, 1H), 3.95 (s, 3H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 138.6, 138.2, 136.3, 134.3, 132.7, 131.7, 130.6, 129.9, 128.9, 126.7, 126.5, 121.6, 93.7, 42.4, 38.7. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3140, 1682, 1634, 1600, 1537, 1403 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>14</sub>N<sub>3</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 312.0801, <i>m</i>/<i>z</i> found 312.0801.</div></div><div id="sec3_2_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 4-Mercaptobutanoic Acid (<b>77</b>)</h4><div class="NLM_p last">Prepared according to the literature procedure.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> A solution of 4-bromobutyric acid (<b>76</b>) (3 g, 18.0 mmol, 1 equiv) and thiourea (2 g, 29.8 mmol, 1.6 equiv) in EtOH (26 mL, 0.7 M) was heated at reflux for 3 h, then allowed to return to room temperature and concentrated under vacuum. The residue was then dissolved in 7.5 M aq NaOH (20 mL) and refluxed for 16 h. The reaction mixture was then cooled to 0 °C, acidified using 2 M aq H<sub>2</sub>SO<sub>4</sub>, and extracted using CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The organics were combined, dried (hydrophobic frit), and concentrated under vacuum to afford the title compound as a colorless oil (1.7 g, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.07 (br s, 1H), 2.62–2.53 (m, 2H), 2.49 (t, <i>J</i> = 7.3 Hz, 2H), 1.95–1.89 (m, 2H), 1.35 (t, <i>J</i> = 8.1 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 179.5, 32.4, 28.6, 23.8. υ<sub>max</sub> (neat): 2960, 2550, 1703 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>4</sub>H<sub>9</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 121.0318, <i>m</i>/<i>z</i> found 121.0315.</div></div><div id="sec3_2_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 4-((2-Oxopropyl)thio)butanoic Acid (<b>78</b>)</h4><div class="NLM_p last">A solution of 4-mercaptobutanoic acid (<b>77</b>) (1.2 g, 10.0 mmol, 1 equiv) and DIPEA (4.4 mL, 25.0 mmol, 2.5 equiv) in THF (30 mL, 0.3 M) was cooled to 0 °C, followed by the addition of chloroacetone (813 μL, 10.5 mmol, 1.05 equiv) portionwise. The reaction mixture was then allowed to return to room temperature and stirred for 16 h. The reaction was then diluted with EtOAc (50 mL) and washed with water (3 × 30 mL) and brine (1 × 30 mL). The organic layer was then collected, dried (hydrophobic frit), and concentrated under vacuum. Purified using silica chromatography, eluting with CH<sub>2</sub>Cl<sub>2</sub>, to afford the title compound as a clear oil (266 mg, 15%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.14 (br s, 1H), 3.20 (s, 2H), 2.52 (t, <i>J</i> = 7.2 Hz, 2H), 2.44 (t, <i>J</i> = 7.3 Hz, 2H), 2.27 (s, 3H), 1.96–1.89 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 203.7, 178.2, 41.0, 32.1, 30.6, 27.3, 23.2. υ<sub>max</sub> (neat): 2924, 2529, 1701 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>7</sub>H<sub>13</sub>O<sub>3</sub>S) <i>m</i>/<i>z</i> requires 177.0580, <i>m</i>/<i>z</i> found 177.0575.</div></div><div id="sec3_2_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-(2-Methyl-1<i>H</i>-indol-3-yl)butanoic Acid (<b>79</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 using 4-((2-oxopropyl)thio)butanoic acid (<b>78</b>) (400 mg, 2.27 mmol, 1 equiv) and phenylhydrazine hydrochloride (329 mg, 2.27 mmol, 1 equiv) in <i>t</i>BuOH (15 mL, 0.2 M) with additional 1 M HCl in Et<sub>2</sub>O (0.4 mL) and AcOH (1 mL). Purified using reverse-phase HPLC to afford the title compound as a yellow oil (308 mg, 54%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.09 (s, 1H), 7.70–7.63 (m, 1H), 7.31–7.27 (m, 1H), 7.19–7.13 (m, 2H), 2.69 (t, <i>J</i> = 7.0 Hz, 2H), 2.53 (s, 3H), 2.50 (t, <i>J</i> = 7.4 Hz, 2H) 1.85–1.78 (m, 2H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 178.7, 140.0, 135.3, 130.5, 121.9, 120.3, 118.6, 110.6, 101.8, 35.1, 32.5, 24.7, 12.2. υ<sub>max</sub> (neat): 3323, 2926, 2851, 1622, 1566 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>13</sub>H<sub>14</sub>NO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 248.0751, <i>m</i>/<i>z</i> found 248.0752.</div></div><div id="sec3_2_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-(2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)butanoic Acid (<b>80</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using 4-(2-methyl-1<i>H</i>-indol-3-yl)butanoic acid (<b>79</b>) (200 mg, 0.803 mmol, 1 equiv), CuO (128 mg, 1.60 mmol, 2 equiv), K<sub>2</sub>CO<sub>3</sub> (144 mg, 1.04 mmol, 1.3 equiv), and 1-methyl-4-bromopyrazole (248 μL, 2.40 mmol, 3 equiv) in pyridine (2 mL, 0.4 M) to afford the title compound as a brown oil (4 mg, 2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (dd, <i>J</i> = 6.5, 1.4 Hz, 1H), 7.60 (s, 1H), 7.54 (s, 1H), 7.22–7.13 (m, 3H), 4.03 (s, 3H), 2.73 (t, <i>J</i> = 7.1 Hz, 2H), 2.52 (t, <i>J</i> = 7.4 Hz, 2H), 2.40 (s, 3H), 1.88–1.80 (m, 2H). CO<sub>2</sub>H proton not observed. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 102.5, 93.6, 92.6, 92.5, 92.3, 90.5, 89.9, 88.5, 88.2, 87.6, 85.5, 83.6, 67.8, 66.6, 65.9, 64.0, 60.7. υ<sub>max</sub> (neat): 2910, 2600, 1719, 1580 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 330.1271, <i>m</i>/<i>z</i> found 333.1267.</div></div><div id="sec3_2_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-((6-Chloro-2-methyl-1-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)butanoic Acid (<b>81</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 using 4-((2-oxopropyl)thio)butanoic acid (<b>78</b>) (400 mg, 2.27 mmol, 1 equiv) and 3-chlorophenylhydrazine hydrochloride (406 mg, 2.27 mmol, 1 equiv) in <i>t</i>BuOH (15 mL, 0.2 M), with additional 1 M HCl in Et<sub>2</sub>O (1 mL) and AcOH (1 mL). The crude material was then used according to general procedure 4 using CuO (225 mg, 2.81 mmol, 1.2 equiv), K<sub>2</sub>CO<sub>3</sub> (252 mg, 1.83 mmol, 0.8 equiv), and 1-methyl-4-bromopyrazole (437 μL, 4.23 mmol, 1.9 equiv) in pyridine (4 mL, 0.6 M). Purified by reverse-phase HPLC to afford the title compound as a brown oil (7 mg, 1% over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.60–7.58 (m, 2H), 7.55 (s, 1H), 7.14 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.11 (d, <i>J</i> = 1.6 Hz, 1H), 4.03 (s, 3H), 2.71 (t, <i>J</i> = 7.1 Hz, 2H), 2.51 (t, <i>J</i> = 7.4 Hz, 2H), 2.38 (s, 3H), 1.87–1.80 (m, 2H). CO<sub>2</sub>H proton not observed.<sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 176.6, 142.8, 138.2, 136.6, 136.6, 128.0, 127.6, 121.0, 119.0, 110.0, 109.7, 102.5, 39.3, 34.8, 31.7, 24.3, 11.1. υ<sub>max</sub> (neat): 3409, 3000, 2900, 1660 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 364.0881, found <i>m</i>/<i>z</i> 364.0878.</div></div><div id="sec3_2_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Ethyl 6-((5-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>82</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (1 g, 4.18 mmol, 1 equiv) and (4-chlorophenyl)hydrazine hydrochloride (749 mg, 4.18 mmol, 1 equiv) in EtOH (25 mL, 0.2 M). Purified using silica chromatography, eluting with 0–50% EtOAc/cyclohexane to afford the title compound as a brown amorphous solid (460 mg, 32%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.75 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.59 (app t, <i>J</i> = 7.9 Hz, 1H), 7.36–7.32 (m, 2H), 7.11 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.75 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 4.43 (q, <i>J</i> = 7.1 Hz, 2H), 2.49 (s, 3H), 1.42 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 164.7, 163.8, 147.5, 144.1, 137.7, 134.6, 130.9, 126.0, 122.3, 121.7, 120.4, 116.8, 112.1, 95.4, 61.6, 13.1, 10.4. υ<sub>max</sub> (neat): 3263, 1720, 1570, 1500 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>16</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 347.0616, <i>m</i>/<i>z</i> found 347.0626.</div></div><div id="sec3_2_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Ethyl 6-((7-Chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>83</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (550 mg, 2.30 mmol, 1 equiv) and (2-chlorophenyl)hydrazine hydrochloride (412 mg, 2.30 mmol, 1 equiv) in EtOH (12 mL, 0.2 M). Purified using silica chromatography, eluting with 0–50% EtOAc/cyclohexane, to afford the title compound as a yellow amorphous solid (386 mg, 48%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.74 (d, <i>J</i> = 7.2 Hz, 1H), 7.57 (app t, <i>J</i> = 7.9 Hz, 1H), 7.32 (d, <i>J</i> = 7.9 Hz, 1H), 7.15 (d, <i>J</i> = 7.6 Hz, 1H), 7.02 (app t, <i>J</i> = 7.8 Hz, 1H), 6.74 (d, <i>J</i> = 8.1 Hz, 1H), 4.43 (q, <i>J</i> = 7.1 Hz, 2H), 2.52 (s, 3H), 1.42 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 164.6, 163.8, 147.5, 143.8, 137.7, 133.2, 131.4, 122.4, 121.1, 120.9, 120.3, 116.3, 116.3, 96.9, 61.6, 13.1, 10.3. υ<sub>max</sub> (neat): 3300, 3000, 1722, 1571 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>16</sub>ClN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 347.0616, <i>m</i>/<i>z</i> found 347.0616.</div></div><div id="sec3_2_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Ethyl 6-((6-Fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>84</b>) and Ethyl 6-((4-Fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>85</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (1 g, 4.18 mmol, 1 equiv) and (3-fluorophenyl)hydrazine hydrochloride (677 mg, 4.18 mmol, 1 equiv) in EtOH (25 mL, 0.2 M). Purified using reverse-phase UPLC to afford ethyl 6-((6-fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>84</b>) as a yellow amorphous solid (563 mg, 41%) and ethyl 6-((4-fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>85</b>) as a yellow amorphous solid (332 mg, 24%). Ethyl 6-((6-fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>84</b>): <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72 (dd, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.58–7.51 (m, 1H), 7.30 (dd, <i>J</i> = 8.6, 5.2 Hz, 1H), 7.09 (dd, <i>J</i> = 9.6, 2.2 Hz, 1H), 6.84–6.79 (m, 1H), 6.74 (dd, <i>J</i> = 8.2, 0.9 Hz, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 2H), 2.46 (s, 3H), 1.41 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 164.6, 164.1, 159.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 236.1 Hz), 147.4, 142.8,(d, <i>J</i><sub>C–F</sub> = 2.9 Hz), 137.7, 136.1 (<sup>3</sup><i>J</i><sub>C–F</sub> = 12.5 Hz), 126.0, 122.4, 120.3, 118.3 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 10.1 Hz), 108.2 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 24.7 Hz), 97.2 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 26.5 Hz), 95.6, 61.6, 13.1, 10.4. <sup>19</sup>F NMR (376 MHz, MeOD): δ −123.5. υ<sub>max</sub> (neat): 3296, 3000, 1722, 1627, 1573, 1560 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>16</sub>FN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 331.0911, <i>m</i>/<i>z</i> found 331.0917. Ethyl 6-((4-fluoro-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>85</b>): <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.74 (dd, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.62–7.57 (m, 1H), 7.19 (d, <i>J</i> = 8.0 Hz, 1H), 7.09–7.04 (m, 1H), 6.86 (dd, <i>J</i> = 8.1, 0.7 Hz, 1H), 6.71–6.66 (m, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 2H), 2.47 (s, 3H), 1.41 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 165.0, 164.7, 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 246.5 Hz), 147.2, 142.8, 139.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 10.3 Hz), 137.6, 122.4, 122.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.6 Hz), 120.1, 117.7 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 17.2 Hz), 107.2 (d, <i>J</i><sub>C–F</sub> = 3.7 Hz), 105.2 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 19.2 Hz), 93.2, 61.6, 13.1, 10.1. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −130.41. υ<sub>max</sub> (neat): 3300, 3000, 1718, 1573 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>17</sub>H<sub>16</sub>FN<sub>2</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 331.0911, <i>m</i>/<i>z</i> found 331.0918.</div></div><div id="sec3_2_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Ethyl 6-((2,6-Dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>86</b>) and Ethyl 6-((2,4-Dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>87</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (1 g, 4.43 mmol, 1 equiv) and <i>m</i>-tolylhydrazine hydrochloride (704 mg, 4.43 mmol, 1 equiv) in EtOH (25 mL, 0.2 M). Purified using reverse-phase UPLC to afford ethyl 6-((2,6-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>86</b>) as a yellow amorphous solid (189 mg, 13%) and ethyl 6-((2,4-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>87</b>) as a yellow amorphous solid (156 mg, 11%). Ethyl 6-((2,6-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>86</b>): <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.70 (dd, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.53–7.46 (m, 1H), 7.22 (d, <i>J</i> = 8.1 Hz, 1H), 7.17 (s, 1H), 6.86 (dd, <i>J</i> = 8.0, 0.9 Hz, 1H), 6.72 (dd, <i>J</i> = 8.2, 0.9 Hz, 1H), 4.41 (q, <i>J</i> = 7.1 Hz, 2H), 2.45 (s, 3H), 2.40 (s, 3H), 1.41 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 164.7, 147.3, 141.4, 137.5, 136.6, 131.4, 127.3, 122.5, 121.6, 120.1, 117.1, 110.8, 95.0, 61.6, 20.3, 13.1, 10.3. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3296, 2950, 1720, 1574 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 327.1162, found <i>m</i>/<i>z</i> 327.1161. Ethyl 6-((2,4-dimethyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>87</b>): <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72 (dd, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.60–7.54 (m, 1H), 7.21 (d, <i>J</i> = 8.1 Hz, 1H), 7.02–6.96 (m, 1H), 6.82–6.73 (m, 2H), 4.42 (q, <i>J</i> = 7.1 Hz, 2H), 2.54 (s, 3H), 2.45 (s, 3H), 1.41 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (101 MHz, MeOD): δ 166.2, 164.7, 147.3, 142.3, 137.7, 136.4, 129.5, 127.1, 122.5, 121.8, 121.4, 120.0, 108.9, 95.1, 61.6, 17.5, 13.1, 10.3. υ<sub>max</sub> (neat): 3153, 2980, 1720, 1674, 1574 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S) requires <i>m</i>/<i>z</i> 327.1162, found <i>m</i>/<i>z</i> 327.1161.</div></div><div id="sec3_2_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Ethyl 6-((6-Methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>88</b>) and Ethyl 6-((4-Methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>89</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using ethyl 6-((2-oxopropyl)thio)picolinate (<b>13</b>) (1 g, 4.18 mmol, 1 equiv) and (3-methoxyphenyl)hydrazine hydrochloride (732 mg, 4.18 mmol, 1 equiv) in EtOH (25 mL, 0.2 M). Purified using reverse-phase UPLC to afford ethyl 6-((6-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>88</b>) as a brown amorphous solid (521 mg, 36%) and ethyl 6-((4-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>89</b>) as a yellow amorphous solid (282 mg, 20%). Ethyl 6-((6-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>88</b>): <sup>1</sup>H NMR (600 MHz, MeOD): δ 7.73 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.61–7.51 (m, 1H), 7.22 (d, <i>J</i> = 8.6 Hz, 1H), 6.93 (d, <i>J</i> = 2.2 Hz, 1H), 6.77 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 6.71 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 4.43 (q, <i>J</i> = 7.1 Hz, 2H), 3.81 (s, 3H), 2.44 (s, 3H), 1.42 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 164.6, 164.5, 156.7, 147.1, 140.9, 137.7, 136.9, 123.6, 122.6, 120.2, 118.0, 109.7, 94.9, 94.7, 61.6, 54.7, 13.1, 10.3. υ<sub>max</sub> (neat): 3000, 1726, 1627 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S) requires <i>m</i>/<i>z</i> 343.1111, found <i>m</i>/<i>z</i> 343.1113. Ethyl 6-((4-methoxy-2-methyl-1<i>H</i>-indol-3-yl)thio)picolinate (<b>89</b>): <sup>1</sup>H NMR (600 MHz, MeOD): δ 7.72 (dd, <i>J</i> = 7.5, 0.8 Hz, 1H), 7.57 (app t, <i>J</i> = 7.9 Hz, 1H), 7.04 (app t, <i>J</i> = 7.9 Hz, 1H), 6.99 (dd, <i>J</i> = 8.1, 0.6 Hz, 1H), 6.88 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 6.51 (d, <i>J</i> = 7.7 Hz, 1H), 4.43 (q, <i>J</i> = 7.1 Hz, 2H), 3.62 (s, 3H), 2.44 (s, 3H), 1.42 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (151 MHz, MeOD): δ 166.4, 164.7, 153.5, 146.7, 140.6, 137.8, 137.3, 123.1, 122.4, 119.8, 118.6, 104.4, 101.0, 94.3, 61.6, 54.4, 13.1, 10.2. υ<sub>max</sub> (neat): 3288, 2800, 1714, 1575, 1543, 1506 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S) requires <i>m</i>/<i>z</i> 343.1111, found <i>m</i>/<i>z</i> 343.1112.</div></div><div id="sec3_2_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Methyl 3-((6-Chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)thio)benzoate (<b>90</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using methyl 3-((6-chloro-2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>46</b>) (100 mg, 0.302 mmol, 1 equiv), CuO (48 mg, 0.604 mmol, 2 equiv), K<sub>2</sub>CO<sub>3</sub> (54 mg, 0.393 mmol, 1.3 equiv), and 1-methyl-4-bromopyrazole (94 μL, 0.906 mmol, 3 equiv) in pyridine (1 mL, 0.3 M). Purified using silica chromatography, eluting with 50% EtOAc/petroleum ether, to afford the title compound as a cream amorphous solid (74 mg, 59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.83–7.82 (m, 1H), 7.74–7.72 (m, 1H), 7.63 (s, 1H), 7.61 (s, 1H), 7.44 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (app t, <i>J</i> = 7.7 Hz, 1H), 7.19–7.15 (m, 2H), 7.11 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 4.05 (s, 3H), 3.87 (s, 3H), 2.38 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.9, 144.7, 139.7, 139.2, 137.2, 130.9, 130.1, 129.0, 128.7, 128.1, 127.7, 127.0, 126.2, 122.1, 119.8, 119.3, 110.6, 100.1, 52.4, 40.0, 11.8. υ<sub>max</sub> (neat): 3057, 2985, 2945, 2920, 2883, 2848, 1710, 1606, 1570, 1539 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>21</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>2</sub>S) <i>m</i>/<i>z</i> requires 414.0850, <i>m</i>/<i>z</i> found 414.0851.</div></div><div id="sec3_2_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 3-((3-Bromophenyl)thio)-2-methyl-1<i>H</i>-indole (<b>91</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 using phenylhydrazine hydrochloride (592 mg, 4.08 mmol, 1 equiv) and 1-((3-bromophenyl)thio)propan-2-one (<b>44</b>) (1 g, 4.08 mmol, 1 equiv) in EtOH (20 mL, 0.2 M). Purified using silica chromatography, eluting with 0–10% EtOAc/petroleum ether, to afford the title compound as a brown oil (1.2 g, 92%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.30 (br s, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.23–7.19 (m, 1H), 7.18–7.11 (m, 3H), 7.00 (app t, <i>J</i> = 8.1 Hz, 1H), 6.98–6.92 (m, 1H), 2.52 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 142.1, 141.5, 135.6, 130.1, 127.9, 127.7, 124.1, 123.0, 122.5, 121.0, 118.9, 110.9, 98.5, 12.3. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3392, 3055, 2980, 1573, 1556 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>15</sub>H<sub>13</sub>BrNS) <i>m</i>/<i>z</i> requires 319.9925, <i>m</i>/<i>z</i> found 319.9931.</div></div><div id="sec3_2_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Methyl 3-((2-Methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>)</h4><div class="NLM_p last">Prepared according to general procedure 7 using <i>trans</i>-bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl]dipalladium(II) (183 mg, 0.195 mmol, 5 mol %), 3-((3-bromophenyl)thio)-2-methyl-1<i>H</i>-indole (<b>91</b>) (1.2 g, 3.77 mmol, 1 equiv), Mo(CO)<sub>6</sub> (995 mg, 3.77 mmol, 1 equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (219 mg, 0.754 mmol, 20 mol %), and DBU (844 μL, 5.66 mmol, 1.5 equiv) in MeCN/MeOH (20 mL, 1:4, 0.2 M) to afford the title compound as a brown amorphous solid (1.03 g, 92%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.49 (br s, 1H), 7.81 (s, 1H), 7.70 (d, <i>J</i> = 7.6 Hz, 1H), 7.51 (d, <i>J</i> = 7.8 Hz, 1H), 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 7.22–7.09 (m, 4H), 3.86 (s, 3H), 2.50 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 166.9, 141.4, 140.4, 135.6, 130.6, 130.1, 129.8, 128.7, 126.6, 125.8, 122.2, 120.8, 118.8, 110.8, 52.1, 29.1, 12.1. υ<sub>max</sub> (neat): 3327, 2850, 1710 cm<sup>–1</sup>. HRMS: exact mass calculated for [M – H]<sup>−</sup> (C<sub>17</sub>H<sub>14</sub>NO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 296.0751, <i>m</i>/<i>z</i> found 296.0753.</div></div><div id="sec3_2_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Methyl 3-((1,2-Dimethyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>93</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 using methyl 3-((2-methyl-1<i>H</i>-indol-3-yl)thio)benzoate (<b>92</b>) (200 mg, 0.673 mmol, 1 equiv), NaH 60% w/w (54 mg, 1.35 mmol, 2 equiv), and MeI (84 μL, 1.35 mmol, 2 equiv) in THF (3 mL, 0.2 M). Purified using silica chromatography, eluting with 10% EtOAc/petroleum ether, to afford the title compound as a pale-yellow amorphous solid (71 mg, 34%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.87 (s, 1H), 7.74 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.59 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 8.2 Hz, 1H), 7.28 (app t, <i>J</i> = 7.1 Hz, 1H), 7.24–7.11 (m, 3H), 3.90 (s, 3H), 3.79 (s, 3H), 2.56 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 166.9, 143.1, 140.8, 137.3, 130.7, 129.9, 129.6, 128.8, 126.7, 125.8, 122.0, 120.7, 118.9, 109.3, 97.5, 52.2, 30.5, 11.0. υ<sub>max</sub> (neat): 2949, 1722, 1572, 1527 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>18</sub>NO<sub>2</sub>S) <i>m</i>/<i>z</i> requires 312.1053, <i>m</i>/<i>z</i> found 312.1055.</div></div><div id="sec3_2_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Ethyl 3-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)oxy)benzoate (<b>94</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 using (3-chlorophenyl)hydrazine hydrochloride (1.6 g, 9.01 mmol, 1 equiv) and ethyl 3-(2-oxopropoxy)benzoate (<b>59</b>) (2 g, 9.01 mmol, 1 equiv) in <i>t</i>BuOH (90 mL, 0.1 M) with additional 1 M HCl in Et<sub>2</sub>O (27 mL) and AcOH (10 mL). Purified by silica chromatography, eluting with 10% EtOAc/petroleum ether, to afford the title compound as a pale-brown amorphous solid (845 mg, 28%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.72–7.65 (m, 2H), 7.62 (dd, <i>J</i> = 2.5, 1.6 Hz, 1H), 7.31 (app t, <i>J</i> = 8.0 Hz, 1H), 7.29 (d, <i>J</i> = 1.6 Hz, 1H), 7.13 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (dd, <i>J</i> = 8.3, 2.6 Hz, 1H), 6.98 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 4.34 (q, <i>J</i> = 7.1 Hz, 2H), 2.32 (s, 3H), 1.36 (t, <i>J</i> = 7.1 Hz, 3H). NH proton not observed. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 166.4, 159.2, 133.6, 132.2, 129.6, 129.4, 127.9, 125.1, 123.1, 120.7, 120.3, 119.8, 118.2, 116.6, 111.0, 61.2, 14.4, 10.4. υ<sub>max</sub> (neat): 3350, 2982, 1713, 1701, 1585 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>17</sub>ClNO<sub>3</sub>) <i>m</i>/<i>z</i> requires 332.0862, <i>m</i>/<i>z</i> found 332.0867.</div></div><div id="sec3_2_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 3-(3-Bromobenzyl)-6-chloro-2-methyl-1<i>H</i>-indole (<b>95</b>)</h4><div class="NLM_p last">Prepared according to general procedure 8 using 3-bromobenzaldehyde (442 mg, 2.39 mmol, 1.1 equiv), 6-chloro-2-methyl-1<i>H</i>-indole (<b>65</b>) (360 mg, 2.17 mmol, 1 equiv), Et<sub>3</sub>SiH (451 μL, 2.83 mmol, 1.3 equiv), and TFA (249 μL, 3.26 mmol, 1.5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL, 0.2 M). Purified using silica chromatography, eluting with 0–5% EtOAc/petroleum ether, to afford the title compound as a white amorphous solid (587 mg, 73%). <sup>1</sup>H NMR (600 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 10.10 (br s, 1H), 7.38 (s, 1H), 7.34–7.28 (m, 3H), 7.23 (d, <i>J</i> = 7.7 Hz, 1H), 7.18 (app t, <i>J</i> = 7.8 Hz, 1H), 6.93 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 4.06 (s, 2H), 2.42 (s, 3H). <sup>13</sup>C NMR (151 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 145.7, 134.5, 131.9, 131.0, 129.5, 128.3, 128.1, 126.8, 122.8, 119.9, 119.7, 111.1, 110.2, 30.0, 11.6. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3409, 3053, 2911, 2850, 1692, 1613, 1593, 1567 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>16</sub>H<sub>14</sub>BrClN) <i>m</i>/<i>z</i> requires 337.9948, <i>m</i>/<i>z</i> found 337.9947.</div></div><div id="sec3_2_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Methyl 3-((6-Chloro-2-methyl-1<i>H</i>-indol-3-yl)methyl)benzoate (<b>96</b>)</h4><div class="NLM_p last">Prepared according to general procedure 7 using <i>trans</i>-bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl] dipalladium(II) (77 mg, 0.0821 mmol, 5 mol %), 3-(3-bromobenzyl)-6-chloro-2-methyl-1<i>H</i>-indole (<b>95</b>) (551 mg, 1.65 mmol, 1 equiv), Mo(CO)<sub>6</sub> (436 mg, 1.65 mmol, 1 equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (96 mg, 0.330 mmol, 20 mol %), and DBU (370 μL, 2.48 mmol, 1.5 equiv) in MeCN/MeOH (10 mL, 1:4, 0.2 M). Purified using silica chromatography, eluting with 0–15% EtOAc/petroleum ether, to afford the title compound as a pale-yellow amorphous solid (348 mg, 67%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 10.11 (br s, 1H), 7.89 (s, 1H), 7.81–7.78 (m, 1H), 7.53–7.44 (m, 1H), 7.37 (app t, <i>J</i> = 7.7 Hz, 1H), 7.33–7.28 (m, 2H), 6.91 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 4.13 (s, 2H), 3.83 (s, 3H), 2.43 (s, 3H). <sup>13</sup>C NMR (101 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 167.3, 143.5, 137.2, 134.4, 133.8, 131.2, 129.9, 129.3, 128.4, 127.7, 126.8, 119.9, 119.8, 111.2, 110.6, 52.2, 30.3, 11.7. υ<sub>max</sub> (neat): 3328, 2945, 2896, 1705, 1621, 1608 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>17</sub>ClNO<sub>2</sub>) <i>m</i>/<i>z</i> requires 316.0913, <i>m</i>/<i>z</i> found 316.0914.</div></div><div id="sec3_2_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 3-((6-Bromopyridin-2-yl)methyl)-6-chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>97</b>)</h4><div class="NLM_p last">Prepared according to general procedure 8 using 6-bromopyridine-2-carbaldehyde (91 mg, 0.489 mmol, 1.2 equiv), 6-chloro-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>66</b>) (100 mg, 0.406 mmol, 1 equiv), Et<sub>3</sub>SiH (84 μL, 0.529 mmol, 1.3 equiv), and TFA (47 μL, 0.610 mmol, 1.5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL, 0.2 M). Purified using silica chromatography, eluting with 0–50% EtOAc/petroleum ether, to afford the title compound as a yellow oil (94 mg, 56%). <sup>1</sup>H NMR (400 MHz, CO(CD<sub>3</sub>)<sub>2</sub>): δ 7.96 (s, 1H), 7.60 (s, 1H), 7.57 (app t, <i>J</i> = 7.7 Hz, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 1H), 7.39 (d, <i>J</i> = 7.8 Hz, 1H), 7.22 (d, <i>J</i> = 7.2 Hz, 1H), 7.08 (d, <i>J</i> = 1.6 Hz, 1H), 7.02 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 4.23 (s, 2H), 4.01 (s, 3H), 2.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 163.8, 141.9, 140.4, 139.5, 137.3, 137.1, 128.9, 127.6, 126.2, 122.4, 120.8, 120.2, 119.9, 110.5, 110.3, 39.8, 33.5, 11.1. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3114, 2921, 1612, 1582, 1554 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>17</sub>BrClN<sub>4</sub>) <i>m</i>/<i>z</i> requires 417.0297, <i>m</i>/<i>z</i> found 417.0294.</div></div><div id="sec3_2_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>98</b>)</h4><div class="NLM_p last">Prepared according to general procedure 4 using 2-methyl-1<i>H</i>-indole (1 g, 7.63 mmol, 1 equiv), 4-bromo-1-methyl-1<i>H</i>-pyrazole (1.2 mL, 11.4 mmol, 1.5 equiv), CuO (1.2 g, 15.3 mmol, 2 equiv), and K<sub>2</sub>CO<sub>3</sub> (1.4 g, 9.92 mmol, 1.3 equiv) in pyridine (10 mL, 0.8 M). Purified using silica chromatography, eluting with 0–30% EtOAc/petroleum ether, to afford the title compound as a brown amorphous solid (679 mg, 42%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.58 (s, 1H), 7.57–7.52 (m, 1H), 7.50 (s, 1H), 7.17–7.07 (m, 3H), 6.37 (s, 1H), 4.01 (s, 3H), 2.31 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 138.9, 137.7, 137.4, 128.3, 127.4, 121.2, 120.3, 120.2, 119.7, 110.0, 101.2, 39.8, 13.3. υ<sub>max</sub> (neat): 3114, 3051, 2984, 2941, 2919, 1612, 1586, 1560 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>13</sub>H<sub>14</sub>N<sub>3</sub>) <i>m</i>/<i>z</i> requires 212.1182, <i>m</i>/<i>z</i> found 212.1182.</div></div><div id="sec3_2_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 3-(3-Bromobenzyl)-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>99</b>)</h4><div class="NLM_p last">Prepared according to general procedure 8 using 2-bromobenzaldehyde (90 mg, 0.486 mmol, 1.02 equiv), 2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>98</b>) (100 mg, 0.474 mmol, 1 equiv), Et<sub>3</sub>SiH (84 μL, 0.529 mmol, 1.1 equiv), and TFA (47 μL, 0.610 mmol, 1.3 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL, 0.2 M). Purified using silica chromatography, eluting with 20–50% EtOAc/petroleum ether, to afford the title compound as a yellow gum (165 mg, 89%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.60 (s, 1H), 7.53 (s, 1H), 7.46–7.38 (m, 2H), 7.30 (d, <i>J</i> = 7.8 Hz, 1H), 7.21–7.04 (m, 5H), 4.09 (s, 2H), 4.02 (s, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 144.1, 138.3, 137.5, 134.6, 131.4, 130.0, 129.1, 128.1, 127.6, 127.1, 122.6, 121.5, 120.4, 120.0, 118.2, 110.5, 109.9, 39.8, 30.3, 11.1. υ<sub>max</sub> (neat): 3116, 3053, 2986, 2941, 2919, 1614, 1582, 1569 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>19</sub>BrN<sub>3</sub>) <i>m</i>/<i>z</i> requires 382.0736, <i>m</i>/<i>z</i> found 382.0737.</div></div><div id="sec3_2_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Methyl 3-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl) Benzoate (<b>100</b>)</h4><div class="NLM_p last">Prepared according to general procedure 7 using <i>trans</i>-bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl]dipalladium(II) (19 mg, 0.0202 mmol, 5 mol %), 3-(3-bromobenzyl)-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>99</b>) (150 mg, 0.395 mmol, 1 equiv), Mo(CO)<sub>6</sub> (104 mg, 0.395 mmol, 1equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (23 mg, 0.0793 mmol, 20 mol %), and DBU (88 μL, 0.593 mmol, 1.5 equiv) in MeCN/MeOH (2.5 mL, 1:4, 0.2 M). Purified using silica chromatography, eluting with 50–70% EtOAc/petroleum ether, to afford the title compound as a yellow oil (111 mg, 78%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.99 (s, 1H), 7.85 (d, <i>J</i> = 7.8 Hz, 1H), 7.59 (s, 1H), 7.53 (s, 1H), 7.41 (app t, <i>J</i> = 8.0 Hz, 2H), 7.31 (app t, <i>J</i> = 7.7 Hz, 1H), 7.18–7.01 (m, 3H), 4.16 (s, 2H), 4.01 (s, 3H), 3.90 (s, 3H), 2.27 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 167.4, 142.1, 138.3, 137.5, 134.5, 133.1, 130.3, 129.6, 128.6, 128.1, 127.6, 127.3, 121.5, 120.4, 120.0, 118.2, 110.8, 109.9, 52.2, 39.8, 30.6, 11.1. υ<sub>max</sub> (neat): 3116, 3051, 2949, 2919, 1718, 1608, 1584 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub>) <i>m</i>/<i>z</i> requires 360.1707, <i>m</i>/<i>z</i> found 360.1705.</div></div><div id="sec3_2_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 3-((6-Bromopyridin-2-yl)methyl)-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>101</b>)</h4><div class="NLM_p last">Prepared according to general procedure 8 using 6-bromopyridine-2-carbaldehyde (91 mg, 0.489 mmol, 1.03 equiv), 2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>98</b>) (100 mg, 0.474 mmol, 1 equiv), Et<sub>3</sub>SiH (84 μL, 0.529 mmol, 1.1 equiv), and TFA (47 μL, 0.610 mmol, 1.3 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL, 0.2 M). Purified using silica chromatography, eluting with 20–60% EtOAc/petroleum ether, to afford the title compound as a yellow gum (158 mg, 85%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.58 (s, 1H), 7.52 (s, 1H), 7.44 (dd, <i>J</i> = 6.6, 1.5 Hz, 1H), 7.34 (app t, <i>J</i> = 7.7 Hz, 1H), 7.27 (d, <i>J</i> = 8.7 Hz, 1H), 7.19–7.05 (m, 3H), 6.98 (dd, <i>J</i> = 7.5, 0.7 Hz, 1H), 4.29 (s, 2H), 4.01 (s, 3H), 2.27 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 163.2, 141.3, 138.9, 138.3, 137.5, 135.2, 128.0, 127.5, 125.4, 121.7, 121.2, 120.3, 120.2, 118.2, 110.0, 109.1, 39.8, 33.2, 11.1. υ<sub>max</sub> (neat): 3114, 3051, 2921, 1616, 1582, 1554 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>18</sub>BrN<sub>4</sub>) <i>m</i>/<i>z</i> requires 383.0689, <i>m</i>/<i>z</i> found 383.0686.</div></div><div id="sec3_2_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Methyl 6-((2-Methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indol-3-yl)methyl)picolinate (<b>102</b>)</h4><div class="NLM_p last">Prepared according to general procedure 7 using <i>trans</i>-bis(acetato)bis[<i>o</i>-(di-<i>o</i>-tolylphosphino)benzyl] dipalladium(II) (17 mg, 0.0181 mmol, 5 mol %), 3-((6-bromopyridin-2-yl)methyl)-2-methyl-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole (<b>101</b>) (140 mg, 0.367 mmol, 1 equiv), Mo(CO)<sub>6</sub> (97 mg, 0.367 mmol, 1 equiv), [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub> (21 mg, 0.0724 mmol, 20 mol %), and DBU (82 μL, 0.550 mmol, 1.5 equiv) in MeCN/MeOH (2.5 mL, 1:4, 0.1 M). Purified using silica chromatography, eluting with 50–100% EtOAc/petroleum ether, to afford the title compound as a yellow oil (55 mg, 42%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.94 (d, <i>J</i> = 7.6 Hz, 1H), 7.62 (app t, <i>J</i> = 7.8 Hz, 1H), 7.59 (s, 1H), 7.53 (s, 1H), 7.42 (d, <i>J</i> = 7.4 Hz, 1H), 7.22–7.04 (m, 4H), 4.44 (s, 2H), 4.04 (s, 3H), 4.02 (s, 3H), 2.27 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.2, 162.2, 147.4, 138.4, 137.5, 135.2, 128.1, 127.5, 125.9, 122.8, 121.7, 120.4, 120.2, 118.3, 110.0, 109.3, 53.1, 39.9, 33.6, 11.1. One carbon not observed/coincident. υ<sub>max</sub> (neat): 3118, 3090, 3001, 2943, 2919, 2855, 1716, 1617, 1591 cm<sup>–1</sup>. HRMS: exact mass calculated for [M + H]<sup>+</sup> (C<sub>21</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub>) <i>m</i>/<i>z</i> requires 361.1659, <i>m</i>/<i>z</i> found 361.1660.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Bis-<i>p</i>NPP Inhibition Assay</h3><div class="NLM_p last">Molecules were tested for their ability to inhibit autotaxin activity using the Autotaxin Inhibitor Screening Kit (Cayman Chemical) with modifications to the manufacturer’s protocol. Briefly, in a 96-well plate, 20 ng/mL autotaxin was incubated with 1 mM bis-<i>p</i>NPP at 30 °C for 30 min in 50 mM Tris-HCl buffer (pH 8.5) containing 10 mM CaCl<sub>2</sub> and 0.02% triton X. Liberated bis-<i>p</i>-nitrophenol was measured using a Wallac Victor2 1420 multilabel counter (PerkinElmer, Beaconsfield, UK) in absorbance mode at 405 nm. The background was determined by incubating bis-<i>p</i>NPP in the absence of enzyme. Activity of the compounds was determined by subtracting the average background optical density from all results and expressing the compound activity as a percentage of the enzyme–substrate reaction in the absence of compound. Compounds were screened against autotaxin at a single concentration or using a dose response curve. Single concentration screens were carried out at an inhibitor concentration of 30 μM; samples which showed inhibition of 60% or greater were considered to be active and progressed to further testing. Dose response curves were performed in the concentration range of 30 nM to 30 μM, or 2 nM to 50 μM, ten point curves. Compounds which showed inhibition of less than 60% at 30 μM or a IC<sub>50</sub> value greater than 30 μM were considered inactive. Data was expressed as mean ± SEM, plotted, and the IC<sub>50</sub> values calculated using Graph Pad Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA, <a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> LPC Choline Release Assay</h3><div class="NLM_p">All biochemical studies were performed with hATX. ATX lysoPLD activity was measured by choline release from LPC. Then 20 nM ATX (prepared from HEK 293 Flp-In cells) was incubated with 150 μM LPC(18:1) in a final volume of 100 μL buffer containing 50 mM Tris pH 7.4, 0.01% Triton X-100, 50 mM CaCl<sub>2</sub>, 1 Unit mL<sup>–1</sup> choline oxidase, 2 Unit mL<sup>–1</sup> HRP, and 2 mM homovanilic acid (HVA). The relative amount of released choline was measured by HVA fluorescence in a 96-well plate (Corning). Fluorescent intensity was determined at λex/λem = 320/450 nm every 30 s for 90 min with a Fluorostar plate reader (BMG Labtech). All compounds were screened initially from 400 nM to 100 μM, <i>n</i> = 3 and categorized into one of four IC<sub>50</sub> categories: (i) < 1 μM, (ii) 1–10 μM, (iii) 10–20 μM, and (iv) > 30 μM. Further screening of active compounds was then carried out from 0.5 nM to 10 μM, <i>n</i> = 2. Data analysis was performed using GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA, <a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>.</div><div class="NLM_p last">ATX production and crystallization. ATX from rat (rATX) and human (hATX) was produced in HEK293 Flip-In cells as described previously.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> For cocrystallization of rATX with <b>51</b>, <b>51</b> was first mixed with a 10 M excess of rATX (3.5 mg mL<sup>–1</sup>) and incubated for 30 min. Crystals were obtained at room temperature (293 K) in a 24-well optimization screen (18–22% PEG 3350, 01–04 M NaSCN, and 0.1–0.4 M NH<sub>4</sub>I) by mixing 1 μL of protein:inhibitor solution and 1 μL of reservoir solution. The structure presented here is from a crystal obtained from a 24-well containing the following conditions: 20% PEG 3350, 0.2 M NH<sub>4</sub>I, and 0.1 M NaSCN.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> Crystallographic Data and Methods</h3><div class="NLM_p last">X-ray diffraction data was collected at SLS on beamline PXIII. The crystallographic diffraction data was recorded on a PILATUS detector to a resolution of 2.4 Å for the ATX-51 complex, PDB reference <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQQ">5LQQ</a>. The data was processed and integrated with XDS,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and scaled with AIMLESS.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The structure was determined by molecular replacement using PHASER<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> with the structure of ATX (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XR9">2XR9</a>) as the search model. Model building and subsequent refinement were performed iteratively with COOT,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> REFMAC,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and PDB_REDO.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i123"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01597">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01597" class="ext-link">10.1021/acs.jmedchem.6b01597</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental and analytical methods, characterization data, assay data, physicochemical data, molecular modeling data, crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf">jm6b01597_si_001.pdf (31.91 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_002.csv">jm6b01597_si_002.csv (4.58 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01597" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig Jamieson</span> - <span class="hlFld-Affiliation affiliation">WestCHEM, Department
of Pure and Applied Chemistry, University
of Strathclyde, Thomas
Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6567-8272" title="Orcid link">http://orcid.org/0000-0002-6567-8272</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ea89988b838dc4808b87838f998584aa999e988b9e82c48b89c49f81"><span class="__cf_email__" data-cfemail="b7d4c5d6ded099ddd6daded2c4d8d9f7c4c3c5d6c3df99d6d499c2dc">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan J. B. Watson</span> - <span class="hlFld-Affiliation affiliation">WestCHEM, Department
of Pure and Applied Chemistry, University
of Strathclyde, Thomas
Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1582-4286" title="Orcid link">http://orcid.org/0000-0002-1582-4286</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#27464b4b464909504653544849091617176754535546534f09464409524c"><span class="__cf_email__" data-cfemail="5e3f32323f3070293f2a2d3130706f6e6e1e2d2a2c3f2a36703f3d702b35">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa M. Miller</span> - <span class="hlFld-Affiliation affiliation">WestCHEM, Department
of Pure and Applied Chemistry, University
of Strathclyde, Thomas
Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Willem-Jan Keune</span> - <span class="hlFld-Affiliation affiliation">Division
of Biochemistry, Netherlands Cancer Institute/Antoni
van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Castagna</span> - <span class="hlFld-Affiliation affiliation">WestCHEM, Department
of Pure and Applied Chemistry, University
of Strathclyde, Thomas
Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise C. Young</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomolecular Science, University of Strathclyde, John Arbuthnott Building (Hamnet Wing), 161 Cathedral Street, Glasgow G1 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emma L. Duffy</span> - <span class="hlFld-Affiliation affiliation">WestCHEM, Department
of Pure and Applied Chemistry, University
of Strathclyde, Thomas
Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frances Potjewyd</span> - <span class="hlFld-Affiliation affiliation">WestCHEM, Department
of Pure and Applied Chemistry, University
of Strathclyde, Thomas
Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Salgado-Polo</span> - <span class="hlFld-Affiliation affiliation">Division
of Biochemistry, Netherlands Cancer Institute/Antoni
van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paloma Engel García</span> - <span class="hlFld-Affiliation affiliation">WestCHEM, Department
of Pure and Applied Chemistry, University
of Strathclyde, Thomas
Graham Building, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dima Semaan</span> - <span class="hlFld-Affiliation affiliation">Division
of Biochemistry, Netherlands Cancer Institute/Antoni
van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Pritchard</span> - <span class="hlFld-Affiliation affiliation">Fibrosis Discovery Performance Unit, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anastassis Perrakis</span> - <span class="hlFld-Affiliation affiliation">Division
of Biochemistry, Netherlands Cancer Institute/Antoni
van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon J. F. Macdonald</span> - <span class="hlFld-Affiliation affiliation">Fibrosis Discovery Performance Unit, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d398e11225-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i124">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Tatjana Heidebrecht and Robbie Joosten for help with crystallization and structure refinement. We thank GlaxoSmithKline for the Ph.D. studentships (L.M.M., D.C., E.L.D., and F.P.), as well as chemical and analytical resources. We also thank the EPSRC UK National Mass Spectrometry Facility at Swansea University for analyses. L.M.M. thanks BMCS-RSC (travel grant 2016) and SAGES (PEER grant 2016) for funding.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i125" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i125"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i126" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i126"> Abbreviations Used</h2><tr><td class="NLM_term">ATX</td><td class="NLM_def"><p class="first last">autotaxin</p></td></tr><tr><td class="NLM_term">bis-<i>p</i>NPP</td><td class="NLM_def"><p class="first last">bis(<i>p</i>-nitrophenol) phosphate</p></td></tr><tr><td class="NLM_term">CLND</td><td class="NLM_def"><p class="first last">chemiluminescent nitrogen detection</p></td></tr><tr><td class="NLM_term">ENPP</td><td class="NLM_def"><p class="first last">ectonucleotide pyrophosphatase and phosphodiesterase family</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">Förster resonance energy transfer</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptor</p></td></tr><tr><td class="NLM_term">LEI</td><td class="NLM_def"><p class="first last">ligand efficiency index</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">liphophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">lysophosphatidic acid</p></td></tr><tr><td class="NLM_term">LPC</td><td class="NLM_def"><p class="first last">lysophosphatodyl choline</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term"><i>p</i>NP-TMP</td><td class="NLM_def"><p class="first last">thymidine 5′monophosphate <i>p</i>-nitrophenyl ester</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i127">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Strackes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krutzsch, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unsworth, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arestad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cioce, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, L. A.</span><span> </span><span class="NLM_article-title">Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=2524-2529&author=M.+L.+Strackesauthor=H.+C.+Krutzschauthor=E.+J.+Unsworthauthor=A.+Arestadauthor=V.+Cioceauthor=E.+Schiffmannauthor=L.+A.+Liotta&title=Identification%2C+purification%2C+and+partial+sequence+analysis+of+autotaxin%2C+a+novel+motility-stimulating+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrackes%26aufirst%3DM.%2BL.%26aulast%3DKrutzsch%26aufirst%3DH.%2BC.%26aulast%3DUnsworth%26aufirst%3DE.%2BJ.%26aulast%3DArestad%26aufirst%3DA.%26aulast%3DCioce%26aufirst%3DV.%26aulast%3DSchiffmann%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26atitle%3DIdentification%252C%2520purification%252C%2520and%2520partial%2520sequence%2520analysis%2520of%2520autotaxin%252C%2520a%2520novel%2520motility-stimulating%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D2524%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tokumura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuzawa, K.</span><span> </span><span class="NLM_article-title">Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">39436</span><span class="NLM_x">–</span> <span class="NLM_lpage">39442</span><span class="refDoi"> DOI: 10.1074/jbc.M205623200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1074%2Fjbc.M205623200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=12176993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVeit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=39436-39442&author=A.+Tokumuraauthor=E.+Majimaauthor=Y.+Kariyaauthor=K.+Tominagaauthor=K.+Kogureauthor=K.+Yasudaauthor=K.+Fukuzawa&title=Identification+of+human+plasma+lysophospholipase+D%2C+a+lysophosphatidic+acid-producing+enzyme%2C+as+autotaxin%2C+a+multifunctional+phosphodiesterase&doi=10.1074%2Fjbc.M205623200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase</span></div><div class="casAuthors">Tokumura, Akira; Majima, Eiji; Kariya, Yuko; Tominaga, Kyoko; Kogure, Kentaro; Yasuda, Katsuhiko; Fukuzawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">39436-39442</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We purified human plasma lysophospholipase D that produces physiol. active lysophosphatidic acid and showed that it is a sol. form of autotaxin, an ecto-nucleotide pyrophosphatase/phosphodiesterase, originally found as a tumor cell motility-stimulating factor.  Its lower Km value for a lysophosphatidylcholine than that for a synthetic substrate of nucleotide suggests that lysophosphatidylcholine is a more likely physiol. substrate for autotaxin and that its predicted physiol. and pathophysiol. functions could be mediated by its activity to produce lysophosphate acid, an intercellular mediator.  Recombinant autotaxin was found to have lysophospholipase D activity; its substrate specificity and metal ion requirement were the same as those of the purified plasma enzyme.  The activity of lysophospholipase D for exogenous lysophosphatidylcholine in human serum was found to increase in normal pregnant women at the third trimester of pregnancy and to a higher extent in patients in threatened preterm delivery, suggesting its roles in induction of parturition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTHkH4G7jBw7Vg90H21EOLACvtfcHk0liT3XmkPEphDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVeit7k%253D&md5=e9074bb4026cd1349670dafb7e580276</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205623200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205623200%26sid%3Dliteratum%253Aachs%26aulast%3DTokumura%26aufirst%3DA.%26aulast%3DMajima%26aufirst%3DE.%26aulast%3DKariya%26aufirst%3DY.%26aulast%3DTominaga%26aufirst%3DK.%26aulast%3DKogure%26aufirst%3DK.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DFukuzawa%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520human%2520plasma%2520lysophospholipase%2520D%252C%2520a%2520lysophosphatidic%2520acid-producing%2520enzyme%252C%2520as%2520autotaxin%252C%2520a%2520multifunctional%2520phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D39436%26epage%3D39442%26doi%3D10.1074%2Fjbc.M205623200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span><span class="refDoi"> DOI: 10.1194/jlr.R046458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1194%2Fjlr.R046458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=24643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1192-1214&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=J.+Chun&title=LPA+receptor+signaling%3A+pharmacology%2C+physiology%2C+and+pathophysiology&doi=10.1194%2Fjlr.R046458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1214</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biol. actions and demonstrates medicinal relevance.  LPA's functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors.  These receptors are named LPA1-6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs.  LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies.  These studies have revealed physiol. and pathophysiol. influences on virtually every organ system and developmental stage of an organism.  These include the nervous, cardiovascular, reproductive, and pulmonary systems.  Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity.  These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7Ll3PB1oubVg90H21EOLACvtfcHk0liT3XmkPEphDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK&md5=77271408ffda2fab00e7e0a0f32540d9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046458%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptor%2520signaling%253A%2520pharmacology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1192%26epage%3D1214%26doi%3D10.1194%2Fjlr.R046458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mutoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Insights into the pharmacological relevance of lysophospholipid receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01622.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1111%2Fj.1476-5381.2011.01622.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21838759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=829-844&author=T.+Mutohauthor=R.+Riveraauthor=J.+Chun&title=Insights+into+the+pharmacological+relevance+of+lysophospholipid+receptors&doi=10.1111%2Fj.1476-5381.2011.01622.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the pharmacological relevance of lysophospholipid receptors</span></div><div class="casAuthors">Mutoh, Tetsuji; Rivera, Richard; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">829-844</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery of lysophospholipid (LP) 7-transmembrane, G protein-coupled receptors (GPCRs) that began in the 1990s, together with research into the functional roles of the major LPs known as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), have opened new research avenues into their biol. processes and mechanisms.  Major examples of LP signaling effects include embryogenesis, nervous system development, vascular development, uterine implantation, immune cell trafficking, and inflammatory reactions.  LP signaling also influences the pathophysiol. of many diseases including cancer, autoimmune and inflammatory diseases, which indicate that LP receptors may be attractive targets for pharmacol. therapies.  A key example of such a therapeutic agent is the S1P receptor modulator FTY720, which upon phosphorylation and continued drug exposure, acts as an S1P receptor functional antagonist.  This compd. (also known as fingolimod or Gilenya) has recently been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.  Continued basic and translational research on LP signaling should provide novel insights into both basic biol. mechanisms, as well as novel therapeutic approaches to combat a range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qOGwbmBPirVg90H21EOLACvtfcHk0liT3XmkPEphDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D&md5=cf240e202ccfa00c40366f7309e36b78</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01622.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01622.x%26sid%3Dliteratum%253Aachs%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520the%2520pharmacological%2520relevance%2520of%2520lysophospholipid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D829%26epage%3D844%26doi%3D10.1111%2Fj.1476-5381.2011.01622.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Nam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMarlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stracke, M. L.</span><span> </span><span class="NLM_article-title">Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">6938</span><span class="NLM_x">–</span> <span class="NLM_lpage">6944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=6938-6944&author=S.+W.+Namauthor=T.+Clairauthor=Y.+S.+Kimauthor=A.+McMarlinauthor=E.+Schiffmannauthor=L.+A.+Liottaauthor=M.+L.+Stracke&title=Autotaxin+%28NPP-2%29%2C+a+metastasis-enhancing+motogen%2C+is+an+angiogenic+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DS.%2BW.%26aulast%3DClair%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DMcMarlin%26aufirst%3DA.%26aulast%3DSchiffmann%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26aulast%3DStracke%26aufirst%3DM.%2BL.%26atitle%3DAutotaxin%2520%2528NPP-2%2529%252C%2520a%2520metastasis-enhancing%2520motogen%252C%2520is%2520an%2520angiogenic%2520factor%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D6938%26epage%3D6944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Zahednasab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harirchian, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesbah-Namin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siroos, B.</span><span> </span><span class="NLM_article-title">Increased autotaxin activity in multiple sclerosis</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.jneuroim.2014.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2Fj.jneuroim.2014.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=24984830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOnt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2014&pages=120-123&author=H.+Zahednasabauthor=M.+Baloodauthor=M.+H.+Harirchianauthor=S.+A.+Mesbah-Naminauthor=N.+Rahimianauthor=B.+Siroos&title=Increased+autotaxin+activity+in+multiple+sclerosis&doi=10.1016%2Fj.jneuroim.2014.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Increased autotaxin activity in multiple sclerosis</span></div><div class="casAuthors">Zahednasab, Hamid; Balood, Mohammad; Harirchian, Mohammad Hossein; Mesbah-Namin, Seyed Alireza; Rahimian, Nasrin; Siroos, Bahaadin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">120-123</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is an enzyme producing lysophosphatidic acid (LPA) from lysophosphatidyl choline (LPC) and it is up-regulated in inflammatory conditions such as various cancers, arthritis and multiple sclerosis (MS).  Numerous studies have shown that the LPA signaling gives rise to angiogenesis, mitosis, cell proliferation and cytokine secretion.  On the one hand, an increasing body of evidence suggests that blockade of ATX has anti-inflammatory properties in a variety of diseases.  The aim of this study was to measure the enzyme activity of ATX in cerebrospinal fluid (CSF) and serum of patients with MS using an enzymic photometric method.  Twenty definite relapsing remitting MS patients along with 20 patients with other neurol. diseases (OND) were recruited.  The results showed that ATX activity was significantly higher (p value < 0.0001) in MS patients than those patients diagnosed with OND.  It is possible that inhibition of the ATX may decrease the rate of MS relapses/progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbfShx57e7pLVg90H21EOLACvtfcHk0lgsJsShAi7BQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOnt7zJ&md5=d57f6b3275da21ef7fd248a0b1b30e6c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2014.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2014.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DZahednasab%26aufirst%3DH.%26aulast%3DBalood%26aufirst%3DM.%26aulast%3DHarirchian%26aufirst%3DM.%2BH.%26aulast%3DMesbah-Namin%26aufirst%3DS.%2BA.%26aulast%3DRahimian%26aufirst%3DN.%26aulast%3DSiroos%26aufirst%3DB.%26atitle%3DIncreased%2520autotaxin%2520activity%2520in%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2014%26volume%3D273%26spage%3D120%26epage%3D123%26doi%3D10.1016%2Fj.jneuroim.2014.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gotoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami-Murofushi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G. J.</span><span> </span><span class="NLM_article-title">Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1042/BST20110608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1042%2FBST20110608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=22260662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=31-36&author=M.+Gotohauthor=Y.+Fujiwaraauthor=J.+Yueauthor=J.+Liuauthor=S.+Leeauthor=J.+Fellsauthor=A.+Uchiyamaauthor=K.+Murakami-Murofushiauthor=S.+Kennelauthor=J.+Wallauthor=R.+Patilauthor=R.+Gupteauthor=L.+Balazsauthor=D.+D.+Millerauthor=G.+J.+Tigyi&title=Controlling+cancer+through+the+autotaxin-lysophosphatidic+acid+receptor+axis&doi=10.1042%2FBST20110608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis</span></div><div class="casAuthors">Gotoh, Mari; Fujiwara, Yuko; Yue, Junming; Liu, Jianxiong; Lee, Sue Chin; Fells, James; Uchiyama, Ayako; Murakami-Murofushi, Kimiko; Kennel, Stephen; Wall, Jonathan; Patil, Renukadevi; Gupte, Renuka; Balazs, Louisa; Miller, Duane D.; Tigyi, Gabor J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-36</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  LPA (lysophosphatidic acid, 1-acyl-2-hydroxy-sn-glycero-3-phosphate), is a growth factor-like lipid mediator that regulates many cellular functions, many of which are unique to malignantly transformed cells.  The simple chem. structure of LPA and its profound effects in cancer cells has attracted the attention of the cancer therapeutics field and drives the development of therapeutics based on the LPA scaffold.  In biol. fluids, LPA is generated by ATX (autotaxin), a lysophospholipase D that cleaves the choline/serine headgroup from lysophosphatidylcholine and lysophosphatidylserine to generate LPA.  In the present article, we review some of the key findings that make the ATX-LPA signalling axis an emerging target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVq4fS9k_amrVg90H21EOLACvtfcHk0lgsJsShAi7BQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtbc%253D&md5=d6f36a7963badbd37ea18887afe9f0a0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2FBST20110608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110608%26sid%3Dliteratum%253Aachs%26aulast%3DGotoh%26aufirst%3DM.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DUchiyama%26aufirst%3DA.%26aulast%3DMurakami-Murofushi%26aufirst%3DK.%26aulast%3DKennel%26aufirst%3DS.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DGupte%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DTigyi%26aufirst%3DG.%2BJ.%26atitle%3DControlling%2520cancer%2520through%2520the%2520autotaxin-lysophosphatidic%2520acid%2520receptor%2520axis%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D31%26epage%3D36%26doi%3D10.1042%2FBST20110608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCamera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Shah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nm1685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak&doi=10.1038%2Fnm1685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0lgsJsShAi7BQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D45%26epage%3D54%26doi%3D10.1038%2Fnm1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kanda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, S.</span><span> </span><span class="NLM_article-title">Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1038/ni1573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fni1573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=18327261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlGms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=415-423&author=H.+Kandaauthor=R.+Newtonauthor=R.+Kleinauthor=Y.+Moritaauthor=M.+Gunnauthor=S.+Rosen&title=Autotaxin%2C+an+ectoenzyme+that+produces+lysophosphatidic+acid%2C+promotes+the+entry+of+lymphocytes+into+secondary+lymphoid+organs&doi=10.1038%2Fni1573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs</span></div><div class="casAuthors">Kanda, Hidenobu; Newton, Rebecca; Klein, Russell; Morita, Yuka; Gunn, Michael D.; Rosen, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-423</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The extracellular lysophospholipase D autotaxin (ATX) and its product, lysophosphatidic acid, have diverse functions in development and cancer, but little is known about their functions in the immune system.  Here we found that ATX had high expression in the high endothelial venules of lymphoid organs and was secreted.  Chemokine-activated lymphocytes expressed receptors with enhanced affinity for ATX, which provides a mechanism for targeting the secreted ATX to lymphocytes undergoing recruitment.  Lysophosphatidic acid induced chemokinesis in T cells.  I.v. injection of enzymically inactive ATX attenuated the homing of T cells to lymphoid tissues, probably through competition with endogenous ATX and exertion of a dominant neg. effect.  These results support the idea of a new and general step in the homing cascade in which the ectoenzyme ATX facilitates the entry of lymphocytes into lymphoid organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq39VaRyMTpqrVg90H21EOLACvtfcHk0ljwcrauYKd8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlGms7c%253D&md5=a9b09e0b4ca5e80504bc2c25162b620e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fni1573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1573%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DGunn%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DS.%26atitle%3DAutotaxin%252C%2520an%2520ectoenzyme%2520that%2520produces%2520lysophosphatidic%2520acid%252C%2520promotes%2520the%2520entry%2520of%2520lymphocytes%2520into%2520secondary%2520lymphoid%2520organs%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D415%26epage%3D423%26doi%3D10.1038%2Fni1573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Awada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grès, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre d’Hellencourt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdon, E.</span><span> </span><span class="NLM_article-title">Autotaxin protects microglial cells against oxidative stress</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2Fj.freeradbiomed.2011.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=22155714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=516-526&author=R.+Awadaauthor=P.+Rondeauauthor=S.+Gr%C3%A8sauthor=J.+S.+Saulnier-Blacheauthor=C.+Lefebvre+d%E2%80%99Hellencourtauthor=E.+Bourdon&title=Autotaxin+protects+microglial+cells+against+oxidative+stress&doi=10.1016%2Fj.freeradbiomed.2011.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin protects microglial cells against oxidative stress</span></div><div class="casAuthors">Awada, Rana; Rondeau, Philippe; Gres, Sandra; Saulnier-Blache, Jean Sebastien; Lefebvre d'Hellencourt, Christian; Bourdon, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-526</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxidative stress occurs when antioxidant defenses are overwhelmed by oxygen-reactive species and can lead to cellular damage, as seen in several neurodegenerative disorders.  Microglia are specialized cells in the central nervous system that act as the first and main form of active immune defense in the response to pathol. events.  Autotaxin (ATX) plays an important role in the modulation of crit. cellular functions, through its enzymic prodn. of lysophosphatidic acid (LPA).  In this study, we investigated the potential role of ATX in the response of microglial cells to oxidative stress.  We show that treatment of a microglial BV2 cell line with hydrogen peroxide (H2O2) stimulates ATX expression and LPA prodn.  Stable overexpression of ATX inhibits microglial activation (CD11b expression) and protects against H2O2-treatment-induced cellular damage.  This protective effect of ATX was partially reduced in the presence of the LPA-receptor antagonist Ki16425.  ATX overexpression was also assocd. with a redn. in intracellular ROS formation, carbonylated protein accumulation, proteasomal activity, and catalase expression.  Our results suggest that up-regulation of ATX expression in microglia could be a mechanism for protection against oxidative stress, thereby reducing inflammation in the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL6Bqivi85ULVg90H21EOLACvtfcHk0ljwcrauYKd8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVygtg%253D%253D&md5=9962485b2cc9f6e2a2b9d551909708c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DAwada%26aufirst%3DR.%26aulast%3DRondeau%26aufirst%3DP.%26aulast%3DGr%25C3%25A8s%26aufirst%3DS.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DLefebvre%2Bd%25E2%2580%2599Hellencourt%26aufirst%3DC.%26aulast%3DBourdon%26aufirst%3DE.%26atitle%3DAutotaxin%2520protects%2520microglial%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D516%26epage%3D526%26doi%3D10.1016%2Fj.freeradbiomed.2011.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J. B.</span><span> </span><span class="NLM_article-title">Development of autotaxin inhibitors: an overview of the patent and primary literature</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5604</span><span class="NLM_x">–</span> <span class="NLM_lpage">5621</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5604-5621&author=D.+Castagnaauthor=D.+C.+Buddauthor=S.+J.+F.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+B.+Watson&title=Development+of+autotaxin+inhibitors%3A+an+overview+of+the+patent+and+primary+literature&doi=10.1021%2Facs.jmedchem.5b01599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature</span></div><div class="casAuthors">Castagna, Diana; Budd, David C.; MacDonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5604-5621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others.  As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities.  This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clin. trial data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzWQadusHW7Vg90H21EOLACvtfcHk0ljwcrauYKd8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D&md5=68ca29436fd3b0a1728a9a52fbaf2cb0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01599%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%2BB.%26atitle%3DDevelopment%2520of%2520autotaxin%2520inhibitors%253A%2520an%2520overview%2520of%2520the%2520patent%2520and%2520primary%2520literature%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5604%26epage%3D5621%26doi%3D10.1021%2Facs.jmedchem.5b01599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Chemical evolution of autotaxin inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span><span class="refDoi"> DOI: 10.1021/cr2003213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2003213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=2593-2603&author=H.+M.+H.+G.+Albersauthor=H.+Ovaa&title=Chemical+evolution+of+autotaxin+inhibitors&doi=10.1021%2Fcr2003213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr2003213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2003213%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DChemical%2520evolution%2520of%2520autotaxin%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D2593%26epage%3D2603%26doi%3D10.1021%2Fcr2003213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchinson, J. H.; Lonergan, D.; Huang, F.; Rowbottom, M.; Calderon, I.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitor compounds</span>. (PharmAkea, Inc.). International Patent Application WO2015/048301 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+H.+Hutchinson&author=D.+Lonergan&author=F.+Huang&author=M.+Rowbottom&author=I.+Calderon&title=Autotaxin+inhibitor+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DAutotaxin%2520inhibitor%2520compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelzer, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1124/mol.115.100404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fmol.115.100404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=26371182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=982-992&author=A.+J.+Steinauthor=G.+Bainauthor=P.+Prodanovichauthor=A.+M.+Santiniauthor=J.+Darlingtonauthor=N.+M.+Stelzerauthor=R.+S.+Sidhuauthor=J.+Schaubauthor=L.+Gouletauthor=D.+Lonerganauthor=I.+Calderonauthor=J.+F.+Evansauthor=J.+H.+Hutchinson&title=Structural+basis+for+inhibition+of+human+autotaxin+by+four+potent+compounds+with+distinct+modes+of+binding&doi=10.1124%2Fmol.115.100404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span></div><div class="casAuthors">Stein, Adam J.; Bain, Gretchen; Prodanovich, Pat; Santini, Angelina M.; Darlington, Janice; Stelzer, Nina M. P.; Sidhu, Ranjinder S.; Schaub, Jeffrey; Goulet, Lance; Lonergan, Dave; Calderon, Imelda; Evans, Jilly F.; Hutchinson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-992</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA).  LPA is a bioactive phospholipid that regulates diverse biol. processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of Gprotein-coupled receptors.  The ATXLPA pathway has been implicated in many pathol. conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain.  Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases.  Mouse and rat ATX have been crystd. previously with LPA or small-mol. inhibitors bound.  Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors.  We demonstrate that the mechanism of inhibition of each compd. reflects its unique interactions with human ATX.  Our studies may provide a basis for the rational design of novel ATX inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8334n30PQrLVg90H21EOLACvtfcHk0litNojXTUxhIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D&md5=f847e18cf228207349d21c449abdb039</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100404%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DStelzer%26aufirst%3DN.%2BM.%26aulast%3DSidhu%26aufirst%3DR.%2BS.%26aulast%3DSchaub%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520human%2520autotaxin%2520by%2520four%2520potent%2520compounds%2520with%2520distinct%2520modes%2520of%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D982%26epage%3D992%26doi%3D10.1124%2Fmol.115.100404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Prestwich, G.; Tigyi, G.; Jiang, G.; Zhang, G.; Gajewiak, J.; Zhang, H.; Xu, X.</span><span> </span><span class="NLM_article-title">α-Chloro and α-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof</span>. WO2008157361A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Prestwich&author=G.+Tigyi&author=G.+Jiang&author=G.+Zhang&author=J.+Gajewiak&author=H.+Zhang&author=X.+Xu&title=%CE%B1-Chloro+and+%CE%B1-bromo+phosphonate+analogs+of+lysophosphatidic+acid+and+methods+of+making+and+using+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrestwich%26aufirst%3DG.%26atitle%3D%25CE%25B1-Chloro%2520and%2520%25CE%25B1-bromo%2520phosphonate%2520analogs%2520of%2520lysophosphatidic%2520acid%2520and%2520methods%2520of%2520making%2520and%2520using%2520thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajewiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration <i>in vitro</i> and causes tumor regression <i>in vivo</i></span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">5441</span><span class="NLM_x">–</span> <span class="NLM_lpage">5449</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-0302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1158%2F0008-5472.CAN-09-0302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=19509223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=5441-5449&author=H.+Zhangauthor=X.+Xuauthor=J.+Gajewiakauthor=R.+Tsukaharaauthor=Y.+Fujiwaraauthor=J.+Liuauthor=J.+I.+Fellsauthor=D.+Peryginauthor=A.+L.+Parrillauthor=G.+Tigyiauthor=G.+D.+Prestwich&title=Dual+activity+lysophosphatidic+acid+receptor+pan-antagonist%2Fautotaxin+inhibitor+reduces+breast+cancer+cell+migration+in+vitro+and+causes+tumor+regression+in+vivo&doi=10.1158%2F0008-5472.CAN-09-0302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo</span></div><div class="casAuthors">Zhang, Honglu; Xu, Xiaoyu; Gajewiak, Joanna; Tsukahara, Ryoko; Fujiwara, Yuko; Liu, Jianxiong; Fells, James I.; Perygin, Donna; Parrill, Abby L.; Tigyi, Gabor; Prestwich, Glenn D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5441-5449</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Signal transduction modifiers that modulate the lysophosphatidic acid (LPA) pathway have potential as anticancer agents.  Herein, we describe metabolically stabilized LPA analogs that reduce cell migration and invasion and cause regression of orthotopic breast tumors in vivo.  Two diastereoisomeric α-bromophosphonates (BrP-LPA) were synthesized, and the pharmacol. was detd. for five LPA G protein-coupled receptors (GPCRs).  The syn and anti diastereomers of BrP-LPA are pan-LPA GPCR antagonists and are also nanomolar inhibitors of the lysophospholipase D activity of autotaxin, the dominant biosynthetic source of LPA.  Computational models correctly predicted the diastereoselectivity of antagonism for three GPCR isoforms.  The anti isomer of BrP-LPA was more effective than syn isomer in reducing migration of MDA-MB-231 cells, and the anti isomer was superior in reducing invasion of these cells.  Finally, orthotopic breast cancer xenografts were established in nude mice by injection of MB-231 cells in an in situ cross-linkable extracellular matrix.  After 2 wk, mice were treated with the BrP-LPA alone (10 mg/kg), Taxol alone (10 mg/kg), or Taxol followed by BrP-LPA.  All treatments significantly reduced tumor burden, and BrP-LPA was superior to Taxol in reducing blood vessel d. in tumors.  Moreover, both the anti- and syn-BrP-LPA significantly reduced tumors at 3 mg/kg. [Cancer Res 2009;69(13):5441-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMJ8_lQcWDqLVg90H21EOLACvtfcHk0litNojXTUxhIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrg%253D&md5=18f67a14de05b9f0d0666315665a47c1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-0302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-0302%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DPerygin%26aufirst%3DD.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DDual%2520activity%2520lysophosphatidic%2520acid%2520receptor%2520pan-antagonist%252Fautotaxin%2520inhibitor%2520reduces%2520breast%2520cancer%2520cell%2520migration%2520in%2520vitro%2520and%2520causes%2520tumor%2520regression%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D5441%26epage%3D5449%26doi%3D10.1158%2F0008-5472.CAN-09-0302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulharat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradère, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Try, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giganti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beucher-Gaudin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonchampt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J. A.</span><span> </span><span class="NLM_article-title">S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span><span class="refDoi"> DOI: 10.1124/jpet.108.141911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fjpet.108.141911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=18755937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=809-819&author=G.+Ferryauthor=N.+Moulharatauthor=J.+P.+Prad%C3%A8reauthor=P.+Desosauthor=A.+Tryauthor=A.+Gentonauthor=A.+Gigantiauthor=M.+Beucher-Gaudinauthor=M.+Lonchamptauthor=M.+Bertrandauthor=J.+S.+Saulnier-Blacheauthor=G.+C.+Tuckerauthor=A.+Cordiauthor=J.+A.+Boutin&title=S32826%2C+a+nanomolar+inhibitor+of+autotaxin%3A+discovery%2C+synthesis+and+applications+as+a+pharmacological+tool&doi=10.1124%2Fjpet.108.141911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool</span></div><div class="casAuthors">Ferry, Gilles; Moulharat, Natacha; Pradere, Jean-Philippe; Desos, Patrice; Try, Anne; Genton, Annie; Giganti, Adeline; Beucher-Gaudin, Monique; Lonchampt, Michel; Bertrand, Marc; Saulnier-Blache, Jean-Sebastien; Tucker, Gordon C.; Cordi, Alex; Boutin, Jean A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">809-819</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin catalyzes the transformation of lyso-phosphatidylcholine to lyso-phosphatidic acid (LPA).  LPA is a phospholipid possessing a large panel of activity, in particular as a motility factor or as a growth signal, through its G-protein coupled seven transmembrane receptors.  Indirect evidence strongly suggests that autotaxin is the main, if not the only source of circulating LPA.  Because of its central role in pathol. conditions, such as oncol. and diabetes/obesity, the biochem. properties of autotaxin has attracted a lot of attention, but confirmation of its role in pathol. remains elusive.  One way to validate and/or confirm its central role, is to find potent and selective inhibitors.  A systematic screening of several thousand compds. using a colorimetric assay and taking advantage of the phosphodiesterase activity of autotaxin that requires the enzymic site for LPA generation, led to the discovery of a potent nanomolar inhibitor, [4-(tetradecanoylamino)benzyl]phosphonic acid (S32826).  This compd. was inhibitory toward the various autotaxin isoforms, using an assay measuring the [14C]lyso-phosphatidylcholine conversion into [14C]LPA.  We also evaluated the activity of S32826 in cellular models of diabesity and oncol.  Nevertheless, the poor in vivo stability and/or bioavailability of the compd. did not permit to use it in animals.  S32826 is the first reported inhibitor of autotaxin with an IC50 in the nanomolar range that can be used to validate the role of autotaxin in various pathologies in cellular models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojxROGoeQsO7Vg90H21EOLACvtfcHk0lhn03BnfRj5Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvF&md5=812d4ceacdeeb8426ad995b3e1519407</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.141911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.141911%26sid%3Dliteratum%253Aachs%26aulast%3DFerry%26aufirst%3DG.%26aulast%3DMoulharat%26aufirst%3DN.%26aulast%3DPrad%25C3%25A8re%26aufirst%3DJ.%2BP.%26aulast%3DDesos%26aufirst%3DP.%26aulast%3DTry%26aufirst%3DA.%26aulast%3DGenton%26aufirst%3DA.%26aulast%3DGiganti%26aufirst%3DA.%26aulast%3DBeucher-Gaudin%26aufirst%3DM.%26aulast%3DLonchampt%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DM.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DTucker%26aufirst%3DG.%2BC.%26aulast%3DCordi%26aufirst%3DA.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26atitle%3DS32826%252C%2520a%2520nanomolar%2520inhibitor%2520of%2520autotaxin%253A%2520discovery%252C%2520synthesis%2520and%2520applications%2520as%2520a%2520pharmacological%2520tool%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D809%26epage%3D819%26doi%3D10.1124%2Fjpet.108.141911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5098</span><span class="NLM_x">–</span> <span class="NLM_lpage">5101</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2Fj.bmcl.2011.03.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5098-5101&author=G.+Jiangauthor=D.+Madanauthor=G.+D.+Prestwich&title=Aromatic+phosphonates+inhibit+the+lysophospholipase+D+activity+of+autotaxin&doi=10.1016%2Fj.bmcl.2011.03.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMadan%26aufirst%3DD.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DAromatic%2520phosphonates%2520inhibit%2520the%2520lysophospholipase%2520D%2520activity%2520of%2520autotaxin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5098%26epage%3D5101%26doi%3D10.1016%2Fj.bmcl.2011.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gierse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw-Pierce, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovskiy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wene, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J.</span><span> </span><span class="NLM_article-title">A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1124/jpet.110.165845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fjpet.110.165845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20392816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Klur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=310-317&author=J.+Gierseauthor=A.+Thorarensenauthor=K.+Belteyauthor=E.+Bradshaw-Pierceauthor=L.+Cortes-Burgosauthor=T.+Hallauthor=A.+Johnstonauthor=M.+Murphyauthor=O.+Nemirovskiyauthor=S.+Ogawaauthor=L.+Peggauthor=M.+Pelcauthor=M.+Prinsenauthor=M.+Schnuteauthor=J.+Wendlingauthor=S.+Weneauthor=R.+Weinbergauthor=A.+Wittwerauthor=B.+Zweifelauthor=J.+Masferrer&title=A+novel+autotaxin+inhibitor+reduces+lysophosphatidic+acid+levels+in+plasma+and+the+site+of+inflammation&doi=10.1124%2Fjpet.110.165845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation</span></div><div class="casAuthors">Gierse, James; Thorarensen, Atli; Beltey, Konstantine; Bradshaw-Pierce, Erica; Cortes-Burgos, Luz; Hall, Troii; Johnston, Amy; Murphy, Michael; Nemirovskiy, Olga; Ogawa, Shinji; Pegg, Lyle; Pelc, Matthew; Prinsen, Michael; Schnute, Mark; Wendling, Jay; Wene, Steven; Weinberg, Robin; Wittwer, Arthur; Zweifel, Ben; Masferrer, Jaime</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">310-317</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin is the enzyme responsible for the prodn. of lysophosphatidic acid (LPA) from lysophosphatidyl choline (LPC), and it is up-regulated in many inflammatory conditions, including but not limited to cancer, arthritis, and multiple sclerosis.  LPA signaling causes angiogenesis, mitosis, cell proliferation, and cytokine secretion.  Inhibition of autotaxin may have anti-inflammatory properties in a variety of diseases; however, this hypothesis has not been tested pharmacol. because of the lack of potent inhibitors.  Here, we report the development of a potent autotaxin inhibitor, PF-8380 [6-(3-(piperazin-1-yl)propanoyl)benzo[d]oxazol-2(3H)-one] with an IC50 of 2.8 nM in isolated enzyme assay and 101 nM in human whole blood.  PF-8380 has adequate oral bioavailability and exposures required for in vivo testing of autotaxin inhibition.  Autotaxin's role in producing LPA in plasma and at the site of inflammation was tested in a rat air pouch model.  The specific inhibitor PF-8380, dosed orally at 30 mg/kg, provided >95% redn. in both plasma and air pouch LPA within 3 h, indicating autotaxin is a major source of LPA during inflammation.  At 30 mg/kg PF-8380 reduced inflammatory hyperalgesia with the same efficacy as 30 mg/kg naproxen.  Inhibition of plasma autotaxin activity correlated with inhibition of autotaxin at the site of inflammation and in ex vivo whole blood.  Furthermore, a close pharmacokinetic/pharmacodynamic relationship was obsd., which suggests that LPA is rapidly formed and degraded in vivo.  PF-8380 can serve as a tool compd. for elucidating LPA's role in inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmRNc2Hmsy67Vg90H21EOLACvtfcHk0lhn03BnfRj5Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Klur8%253D&md5=ee20fe2e5906e24646dc5e28b6023e9c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.165845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.165845%26sid%3Dliteratum%253Aachs%26aulast%3DGierse%26aufirst%3DJ.%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DBeltey%26aufirst%3DK.%26aulast%3DBradshaw-Pierce%26aufirst%3DE.%26aulast%3DCortes-Burgos%26aufirst%3DL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DJohnston%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DM.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DPegg%26aufirst%3DL.%26aulast%3DPelc%26aufirst%3DM.%26aulast%3DPrinsen%26aufirst%3DM.%26aulast%3DSchnute%26aufirst%3DM.%26aulast%3DWendling%26aufirst%3DJ.%26aulast%3DWene%26aufirst%3DS.%26aulast%3DWeinberg%26aufirst%3DR.%26aulast%3DWittwer%26aufirst%3DA.%26aulast%3DZweifel%26aufirst%3DB.%26aulast%3DMasferrer%26aufirst%3DJ.%26atitle%3DA%2520novel%2520autotaxin%2520inhibitor%2520reduces%2520lysophosphatidic%2520acid%2520levels%2520in%2520plasma%2520and%2520the%2520site%2520of%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D310%26epage%3D317%26doi%3D10.1124%2Fjpet.110.165845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tilburg, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Discovery and optimization of boronic acid based inhibitors of autotaxin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4958</span><span class="NLM_x">–</span> <span class="NLM_lpage">4967</span><span class="refDoi"> DOI: 10.1021/jm1005012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4958-4967&author=H.+M.+H.+G.+Albersauthor=L.+A.+van+Meeterenauthor=D.+A.+Eganauthor=E.+W.+van+Tilburgauthor=W.+H.+Moolenaarauthor=H.+Ovaa&title=Discovery+and+optimization+of+boronic+acid+based+inhibitors+of+autotaxin&doi=10.1021%2Fjm1005012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm1005012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005012%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DEgan%26aufirst%3DD.%2BA.%26aulast%3Dvan%2BTilburg%26aufirst%3DE.%2BW.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520boronic%2520acid%2520based%2520inhibitors%2520of%2520autotaxin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4958%26epage%3D4967%26doi%3D10.1021%2Fjm1005012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchinson, J. H.; Parr, T. A.; Roppe, J. R.; Stock, N. S.; Volkots, D.</span><span> </span><span class="NLM_article-title">Heterocyclic autotaxin inhibitors and uses thereof</span>. (Amira Pharmaceuticals, Inc.). International Patent Application WO/2012/024620-A2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+H.+Hutchinson&author=T.+A.+Parr&author=J.+R.+Roppe&author=N.+S.+Stock&author=D.+Volkots&title=Heterocyclic+autotaxin+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DHeterocyclic%2520autotaxin%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roppe, J. R.; Parr, T. A.; Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Heterocyclic autotaxin inhibitors and uses thereof</span>. (Amira Pharmaceuticals, Inc.). International Patent Application WO/2012/166415-A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Roppe&author=T.+A.+Parr&author=J.+H.+Hutchinson&title=Heterocyclic+autotaxin+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoppe%26aufirst%3DJ.%2BR.%26atitle%3DHeterocyclic%2520autotaxin%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roppe, J. R.; Parr, T. A.; Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Heterocyclic autotaxin inhibitors and uses thereof</span>. (Amira Pharmaceuticals, Inc.). United States Patent Application US/2013/029948-A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Roppe&author=T.+A.+Parr&author=J.+H.+Hutchinson&title=Heterocyclic+autotaxin+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoppe%26aufirst%3DJ.%2BR.%26atitle%3DHeterocyclic%2520autotaxin%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trost, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godwin, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G.</span><span> </span><span class="NLM_article-title">Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">433</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0076-6879(07)33001-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2FS0076-6879%2807%2933001-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2007&pages=1-25&author=M.+Murphauthor=T.+Tanakaauthor=J.+Pangauthor=E.+Felixauthor=S.+Liuauthor=R.+Trostauthor=A.+K.+Godwinauthor=R.+Newmanauthor=G.+Mills&title=Liquid+chromatography+mass+spectrometry+for+quantifying+plasma+lysophospholipids%3A+potential+biomarkers+for+cancer+diagnosis&doi=10.1016%2FS0076-6879%2807%2933001-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2807%2933001-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252807%252933001-2%26sid%3Dliteratum%253Aachs%26aulast%3DMurph%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DFelix%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DTrost%26aufirst%3DR.%26aulast%3DGodwin%26aufirst%3DA.%2BK.%26aulast%3DNewman%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DG.%26atitle%3DLiquid%2520chromatography%2520mass%2520spectrometry%2520for%2520quantifying%2520plasma%2520lysophospholipids%253A%2520potential%2520biomarkers%2520for%2520cancer%2520diagnosis%26jtitle%3DMethods%2520Enzymol.%26date%3D2007%26volume%3D433%26spage%3D1%26epage%3D25%26doi%3D10.1016%2FS0076-6879%2807%2933001-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Umezu-Goto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1083/jcb.200204026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1083%2Fjcb.200204026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=12119361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Shsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2002&pages=227-233&author=M.+Umezu-Gotoauthor=Y.+Kishiauthor=A.+Tairaauthor=K.+Hamaauthor=N.+Dohmaeauthor=K.+Takioauthor=T.+Yamoriauthor=G.+B.+Millsauthor=K.+Inoueauthor=J.+Aokiauthor=H.+Arai&title=Autotaxin+has+lysophospholipase+D+activity+leading+to+tumor+cell+growth+and+motility+by+lysophosphatidic+acid+production&doi=10.1083%2Fjcb.200204026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production</span></div><div class="casAuthors">Umezu-Goto, Makiko; Kishi, Yasuhiro; Taira, Akitsu; Hama, Kotaro; Dohmae, Naoshi; Takio, Koji; Yamori, Takao; Mills, Gordon B.; Inoue, Keizo; Aoki, Junken; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-233</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a tumor cell motility-stimulating factor, originally isolated from melanoma cell supernatants.  ATX had been proposed to mediate its effects through 5'-nucleotide pyrophosphatase and phosphodiesterase activities.  However, the ATX substrate mediating the increase in cellular motility remains to be identified.  Here, we demonstrated that lysophospholipase D (lysoPLD) purified from fetal bovine serum, which catalyzes the prodn. of the bioactive phospholipid mediator, lysophosphatidic acid (LPA), from lysophosphatidylcholine (LPC), is identical to ATX.  The Km value of ATX for LPC was 25-fold lower than that for the synthetic nucleoside substrate, p-nitrophenyl-tri-monophosphate.  LPA mediates multiple biol. functions including cytoskeletal reorganization, chemotaxis, and cell growth through activation of specific G protein-coupled receptors.  Recombinant ATX, particularly in the presence of LPC, dramatically increased chemotaxis and proliferation of multiple different cell lines.  Moreover, we demonstrate that several cancer cell lines release significant amts. of LPC, a substrate for ATX, into the culture medium.  The demonstration that ATX and lysoPLD are identical suggests that autocrine or paracrine prodn. of LPA contributes to tumor cell motility, survival, and proliferation.  It also provides potential novel targets for therapy of pathophysiol. states including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrvee1BK52h7Vg90H21EOLACvtfcHk0lh9uPYvirZ34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Shsrg%253D&md5=8c091eeb8d9f6da65b0aa75ad7db4011</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200204026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200204026%26sid%3Dliteratum%253Aachs%26aulast%3DUmezu-Goto%26aufirst%3DM.%26aulast%3DKishi%26aufirst%3DY.%26aulast%3DTaira%26aufirst%3DA.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DTakio%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DAutotaxin%2520has%2520lysophospholipase%2520D%2520activity%2520leading%2520to%2520tumor%2520cell%2520growth%2520and%2520motility%2520by%2520lysophosphatidic%2520acid%2520production%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D158%26spage%3D227%26epage%3D233%26doi%3D10.1083%2Fjcb.200204026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Imamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuti, Y.</span><span> </span><span class="NLM_article-title">Enzymatic determination of phospholipase D activity with choline oxidase</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1093/oxfordjournals.jbchem.a131960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1093%2Foxfordjournals.jbchem.a131960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=641031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVOru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1978&pages=677-680&author=S.+Imamuraauthor=Y.+Horiuti&title=Enzymatic+determination+of+phospholipase+D+activity+with+choline+oxidase&doi=10.1093%2Foxfordjournals.jbchem.a131960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic determination of phospholipase D activity with choline oxidase</span></div><div class="casAuthors">Imamura, Shigeyuki; Horiuti, Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">677-80</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">An enzymic method was developed for the assay of phospholipase D from cabbage leaves using choline oxidase from Arthrobacter globiformis cells.  The method was based on the estn. of choline by a series of enzymic reactions after ending the phospholipase D reaction.  The amt. of choline was proportional to the amt. of resulting quinoneimine dye with an absorbance max. at 500 nm.  The phospholipase D reaction (choline liberation) was carried out at pH 5.5 in the presence of Ca2+ and ended by adding EDTA in concd. Tris-HCl buffer, pH 8, to give a final pH of around 8.  The initial rate of the phospholipase D reaction was proportional to the enzyme concn. over the absorbance change range of 0-0.25 (equiv. to 0-21 μM choline) under the optimal reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbuEFRvRtu4LVg90H21EOLACvtfcHk0lh9uPYvirZ34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVOru7c%253D&md5=3558ef83a0d48c699d6f4578c3a1aab0</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a131960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a131960%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DHoriuti%26aufirst%3DY.%26atitle%3DEnzymatic%2520determination%2520of%2520phospholipase%2520D%2520activity%2520with%2520choline%2520oxidase%26jtitle%3DJ.%2520Biochem.%26date%3D1978%26volume%3D83%26spage%3D677%26epage%3D680%26doi%3D10.1093%2Foxfordjournals.jbchem.a131960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gijsbers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, M.</span><span> </span><span class="NLM_article-title">The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">538</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00133-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2FS0014-5793%2803%2900133-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=538&publication_year=2003&pages=60-64&author=R.+Gijsbersauthor=J.+Aokiauthor=H.+Araiauthor=M.+Bollen&title=The+hydrolysis+of+lysophospholipids+and+nucleotides+by+autotaxin+%28NPP2%29+involves+a+single+catalytic+site&doi=10.1016%2FS0014-5793%2803%2900133-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900133-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900133-9%26sid%3Dliteratum%253Aachs%26aulast%3DGijsbers%26aufirst%3DR.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DThe%2520hydrolysis%2520of%2520lysophospholipids%2520and%2520nucleotides%2520by%2520autotaxin%2520%2528NPP2%2529%2520involves%2520a%2520single%2520catalytic%2520site%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D538%26spage%3D60%26epage%3D64%26doi%3D10.1016%2FS0014-5793%2803%2900133-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of an enzyme-cleavable sensor molecule for phosphodiesterase activity based on fluorescence resonance energy transfer</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1021/ja011251q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja011251q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Wgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=1653-1657&author=H.+Takakusaauthor=K.+Kikuchiauthor=Y.+Uranoauthor=S.+Sakamotoauthor=K.+Yamaguchiauthor=T.+Nagano&title=Design+and+synthesis+of+an+enzyme-cleavable+sensor+molecule+for+phosphodiesterase+activity+based+on+fluorescence+resonance+energy+transfer&doi=10.1021%2Fja011251q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of an Enzyme-Cleavable Sensor Molecule for Phosphodiesterase Activity Based on Fluorescence Resonance Energy Transfer</span></div><div class="casAuthors">Takakusa, Hideo; Kikuchi, Kazuya; Urano, Yasuteru; Sakamoto, Shigeru; Yamaguchi, Kentaro; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1653-1657</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ratiometric measurement is a technique that can provide precise data and even quant. detection.  To carry out ratiometric measurements, it is necessary that the sensor mol. exhibits a large shift in its emission or excitation spectrum after reaction with the target mol.  Fluorescence resonance energy transfer (FRET) is one mechanism used to obtain a large spectral shift.  In this study, our aim was to develop a ratiometric fluorescent sensor mol. for phosphodiesterase activity based on FRET.  We designed and synthesized CPF4 with a coumarin donor, a fluorescein acceptor, and two Ph linkers having the phosphodiester moiety interposed between them.  In the emission spectrum of CPF4 in aq. buffer excited at 370 nm, the emission of the coumarin donor was strongly quenched and the emission of the fluorescein acceptor was obsd.  This emission spectrum demonstrates that energy transfer from the coumarin donor to the fluorescein acceptor proceeds efficiently.  Addn. of a phosphodiesterase to an aq. soln. of CPF4 resulted in an increase in the donor fluorescence and a decrease in the acceptor fluorescence.  CPF4 exhibited a large shift in its emission spectrum after the hydrolysis of the phosphodiester group by the enzyme.  This large shift of the emission spectrum indicates that ratiometric measurements can be made by using CPF4.  The method described in this paper for designing enzyme-cleavable sensor mols. based on FRET should be readily applicable to other hydrolytic enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF7A_cE3st8LVg90H21EOLACvtfcHk0lgzw92VzBKVqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Wgsw%253D%253D&md5=9542a153a4ca8d9b6c975a410b8cae11</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja011251q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja011251q%26sid%3Dliteratum%253Aachs%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520enzyme-cleavable%2520sensor%2520molecule%2520for%2520phosphodiesterase%2520activity%2520based%2520on%2520fluorescence%2520resonance%2520energy%2520transfer%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D1653%26epage%3D1657%26doi%3D10.1021%2Fja011251q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ferguson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G.</span><span> </span><span class="NLM_article-title">Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span><span class="refDoi"> DOI: 10.1021/ol060414i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol060414i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2023-2026&author=C.+Fergusonauthor=C.+Bigmanauthor=R.+Richardsonauthor=L.+A.+van+Meeterenauthor=W.+H.+Moolenaarauthor=G.+Prestwich&title=Fluorogenic+phospholipid+substrate+to+detect+lysophospholipase+D%2Fautotaxin+activity&doi=10.1021%2Fol060414i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fol060414i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol060414i%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DC.%26aulast%3DBigman%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DR.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPrestwich%26aufirst%3DG.%26atitle%3DFluorogenic%2520phospholipid%2520substrate%2520to%2520detect%2520lysophospholipase%2520D%252Fautotaxin%2520activity%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2023%26epage%3D2026%26doi%3D10.1021%2Fol060414i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kawaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span> </span><span class="NLM_article-title">Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1721</span><span class="refDoi"> DOI: 10.1021/cb400150c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400150c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1713-1721&author=M.+Kawaguchiauthor=T.+Okabeauthor=S.+Okudairaauthor=H.+Nishimasuauthor=R.+Ishitaniauthor=H.+Kojimaauthor=O.+Nurekiauthor=J.+Aokiauthor=T.+Nagano&title=Screening+and+X-ray+crystal+structure-based+optimization+of+autotaxin+%28ENPP2%29+inhibitors%2C+using+a+newly+developed+fluorescence+probe&doi=10.1021%2Fcb400150c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and X-ray Crystal Structure-based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Okabe, Takayoshi; Okudaira, Shinichi; Nishimasu, Hiroshi; Ishitani, Ryuichiro; Kojima, Hirotatsu; Nureki, Osamu; Aoki, Junken; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1713-1721</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), was originally identified as a tumor cell autocrine motility factor and is identical to plasma lysophospholipase D, which is the predominant contributor to lysophosphatidic acid (LPA) prodn. from lysophospholipids.  ATX is therefore considered to regulate the physiol. and pathol. roles of LPA, including angiogenesis, lymphocyte trafficking, tissue fibrosis, and cancer cell invasion and metastasis.  Thus, it is a potential therapeutic target.  Here, the authors first developed a sensitive and specific ATX fluorescence probe, TG-mTMP, and used it to screen ATX inhibitors in a large chem. library.  This probe, which is superior to previously available probes FS-3 and CPF4 in terms of sensitivity or specificity, enabled the authors to identify several novel ATX inhibitor scaffolds.  The authors solved the crystal structures of ATX complexes with the hit compds. at high resoln. (1.75-1.95 Å) and used this information to guide optimization of the structure of a selected inhibitor.  The optimized compds., 3BoA and its derivs., exhibited potent ATX-inhibitory activity both in vitro and in vivo.  These inhibitors are expected to be useful tools to understand the roles of ATX in vitro and in vivo and may also be candidate anti-ATX therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-DjhUd2uXULVg90H21EOLACvtfcHk0lgzw92VzBKVqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D&md5=fdd7e4fcad2cda139edb17673fc4c829</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb400150c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400150c%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DNureki%26aufirst%3DO.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DScreening%2520and%2520X-ray%2520crystal%2520structure-based%2520optimization%2520of%2520autotaxin%2520%2528ENPP2%2529%2520inhibitors%252C%2520using%2520a%2520newly%2520developed%2520fluorescence%2520probe%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1713%26epage%3D1721%26doi%3D10.1021%2Fcb400150c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">North, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanjala, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, T. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span> </span><span class="NLM_article-title">Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3105</span><span class="refDoi"> DOI: 10.1021/jm901718z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901718z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3095-3105&author=E.+J.+Northauthor=A.+L.+Howardauthor=I.+W.+Wanjalaauthor=T.+C.+T.+Phamauthor=D.+L.+Bakerauthor=A.+L.+Parrill&title=Pharmacophore+development+and+application+toward+the+identification+of+novel%2C+small-molecule+autotaxin+inhibitors&doi=10.1021%2Fjm901718z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901718z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901718z%26sid%3Dliteratum%253Aachs%26aulast%3DNorth%26aufirst%3DE.%2BJ.%26aulast%3DHoward%26aufirst%3DA.%2BL.%26aulast%3DWanjala%26aufirst%3DI.%2BW.%26aulast%3DPham%26aufirst%3DT.%2BC.%2BT.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26atitle%3DPharmacophore%2520development%2520and%2520application%2520toward%2520the%2520identification%2520of%2520novel%252C%2520small-molecule%2520autotaxin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3095%26epage%3D3105%26doi%3D10.1021%2Fjm901718z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><div class="note"><p class="first last">GVK Biosciences Private Limited, Plot No. 28 A, IDA, Nacharam, Hyderabad 500076, India.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GVK+Biosciences+Private+Limited%2C+Plot+No.+28+A%2C+IDA%2C+Nacharam%2C+Hyderabad+500076%2C+India."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papoian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span><span class="refDoi"> DOI: 10.1124/mol.113.087080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fmol.113.087080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=415-424&author=J.+I.+Fellsauthor=S.+C.+Leeauthor=Y.+Fujiwaraauthor=D.+D.+Normanauthor=K.+G.+Limauthor=R.+Tsukaharaauthor=J.+Liuauthor=R.+Patilauthor=D.+D.+Millerauthor=R.+J.+Kirbyauthor=S.+Nelsonauthor=W.+Seibelauthor=R.+Papoianauthor=A.+L.+Parrillauthor=D.+L.+Bakerauthor=R.+Bittmanauthor=G.+Tigyi&title=Hits+of+a+high-throughput+screen+identify+the+hydrophobic+pocket+of+autotaxin%2Flysophospholipase+D+as+an+inhibitory+surface&doi=10.1124%2Fmol.113.087080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087080%26sid%3Dliteratum%253Aachs%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DNorman%26aufirst%3DD.%2BD.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DKirby%26aufirst%3DR.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DSeibel%26aufirst%3DW.%26aulast%3DPapoian%26aufirst%3DR.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DHits%2520of%2520a%2520high-throughput%2520screen%2520identify%2520the%2520hydrophobic%2520pocket%2520of%2520autotaxin%252Flysophospholipase%2520D%2520as%2520an%2520inhibitory%2520surface%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D415%26epage%3D424%26doi%3D10.1124%2Fmol.113.087080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papoian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span><span class="refDoi"> DOI: 10.1111/febs.12674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1111%2Ffebs.12674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=1017-1028&author=J.+I.+Fellsauthor=S.+C.+Leeauthor=D.+D.+Normanauthor=R.+Tsukaharaauthor=R.+J.+Kirbyauthor=S.+Nelsonauthor=W.+Seibelauthor=R.+Papoianauthor=R.+Patilauthor=D.+D.+Millerauthor=A.+L.+Parrillauthor=T.+C.+Phamauthor=D.+L.+Bakerauthor=R.+Bittmanauthor=G.+Tigyi&title=Targeting+the+hydrophobic+pocket+of+autotaxin+with+virtual+screening+of+inhibitors+identifies+a+common+aromatic+sulfonamide+structural+motif&doi=10.1111%2Ffebs.12674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12674%26sid%3Dliteratum%253Aachs%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DNorman%26aufirst%3DD.%2BD.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DR.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DSeibel%26aufirst%3DW.%26aulast%3DPapoian%26aufirst%3DR.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DPham%26aufirst%3DT.%2BC.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DTargeting%2520the%2520hydrophobic%2520pocket%2520of%2520autotaxin%2520with%2520virtual%2520screening%2520of%2520inhibitors%2520identifies%2520a%2520common%2520aromatic%2520sulfonamide%2520structural%2520motif%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26spage%3D1017%26epage%3D1028%26doi%3D10.1111%2Ffebs.12674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulkerson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeijl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasiem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Structural basis of substrate discrimination and integrin binding by autotaxin</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1038/nsmb.1980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fnsmb.1980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21240271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=198-204&author=J.+Hausmannauthor=S.+Kamtekarauthor=E.+Christodoulouauthor=J.+E.+Dayauthor=T.+Wuauthor=Z.+Fulkersonauthor=H.+M.+Albersauthor=L.+A.+van+Meeterenauthor=A.+J.+Houbenauthor=L.+van+Zeijlauthor=S.+Jansenauthor=M.+Andriesauthor=T.+Hallauthor=L.+E.+Peggauthor=T.+E.+Bensonauthor=M.+Kasiemauthor=K.+Harlosauthor=C.+W.+Kooiauthor=S.+S.+Smythauthor=H.+Ovaaauthor=M.+Bollenauthor=A.+J.+Morrisauthor=W.+H.+Moolenaarauthor=A.+Perrakis&title=Structural+basis+of+substrate+discrimination+and+integrin+binding+by+autotaxin&doi=10.1038%2Fnsmb.1980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of substrate discrimination and integrin binding by autotaxin</span></div><div class="casAuthors">Hausmann, Jens; Kamtekar, Satwik; Christodoulou, Evangelos; Day, Jacqueline E.; Wu, Tao; Fulkerson, Zachary; Albers, Harald M. H. G.; van Meeteren, Laurens A.; Houben, Anna J. S.; van Zeijl, Leonie; Jansen, Silvia; Andries, Maria; Hall, Troii; Pegg, Lyle E.; Benson, Timothy E.; Kasiem, Mobien; Harlos, Karl; Vander Kooi, Craig W.; Smyth, Susan S.; Ovaa, Huib; Bollen, Mathieu; Morris, Andrew J.; Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as ectonucleotide pyrophosphatase/phosphodiesterase-2, ENPP2) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types.  ATX-LPA signaling is involved in various pathologies including tumor progression and inflammation.  However, the mol. basis of substrate recognition and catalysis by ATX and the mechanism by which it interacts with target cells are unclear.  Here, we present the crystal structure of ATX, alone and in complex with a small-mol. inhibitor.  We have identified a hydrophobic lipid-binding pocket and mapped key residues for catalysis and selection between nucleotide and phospholipid substrates.  We have shown that ATX interacts with cell-surface integrins through its N-terminal somatomedin B-like domains, using an atypical mechanism.  Our results define determinants of substrate discrimination by the ENPP family, suggest how ATX promotes localized LPA signaling and suggest new approaches for targeting ATX with small-mol. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fkNlSRtsTbVg90H21EOLACvtfcHk0liU2ovqmii0hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D&md5=bc2ab613ace29ee008825cec69d65fce</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1980%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DFulkerson%26aufirst%3DZ.%26aulast%3DAlbers%26aufirst%3DH.%2BM.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DHouben%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BZeijl%26aufirst%3DL.%26aulast%3DJansen%26aufirst%3DS.%26aulast%3DAndries%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DPegg%26aufirst%3DL.%2BE.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DKasiem%26aufirst%3DM.%26aulast%3DHarlos%26aufirst%3DK.%26aulast%3DKooi%26aufirst%3DC.%2BW.%26aulast%3DSmyth%26aufirst%3DS.%2BS.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520substrate%2520discrimination%2520and%2520integrin%2520binding%2520by%2520autotaxin%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D198%26epage%3D204%26doi%3D10.1038%2Fnsmb.1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1038/nsmb.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fnsmb.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21240269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=205-212&author=H.+Nishimasuauthor=S.+Okudairaauthor=K.+Hamaauthor=E.+Miharaauthor=N.+Dohmaeauthor=A.+Inoueauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+structure+of+autotaxin+and+insight+into+GPCR+activation+by+lipid+mediators&doi=10.1038%2Fnsmb.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span></div><div class="casAuthors">Nishimasu, Hiroshi; Okudaira, Shinichi; Hama, Kotaro; Mihara, Emiko; Dohmae, Naoshi; Inoue, Asuka; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as Enpp2) is a secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine to generate lysophosphatidic acid (LPA), a lipid mediator that activates G protein-coupled receptors to evoke various cellular responses.  Here, we report the crystal structures of mouse ATX alone and in complex with LPAs with different acyl-chain lengths and saturations.  These structures reveal that the multidomain architecture helps to maintain the structural rigidity of the lipid-binding pocket, which accommodates the resp. LPA mols. in distinct conformations.  They indicate that a loop region in the catalytic domain is a major determinant for the substrate specificity of the Enpp family enzymes.  Furthermore, along with biochem. and biol. data, these structures suggest that the produced LPAs are delivered from the active site to cognate G protein-coupled receptors through a hydrophobic channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9dHNmB6yTbVg90H21EOLACvtfcHk0liU2ovqmii0hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D&md5=f2f9ccaadf5c7de7bfd8431e5f954b2a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1998%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520structure%2520of%2520autotaxin%2520and%2520insight%2520into%2520GPCR%2520activation%2520by%2520lipid%2520mediators%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D205%26epage%3D212%26doi%3D10.1038%2Fnsmb.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Keune, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolenaars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidebrecht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunkara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matas-Rico, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Elferink, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11248</span><span class="refDoi"> DOI: 10.1038/ncomms11248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fncomms11248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=27075612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11248&author=W.+Keuneauthor=J.+Hausmannauthor=R.+Bolierauthor=D.+Tolenaarsauthor=A.+Kremerauthor=T.+Heidebrechtauthor=R.+P.+Joostenauthor=M.+Sunkaraauthor=A.+J.+Morrisauthor=E.+Matas-Ricoauthor=W.+H.+Moolenaarauthor=R.+P.+Oude+Elferinkauthor=A.+Perrakis&title=Steroid+binding+to+Autotaxin+links+bile+salts+and+lysophosphatidic+acid+signalling&doi=10.1038%2Fncomms11248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span></div><div class="casAuthors">Keune, Willem-Jan; Hausmann, Jens; Bolier, Ruth; Tolenaars, Dagmar; Kremer, Andreas; Heidebrecht, Tatjana; Joosten, Robbie P.; Sunkara, Manjula; Morris, Andrew J.; Matas-Rico, Elisa; Moolenaar, Wouter H.; Oude Elferink, Ronald P.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11248</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX) generates the lipid mediator lysophosphatidic acid (LPA).  ATX-LPA signalling is involved in multiple biol. and pathophysiol. processes, including vasculogenesis, fibrosis, cholestatic pruritus and tumor progression.  ATX has a tripartite active site, combining a hydrophilic groove, a hydrophobic lipid-binding pocket and a tunnel of unclear function.  We present crystal structures of rat ATX bound to 7α-hydroxycholesterol and the bile salt tauroursodeoxycholate (TUDCA), showing how the tunnel selectively binds steroids.  A structure of ATX simultaneously harbouring TUDCA in the tunnel and LPA in the pocket, together with kinetic anal., reveals that bile salts act as partial non-competitive inhibitors of ATX, thereby attenuating LPA receptor activation.  This unexpected interplay between ATX-LPA signalling and select steroids, notably natural bile salts, provides a mol. basis for the emerging assocn. of ATX with disorders assocd. with increased circulating levels of bile salts.  Furthermore, our findings suggest potential clin. implications in the use of steroid drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3bO2RWT8ZrVg90H21EOLACvtfcHk0ljMg270ZvV8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D&md5=29178b1c529c8c72ea6890fe32a66372</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms11248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11248%26sid%3Dliteratum%253Aachs%26aulast%3DKeune%26aufirst%3DW.%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DBolier%26aufirst%3DR.%26aulast%3DTolenaars%26aufirst%3DD.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DHeidebrecht%26aufirst%3DT.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DSunkara%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMatas-Rico%26aufirst%3DE.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DOude%2BElferink%26aufirst%3DR.%2BP.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DSteroid%2520binding%2520to%2520Autotaxin%2520links%2520bile%2520salts%2520and%2520lysophosphatidic%2520acid%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11248%26doi%3D10.1038%2Fncomms11248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Cole, J. C.; Nissink, J. W. M.; Taylor, R.</span> <span class="citation_source-book">Protein–Ligand Docking and Virtual Screening with GOLD</span>; <span class="NLM_series">Virtual Screening in Drug Discovery</span>; <span class="NLM_contrib-group">Shoichet, B.; Alvarez, J.</span>, Eds.; <span class="NLM_publisher-name">Taylor & Francis CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+C.+Cole&author=J.+W.+M.+Nissink&author=R.+Taylorauthor=B.+Shoichet&author=J.+Alvarez&title=Protein%E2%80%93Ligand+Docking+and+Virtual+Screening+with+GOLD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DJ.%2BC.%26btitle%3DProtein%25E2%2580%2593Ligand%2520Docking%2520and%2520Virtual%2520Screening%2520with%2520GOLD%26aulast%3DShoichet%26aufirst%3DB.%26pub%3DTaylor%2520%2526%2520Francis%2520CRC%2520Press%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span>Discovery Studio Modelling Environment, <span class="NLM_edition">release 4.5</span>; <span class="NLM_publisher-name">Dassault Systèmes BIOVIA</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discovery+Studio+Modelling+Environment%2C+release+4.5%3B+Dassault+Syst%C3%A8mes+BIOVIA%3A+San+Diego%2C+CA%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DDiscovery%2520Studio%2520Modelling%2520Environment%26pub%3DDassault%2520Syst%25C3%25A8mes%2520BIOVIA%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Brooks, H. B.; Geeganage, S.; Kahl, S. D.; Montrose, C.; Sittampalam, S.; Smith, M. C.; Weidner, J. R.</span><span> </span><span class="NLM_article-title">Basics of Enzymatic Assays for HTS</span>. In:  <span class="citation_source-book">Assay Guidance Manual</span>; <span class="NLM_contrib-group">Sittampalam, G. S.; Coussens, N. P.; Nelson, H.</span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span><a href="https://www.ncbi.nlm.nih.gov/books/NBK53196/" class="extLink">https://www.ncbi.nlm.nih.gov/books/NBK53196/</a> (accessed December 8, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=H.+B.+Brooks&author=S.+Geeganage&author=S.+D.+Kahl&author=C.+Montrose&author=S.+Sittampalam&author=M.+C.+Smith&author=J.+R.+Weidnerauthor=G.+S.+Sittampalam&author=N.+P.+Coussens&author=H.+Nelson&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DH.%2BB.%26atitle%3DBasics%2520of%2520Enzymatic%2520Assays%2520for%2520HTS%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruurs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goding, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">21155</span><span class="NLM_x">–</span> <span class="NLM_lpage">21161</span><span class="refDoi"> DOI: 10.1074/jbc.M413183200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1074%2Fjbc.M413183200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=21155-21161&author=L.+A.+van+Meeterenauthor=P.+Ruursauthor=E.+Christodoulouauthor=J.+W.+Godingauthor=H.+Takakusaauthor=K.+Kikuchiauthor=A.+Perrakisauthor=T.+Naganoauthor=W.+H.+Moolenaar&title=Inhibition+of+autotaxin+by+lysophosphatidic+acid+and+sphingosine+1-phosphate&doi=10.1074%2Fjbc.M413183200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413183200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413183200%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DRuurs%26aufirst%3DP.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DGoding%26aufirst%3DJ.%2BW.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DInhibition%2520of%2520autotaxin%2520by%2520lysophosphatidic%2520acid%2520and%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D21155%26epage%3D21161%26doi%3D10.1074%2Fjbc.M413183200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists</span>. <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>Chapter 3.2, p  <span class="NLM_fpage">53</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=53&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery%3A+A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%253A%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DWiley%26date%3D2005%26spage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljMg270ZvV8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Potterton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M.</span><span> </span><span class="NLM_article-title">Developments in the CCP4 molecular-graphics project</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2288</span><span class="NLM_x">–</span> <span class="NLM_lpage">2294</span><span class="refDoi"> DOI: 10.1107/S0907444904023716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444904023716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=15572783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2288-2294&author=L.+Pottertonauthor=S.+McNicholasauthor=E.+Krissinelauthor=J.+Gruberauthor=K.+Cowtanauthor=P.+Emsleyauthor=G.+N.+Murshudovauthor=S.+Cohenauthor=A.+Perrakisauthor=M.+Noble&title=Developments+in+the+CCP4+molecular-graphics+project&doi=10.1107%2FS0907444904023716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in the CCP4 molecular-graphics project</span></div><div class="casAuthors">Potterton, Liz; McNicholas, Stuart; Krissinel, Eugene; Gruber, Jan; Cowtan, Kevin; Emsley, Paul; Murshudov, Garib N.; Cohen, Serge; Perrakis, Anastassis; Noble, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2288-2294</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Progress towards structure detn. that is both high-throughput and high-value is dependent on the development of integrated and automatic tools for electron-d. map interpretation and for the anal. of the resulting at. models.  Advances in map-interpretation algorithms are extending the resoln. regime in which fully automatic tools can work reliably, but at present human intervention is required to interpret poor regions of macromol. electron d., particularly where crystallog. data is only available to modest resoln. [for example, I/σ(I) < 2.0 for min. resoln. 2.5 Å].  In such cases, a set of manual and semi-manual model-building mol.-graphics tools is needed.  At the same time, converting the knowledge encapsulated in a mol. structure into understanding is dependent upon visualization tools, which must be able to communicate that understanding to others by both static and dynamic representations.  CCP4mg is a program designed to meet these needs in a way that is closely integrated with the ongoing development of CCP4 as a program suite suitable for both low- and high-intervention computational structural biol.  As well as providing a carefully designed user interface to advanced algorithms of model building and anal., CCP4mg is intended to present a graphical toolkit to developers of novel algorithms in these fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptPa3hk2BiOrVg90H21EOLACvtfcHk0lgxOIgdBUhCuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars7vN&md5=6bdc27bb8dc2d7c5ed37ef306e686001</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444904023716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904023716%26sid%3Dliteratum%253Aachs%26aulast%3DPotterton%26aufirst%3DL.%26aulast%3DMcNicholas%26aufirst%3DS.%26aulast%3DKrissinel%26aufirst%3DE.%26aulast%3DGruber%26aufirst%3DJ.%26aulast%3DCowtan%26aufirst%3DK.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DNoble%26aufirst%3DM.%26atitle%3DDevelopments%2520in%2520the%2520CCP4%2520molecular-graphics%2520project%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2288%26epage%3D2294%26doi%3D10.1107%2FS0907444904023716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Perrin, D. D.; Armarego, W. L. F.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_publisher-name">Pergamon Press</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">391</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=391&author=D.+D.+Perrin&author=W.+L.+F.+Armarego&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin%26aufirst%3DD.%2BD.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DPergamon%2520Press%26date%3D1988%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Huang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">7-Azaindolyl- and indolyl-functionalized starburst molecules with a 1,3,5-triazine or a benzene core – syntheses and luminescence</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1139/v06-022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1139%2Fv06-022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=477-485&author=W.+H.+Huangauthor=W.+L.+Jiaauthor=S.+Wang&title=7-Azaindolyl-+and+indolyl-functionalized+starburst+molecules+with+a+1%2C3%2C5-triazine+or+a+benzene+core+%E2%80%93+syntheses+and+luminescence&doi=10.1139%2Fv06-022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1139%2Fv06-022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv06-022%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BH.%26aulast%3DJia%26aufirst%3DW.%2BL.%26aulast%3DWang%26aufirst%3DS.%26atitle%3D7-Azaindolyl-%2520and%2520indolyl-functionalized%2520starburst%2520molecules%2520with%2520a%25201%252C3%252C5-triazine%2520or%2520a%2520benzene%2520core%2520%25E2%2580%2593%2520syntheses%2520and%2520luminescence%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D2006%26volume%3D84%26spage%3D477%26epage%3D485%26doi%3D10.1139%2Fv06-022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, B.</span><span> </span><span class="NLM_article-title">Sequence-specific association in aqueous media by integrating hydrogen bonding and dynamic covalent interactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">12628</span><span class="NLM_x">–</span> <span class="NLM_lpage">12629</span><span class="refDoi"> DOI: 10.1021/ja064515n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja064515n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=12628-12629&author=M.+Liauthor=K.+Yamatoauthor=J.+S.+Fergusonauthor=B.+Gong&title=Sequence-specific+association+in+aqueous+media+by+integrating+hydrogen+bonding+and+dynamic+covalent+interactions&doi=10.1021%2Fja064515n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja064515n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja064515n%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYamato%26aufirst%3DK.%26aulast%3DFerguson%26aufirst%3DJ.%2BS.%26aulast%3DGong%26aufirst%3DB.%26atitle%3DSequence-specific%2520association%2520in%2520aqueous%2520media%2520by%2520integrating%2520hydrogen%2520bonding%2520and%2520dynamic%2520covalent%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D12628%26epage%3D12629%26doi%3D10.1021%2Fja064515n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasiem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Mammalian cell expression, purification, crystallization and microcrystal data collection of autotaxin/ENPP2, a secreted mammalian glycoprotein</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span><span class="refDoi"> DOI: 10.1107/S1744309110032938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS1744309110032938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20823545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1130-1135&author=J.+Hausmannauthor=E.+Christodoulouauthor=M.+Kasiemauthor=V.+De+Marcoauthor=L.+A.+van+Meeterenauthor=W.+H.+Moolenaarauthor=D.+Axfordauthor=R.+L.+Owenauthor=G.+Evansauthor=A.+Perrakis&title=Mammalian+cell+expression%2C+purification%2C+crystallization+and+microcrystal+data+collection+of+autotaxin%2FENPP2%2C+a+secreted+mammalian+glycoprotein&doi=10.1107%2FS1744309110032938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian cell expression, purification, crystallization and microcrystal data collection of autotaxin/ENPP2, a secreted mammalian glycoprotein</span></div><div class="casAuthors">Hausmann, Jens; Christodoulou, Evangelos; Kasiem, Mobien; De Marco, Valeria; van Meeteren, Laurens A.; Moolenaar, Wouter H.; Axford, Danny; Owen, Robin L.; Evans, Gwyndaf; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1130-1135</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Autotaxin (ATX or ENPP2) is a secreted glycosylated mammalian enzyme that exhibits lysophospholipase D activity, hydrolyzing lysophosphatidylcholine to the signaling lipid, lysophosphatidic acid.  ATX is an ∼100 kDa multi-domain protein encompassing 2 N-terminal somatomedin B-like domains, a central catalytic phosphodiesterase domain, and a C-terminal nuclease-like domain.  Protocols for the efficient expression of ATX from stably transfected mammalian HEK293 cells in amts. sufficient for crystallog. studies are reported.  The purifn. resulted in protein that crystd. readily, but various attempts to grow crystals suitable in size for routine crystallog. structure detn. were not successful.  However, the available micrometer-thick plates diffracted x-rays beyond 2.0 Å resoln. and allowed the collection of complete diffraction data to ∼2.6 Å resoln.  The problems encountered and the current advantages and limitations of diffraction data collection from thin crystal plates are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohhtw5mdkwvLVg90H21EOLACvtfcHk0lgxOIgdBUhCuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamt7nI&md5=5cd367280e3ae14280b422ee78269235</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS1744309110032938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309110032938%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DKasiem%26aufirst%3DM.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DAxford%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DR.%2BL.%26aulast%3DEvans%26aufirst%3DG.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DMammalian%2520cell%2520expression%252C%2520purification%252C%2520crystallization%2520and%2520microcrystal%2520data%2520collection%2520of%2520autotaxin%252FENPP2%252C%2520a%2520secreted%2520mammalian%2520glycoprotein%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2010%26volume%3D66%26spage%3D1130%26epage%3D1135%26doi%3D10.1107%2FS1744309110032938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kabsch, W.</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kabsch%2C+W.Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+2010%2C+66%2C+125%E2%80%93132+10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljnUKihQ3B8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Evans, P. R.</span><span> </span><span class="NLM_article-title">An introduction to data reduction: space-group determination, scaling and intensity statistics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1107/S090744491003982X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS090744491003982X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21460446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=282-292&author=P.+R.+Evans&title=An+introduction+to+data+reduction%3A+space-group+determination%2C+scaling+and+intensity+statistics&doi=10.1107%2FS090744491003982X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An introduction to data reduction: Space-group determination, scaling and intensity statistics</span></div><div class="casAuthors">Evans, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">282-292</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  This paper presents an overview of how to run the CCP4 programs for data redn. (SCALA, POINTLESS and CTRUNCATE) through the CCP4 graphical interface ccp4i and points out some issues that need to be considered, together with a few examples.  It covers detn. of the point-group symmetry of the diffraction data (the Laue group), which is required for the subsequent scaling step, examn. of systematic absences, which in many cases will allow inference of the space group, putting multiple data sets on a common indexing system when there are alternatives, the scaling step itself, which produces a large set of data-quality indicators, estn. of |F| from intensity and finally examn. of intensity statistics to detect crystal pathologies such as twinning.  An appendix outlines the scoring schemes used by the program POINTLESS to assign probabilities to possible Laue and space groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEq8RhfQOW8LVg90H21EOLACvtfcHk0ljnUKihQ3B8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D&md5=f425388a87744d721d324118d50e4f9a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS090744491003982X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491003982X%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26atitle%3DAn%2520introduction%2520to%2520data%2520reduction%253A%2520space-group%2520determination%252C%2520scaling%2520and%2520intensity%2520statistics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D282%26epage%3D292%26doi%3D10.1107%2FS090744491003982X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">McCoy, A.</span><span> </span><span class="NLM_article-title">Solving structures of protein complexes by molecular replacement with Phaser</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1107/S0907444906045975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444906045975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=17164524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=32-41&author=A.+McCoy&title=Solving+structures+of+protein+complexes+by+molecular+replacement+with+Phaser&doi=10.1107%2FS0907444906045975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Solving structures of protein complexes by molecular replacement with Phaser</span></div><div class="casAuthors">McCoy, Airlie J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Mol. replacement (MR) generally becomes more difficult as the no. of components in the asym. unit requiring sep. MR models (i.e. the dimensionality of the search) increases.  When the proportion of the total scattering contributed by each search component is small, the signal in the search for each component in isolation is weak or non-existent.  Maximum-likelihood MR functions enable complex asym. units to be built up from individual components with a 'tree search with pruning' approach.  This method, as implemented in the automated search procedure of the program Phaser, has been very successful in solving many previously intractable MR problems.  However, there are a no. of cases in which the automated search procedure of Phaser is suboptimal or encounters difficulties.  These include cases where there are a large no. of copies of the same component in the asym. unit or where the components of the asym. unit have greatly varying B factors.  Two case studies are presented to illustrate how Phaser can be used to best advantage in the std. 'automated MR' mode and two case studies are used to show how to modify the automated search strategy for problematic cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAvs9W8hQ3l7Vg90H21EOLACvtfcHk0ljnUKihQ3B8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqu77F&md5=323a5297bdf622ebaf398a87c39dc794</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444906045975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906045975%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%26atitle%3DSolving%2520structures%2520of%2520protein%2520complexes%2520by%2520molecular%2520replacement%2520with%2520Phaser%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2007%26volume%3D63%26spage%3D32%26epage%3D41%26doi%3D10.1107%2FS0907444906045975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubák, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0ljnUKihQ3B8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Joosten, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">The PDB_REDO server for macromolecular structure model optimization</span> <span class="citation_source-journal">IUCrJ</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1107/S2052252514009324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS2052252514009324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=25075342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=213-220&author=R.+P.+Joostenauthor=F.+Longauthor=G.+N.+Murshudovauthor=A.+Perrakis&title=The+PDB_REDO+server+for+macromolecular+structure+model+optimization&doi=10.1107%2FS2052252514009324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The PDBREDO server for macromolecular structure model optimization</span></div><div class="casAuthors">Joosten, Robbie P.; Long, Fei; Murshudov, Garib N.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">IUCrJ</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-220</span>CODEN:
                <span class="NLM_cas:coden">IUCRAJ</span>;
        ISSN:<span class="NLM_cas:issn">2052-2525</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The refinement and validation of a crystallog. structure model is the last step before the coordinates and the assocd. data are submitted to the Protein Data Bank (PDB).  The success of the refinement procedure is typically assessed by validating the models against geometrical criteria and the diffraction data, and is an important step in ensuring the quality of the PDB public archive [Read et al. (2011), Structure, 19, 1395-1412].  The PDBREDO procedure aims for 'constructive validation', aspiring to consistent and optimal refinement parameterization and pro-active model rebuilding, not only correcting errors but striving for optimal interpretation of the electron d.  A web server for PDBREDO has been implemented, allowing thorough, consistent and fully automated optimization of the refinement procedure in REFMAC and partial model rebuilding.  The goal of the web server is to help practicing crystallographers to improve their model prior to submission to the PDB.  For this, addnl. steps were implemented in the PDBREDO pipeline, both in the refinement procedure, e.g. testing of resoln. limits and k-fold cross-validation for small test sets, and as new validation criteria, e.g. the d.-fit metrics implemented in EDSTATS and ligand validation as implemented in YASARA.  Innovative ways to present the refinement and validation results to the user are also described, which together with auto-generated Coot scripts can guide users to subsequent model inspection and improvement.  It is demonstrated that using the server can lead to substantial improvement of structure models before they are submitted to the PDB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRplzNLO6ThbVg90H21EOLACvtfcHk0lh8uqpakJh_7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnJ&md5=d7e448dc44857536ac5d71c1d92d5f10</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS2052252514009324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052252514009324%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DThe%2520PDB_REDO%2520server%2520for%2520macromolecular%2520structure%2520model%2520optimization%26jtitle%3DIUCrJ%26date%3D2014%26volume%3D1%26spage%3D213%26epage%3D220%26doi%3D10.1107%2FS2052252514009324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><div class="note"><p class="first last">For details of this assay, see:</p></div><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semaan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J. B.</span><span> </span><span class="NLM_article-title">Identification of a novel class of autotaxin inhibitors through cross-screening</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span><span class="refDoi"> DOI: 10.1039/C5MD00081E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1039%2FC5MD00081E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1149-1155&author=D.+Castagnaauthor=E.+L.+Duffyauthor=D.+Semaanauthor=L.+C.+Youngauthor=J.+M.+Pritchardauthor=S.+J.+F.+MacDonaldauthor=D.+C.+Buddauthor=C.+Jamiesonauthor=A.+J.+B.+Watson&title=Identification+of+a+novel+class+of+autotaxin+inhibitors+through+cross-screening&doi=10.1039%2FC5MD00081E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1039%2FC5MD00081E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00081E%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DDuffy%26aufirst%3DE.%2BL.%26aulast%3DSemaan%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DL.%2BC.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%2BB.%26atitle%3DIdentification%2520of%2520a%2520novel%2520class%2520of%2520autotaxin%2520inhibitors%2520through%2520cross-screening%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1149%26epage%3D1155%26doi%3D10.1039%2FC5MD00081E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19a','cit19b','cit19c','cit19d'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mitsuyasu Kawaguchi, Takayoshi Okabe, Shinichi Okudaira, Kotaro Hama, Kuniyuki Kano, Hiroshi Nishimasu, Hidehiko Nakagawa, Ryuichiro Ishitani, Hirotatsu Kojima, Osamu Nureki, Junken Aoki, <span class="NLM_string-name hlFld-ContribAuthor">Tetsuo Nagano</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Potent In Vivo Autotaxin Inhibitors that Bind to Both Hydrophobic Pockets and Channels in the Catalytic Domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3188-3204. <a href="https://doi.org/10.1021/acs.jmedchem.9b01967" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01967%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotent%252BIn%252BVivo%252BAutotaxin%252BInhibitors%252Bthat%252BBind%252Bto%252BBoth%252BHydrophobic%252BPockets%252Band%252BChannels%252Bin%252Bthe%252BCatalytic%252BDomain%26aulast%3DKawaguchi%26aufirst%3DMitsuyasu%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26112019%26date%3D13032020%26date%3D05032020%26volume%3D63%26issue%3D6%26spage%3D3188%26epage%3D3204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aikaterini Nikolaou, Ioanna Ninou, Maroula G. Kokotou, Eleanna Kaffe, Antreas Afantitis, Vassilis Aidinis, <span class="NLM_string-name hlFld-ContribAuthor">George Kokotos</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3697-3711. <a href="https://doi.org/10.1021/acs.jmedchem.8b00232" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00232%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHydroxamic%252BAcids%252BConstitute%252Ba%252BNovel%252BClass%252Bof%252BAutotaxin%252BInhibitors%252Bthat%252BExhibit%252Bin%252BVivo%252BEfficacy%252Bin%252Ba%252BPulmonary%252BFibrosis%252BModel%26aulast%3DNikolaou%26aufirst%3DAikaterini%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12022018%26date%3D18042018%26date%3D05042018%26volume%3D61%26issue%3D8%26spage%3D3697%26epage%3D3711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnès  Joncour</span>, <span class="hlFld-ContribAuthor ">Nicolas  Desroy</span>, <span class="hlFld-ContribAuthor ">Christopher  Housseman</span>, <span class="hlFld-ContribAuthor ">Xavier  Bock</span>, <span class="hlFld-ContribAuthor ">Natacha  Bienvenu</span>, <span class="hlFld-ContribAuthor ">Laëtitia  Cherel</span>, <span class="hlFld-ContribAuthor ">Virginie  Labeguere</span>, <span class="hlFld-ContribAuthor ">Christophe  Peixoto</span>, <span class="hlFld-ContribAuthor ">Denis  Annoot</span>, <span class="hlFld-ContribAuthor ">Luce  Lepissier</span>, <span class="hlFld-ContribAuthor ">Jörg  Heiermann</span>, <span class="hlFld-ContribAuthor ">Willem Jan  Hengeveld</span>, <span class="hlFld-ContribAuthor ">Gregor  Pilzak</span>, <span class="hlFld-ContribAuthor ">Alain  Monjardet</span>, <span class="hlFld-ContribAuthor ">Emanuelle  Wakselman</span>, <span class="hlFld-ContribAuthor ">Veronique  Roncoroni</span>, <span class="hlFld-ContribAuthor ">Sandrine  Le Tallec</span>, <span class="hlFld-ContribAuthor ">René  Galien</span>, <span class="hlFld-ContribAuthor ">Christelle  David</span>, <span class="hlFld-ContribAuthor ">Nele  Vandervoort</span>, <span class="hlFld-ContribAuthor ">Thierry  Christophe</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>, <span class="hlFld-ContribAuthor ">Mia  Jans</span>, <span class="hlFld-ContribAuthor ">Alexandre  Wohlkonig</span>, <span class="hlFld-ContribAuthor ">Sameh  Soror</span>, <span class="hlFld-ContribAuthor ">Jan  Steyaert</span>, <span class="hlFld-ContribAuthor ">Robert  Touitou</span>, <span class="hlFld-ContribAuthor ">Damien  Fleury</span>, <span class="hlFld-ContribAuthor ">Lionel  Vercheval</span>, <span class="hlFld-ContribAuthor ">Patrick  Mollat</span>, <span class="hlFld-ContribAuthor ">Nicolas  Triballeau</span>, <span class="hlFld-ContribAuthor ">Ellen  van der Aar</span>, <span class="hlFld-ContribAuthor ">Reginald  Brys</span>, and <span class="hlFld-ContribAuthor ">Bertrand  Heckmann</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7371-7392. <a href="https://doi.org/10.1021/acs.jmedchem.7b00647" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00647%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationship%25252C%252Band%252BBinding%252BMode%252Bof%252Ban%252BImidazo%25255B1%25252C2-a%25255Dpyridine%252BSeries%252Bof%252BAutotaxin%252BInhibitors%26aulast%3DJoncour%26aufirst%3DAgn%25C3%25A8s%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03052017%26date%3D18082017%26date%3D14092017%26date%3D21072017%26volume%3D60%26issue%3D17%26spage%3D7371%26epage%3D7392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiana  Magkrioti</span>, <span class="hlFld-ContribAuthor ">Eleanna  Kaffe</span>, <span class="hlFld-ContribAuthor ">Elli-Anna  Stylianaki</span>, <span class="hlFld-ContribAuthor ">Camelia  Sidahmet</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7002. <a href="https://doi.org/10.3390/ijms21197002" title="DOI URL">https://doi.org/10.3390/ijms21197002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197002%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BNovel%252BChemical%252BClasses%252Bof%252BAutotaxin%252BInhibitors%26aulast%3DMagkrioti%26aufirst%3DChristiana%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keisuke  Yanagida</span>, <span class="hlFld-ContribAuthor ">William J.  Valentine</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable Lysophospholipid Signaling Pathways. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 137-176. <a href="https://doi.org/10.1007/978-3-030-50621-6_7" title="DOI URL">https://doi.org/10.1007/978-3-030-50621-6_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50621-6_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50621-6_7%26sid%3Dliteratum%253Aachs%26atitle%3DDruggable%252BLysophospholipid%252BSignaling%252BPathways%26aulast%3DYanagida%26aufirst%3DKeisuke%26date%3D2020%26date%3D2020%26spage%3D137%26epage%3D176%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDruggable%252BLipid%252BSignaling%252BPathways%26aulast%3DKihara%26aufirst%3DYasuyuki%26date%3D2020%26volume%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Salgado-Polo</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>. </span><span class="cited-content_cbyCitation_article-title">The Structural Binding Mode of the Four Autotaxin Inhibitor Types that Differentially Affect Catalytic and Non-Catalytic Functions. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (10)
                                     , 1577. <a href="https://doi.org/10.3390/cancers11101577" title="DOI URL">https://doi.org/10.3390/cancers11101577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11101577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11101577%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BStructural%252BBinding%252BMode%252Bof%252Bthe%252BFour%252BAutotaxin%252BInhibitor%252BTypes%252Bthat%252BDifferentially%252BAffect%252BCatalytic%252Band%252BNon-Catalytic%252BFunctions%26aulast%3DSalgado-Polo%26aufirst%3DFernando%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 976-1013. <a href="https://doi.org/10.1002/med.21551" title="DOI URL">https://doi.org/10.1002/med.21551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21551%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDevelopment%252Band%252Btherapeutic%252Bpotential%252Bof%252Bautotaxin%252Bsmall%252Bmolecule%252Binhibitors%25253A%252BFrom%252Bbench%252Bto%252Badvanced%252Bclinical%252Btrials%26aulast%3DMatralis%26aufirst%3DAlexios%2BN.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D976%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamie  Suzuki</span>, <span class="hlFld-ContribAuthor ">John D.  Chisholm</span>. </span><span class="cited-content_cbyCitation_article-title">Friedel-Crafts alkylation of indoles with trichloroacetimidates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (19)
                                     , 1325-1329. <a href="https://doi.org/10.1016/j.tetlet.2019.04.007" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFriedel-Crafts%252Balkylation%252Bof%252Bindoles%252Bwith%252Btrichloroacetimidates%26aulast%3DSuzuki%26aufirst%3DTamie%26date%3D2019%26volume%3D60%26issue%3D19%26spage%3D1325%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Döhler</span>, <span class="hlFld-ContribAuthor ">Matthias  Zebisch</span>, <span class="hlFld-ContribAuthor ">Dana  Krinke</span>, <span class="hlFld-ContribAuthor ">Andrea  Robitzki</span>, <span class="hlFld-ContribAuthor ">Norbert  Sträter</span>. </span><span class="cited-content_cbyCitation_article-title">Crystallization of ectonucleotide phosphodiesterase/pyrophosphatase-3 and orientation of the SMB domains in the full-length ectodomain. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section F Structural Biology Communications</span><span> <strong>2018,</strong> <em>74 </em>
                                    (11)
                                     , 696-703. <a href="https://doi.org/10.1107/S2053230X18011111" title="DOI URL">https://doi.org/10.1107/S2053230X18011111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053230X18011111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053230X18011111%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520F%2520Structural%2520Biology%2520Communications%26atitle%3DCrystallization%252Bof%252Bectonucleotide%252Bphosphodiesterase%25252Fpyrophosphatase-3%252Band%252Borientation%252Bof%252Bthe%252BSMB%252Bdomains%252Bin%252Bthe%252Bfull-length%252Bectodomain%26aulast%3DD%25C3%25B6hler%26aufirst%3DChristoph%26date%3D2018%26date%3D2018%26volume%3D74%26issue%3D11%26spage%3D696%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojun  Luo</span>, <span class="hlFld-ContribAuthor ">Qiang  Liu</span>, <span class="hlFld-ContribAuthor ">Hongxia  Zhu</span>, <span class="hlFld-ContribAuthor ">Huoji  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalysed regioselective sulfenylation of indoles with sodium sulfinates. </span><span class="cited-content_cbyCitation_journal-name">Royal Society Open Science</span><span> <strong>2018,</strong> <em>5 </em>
                                    (5)
                                     , 180170. <a href="https://doi.org/10.1098/rsos.180170" title="DOI URL">https://doi.org/10.1098/rsos.180170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsos.180170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsos.180170%26sid%3Dliteratum%253Aachs%26jtitle%3DRoyal%2520Society%2520Open%2520Science%26atitle%3DCopper-catalysed%252Bregioselective%252Bsulfenylation%252Bof%252Bindoles%252Bwith%252Bsodium%252Bsulfinates%26aulast%3DLuo%26aufirst%3DXiaojun%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D5%26spage%3D180170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert D.  Barrows</span>, <span class="hlFld-ContribAuthor ">Kristin M.  Blacklock</span>, <span class="hlFld-ContribAuthor ">Paul R.  Rablen</span>, <span class="hlFld-ContribAuthor ">Sagar D.  Khare</span>, <span class="hlFld-ContribAuthor ">Spencer  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Computational assessment of thioether isosteres. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2018,</strong> <em>80 </em>, 282-292. <a href="https://doi.org/10.1016/j.jmgm.2018.01.018" title="DOI URL">https://doi.org/10.1016/j.jmgm.2018.01.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2018.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2018.01.018%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DComputational%252Bassessment%252Bof%252Bthioether%252Bisosteres%26aulast%3DBarrows%26aufirst%3DRobert%2BD.%26date%3D2018%26volume%3D80%26spage%3D282%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mindaugas  Šiaučiulis</span>, <span class="hlFld-ContribAuthor ">Selma  Sapmaz</span>, <span class="hlFld-ContribAuthor ">Alexander P.  Pulis</span>, <span class="hlFld-ContribAuthor ">David J.  Procter</span>. </span><span class="cited-content_cbyCitation_article-title">Dual vicinal functionalisation of heterocycles
              via
              an interrupted Pummerer coupling/[3,3]-sigmatropic rearrangement cascade. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 754-759. <a href="https://doi.org/10.1039/C7SC04723A" title="DOI URL">https://doi.org/10.1039/C7SC04723A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7SC04723A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7SC04723A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDual%252Bvicinal%252Bfunctionalisation%252Bof%252Bheterocycles%252Bvia%252Ban%252Binterrupted%252BPummerer%252Bcoupling%25252F%25255B3%25252C3%25255D-sigmatropic%252Brearrangement%252Bcascade%26aulast%3D%25C5%25A0iau%25C4%258Diulis%26aufirst%3DMindaugas%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D754%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Dae-Yon  Lee</span>, <span class="hlFld-ContribAuthor ">Myeong Hwi  Lee</span>, <span class="hlFld-ContribAuthor ">Sangeun  Chae</span>, <span class="hlFld-ContribAuthor ">Eunmi  Jung</span>, <span class="hlFld-ContribAuthor ">Yunki  Kim</span>, <span class="hlFld-ContribAuthor ">Jeonghee  Ryu</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (17)
                                     , 4156-4164. <a href="https://doi.org/10.1016/j.bmcl.2017.07.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bdocking%252Band%252Bbiological%252Bevaluation%252Bof%252B4-phenyl-thiazole%252Bderivatives%252Bas%252Bautotaxin%252B%252528ATX%252529%252Binhibitors%26aulast%3DBalupuri%26aufirst%3DAnand%26date%3D2017%26volume%3D27%26issue%3D17%26spage%3D4156%26epage%3D4164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatu  Pantsar</span>, <span class="hlFld-ContribAuthor ">Prosanta  Singha</span>, <span class="hlFld-ContribAuthor ">Tapio J.  Nevalainen</span>, <span class="hlFld-ContribAuthor ">Igor  Koshevoy</span>, <span class="hlFld-ContribAuthor ">Jukka  Leppänen</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Juha M.A.  Niskanen</span>, <span class="hlFld-ContribAuthor ">Sanna  Pasonen-Seppänen</span>, <span class="hlFld-ContribAuthor ">Juha R.  Savinainen</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Jarmo T.  Laitinen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 2,4-dihydropyrano[2,3-c]pyrazole derivatives as autotaxin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>107 </em>, 97-111. <a href="https://doi.org/10.1016/j.ejps.2017.07.002" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B2%25252C4-dihydropyrano%25255B2%25252C3-c%25255Dpyrazole%252Bderivatives%252Bas%252Bautotaxin%252Binhibitors%26aulast%3DPantsar%26aufirst%3DTatu%26date%3D2017%26volume%3D107%26spage%3D97%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. ATX-Mediated Hydrolysis of LPC Releasing LPA: Disease States via LPA Action on the GPCRs LPA<sub>1-6</sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R group = fatty acid chain with varying degrees of unsaturation.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lipid-based inhibitors and small molecule inhibitors of ATX: <b>4</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a><b>5</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>6</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><b>7</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>8</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and <b>9</b> (previously reported activity from patent literature).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> FS-3 assay (a); LPC choline release assay (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0016.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. ATX-Mediated Choline Release Colorimetric Assay for ATX Inhibition<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R group = fatty acid chain with varying degrees of unsaturation.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0017.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. ATX-Mediated Hydrolysis of Bis-<i>p</i>NPP <b>11</b> Releasing 4-Nitrophenol <b>12</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of indole <b>9</b> extracted from data reported by Amira Pharmaceuticals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0018.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Amira Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>t</i>BuOH, 3-chlorophenylhydrazine hydrochloride, reflux, (ii) HCl, AcOH; (b) 2 M aq NaOH, THF, RT; (c) 4-iodo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0003.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Substitution on the indole ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0019.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>t</i>BuOH, phenylhydrazine hydrochloride, reflux, (ii) HCl, AcOH; (b) NaH, MeI, THF, reflux; (c) 2 M aq NaOH, THF, RT.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0004.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Substitution on the indole nitrogen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0020.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>45</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chloroacetone, DIPEA, MeCN, reflux; (b) 3-chlorophenylhydrazine hydrochloride, EtOH, reflux; (c) Herrmann’s catalyst, Mo(CO)<sub>6</sub>, [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub>, DBU, MeOH/MeCN (1:4), 70 °C; (d) NaH, MeI, THF, reflux; (e) 2 M aq NaOH, THF, RT.</p></p></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0005.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Substitution on the indole nitrogen, benzoic acid analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0021.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>59</b>–<b>62</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chloroacetone, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) phenylhydrazine hydrochloride, EtOH, reflux; (c) 2 M aq NaOH, THF, RT; (d) 4-bromo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C.</p></p></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0006.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ether linked analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0022.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compounds <b>66</b>–<b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-bromo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C; (b) (i) 6-bromopicolinaldehyde, CH<sub>2</sub>Cl<sub>2</sub>, (ii) Et<sub>3</sub>SiH, TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) Herrmann’s catalyst, Mo(CO)<sub>6</sub>, [<i>t</i>Bu<sub>3</sub>PH]BF<sub>4</sub>, DBU, MeOH/MeCN (1:4), 70 °C; (d) 2 M aq NaOH, THF, RT.</p></p></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0007.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Methylene linked analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0023.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Analogue <b>75</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) conc H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux; (b) 4-bromothiophenol, DMF, 45 °C; (c) 1-methylpyrazole-4-boronic acid pinacol ester, K<sub>3</sub>PO<sub>4</sub>, Pd(OAc)<sub>2</sub>, SPhos, THF/H<sub>2</sub>O (7:1), 50 °C; (d) 2 M aq NaOH, THF, RT.</p></p></figure><figure data-id="sch10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0024.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Aliphatic Carboxylic Acid Analogue <b>80</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thiourea, EtOH, reflux; (b) chloroacetone, DIPEA, THF, RT; (c) phenylhydrazine hydrochloride, EtOH, reflux; (d) 4-bromo-1-methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, CuO, pyridine, 170 °C.</p></p></figure><figure data-id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0008.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Aliphatic acid analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0009.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Testing of <b>9</b> in the bis-<i>p</i>NPP assay from 30 nM to 30 μM of inhibitor. Dashed line indicates 60% inhibition criteria of initial screen. Control reactions confirmed there was no hydrolysis of <b>11</b> in the absence of ATX (data not shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0010.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Three binding sites of ATX: catalytic site, hydrophobic pocket, and tunnel. Complex of LPA 14:0 (red) in mouse ATX (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NKN">3NKN</a>) with the docked position of bis-<i>p</i>NPP <b>11</b> (green) overlaid. Docked using GOLD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and viewed using Discovery Studio Visualizer.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0011.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. In silico studies created using cocrystal of ATX with <b>2</b> and <b>8</b> PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZG7">4ZG7</a>. (A) Model of <b>51</b> (yellow) overlaid with cocrystal of <b>8</b> (colored by atom type) and ATX, with <b>2</b> residing in the catalytic site and hydrophobic pocket. (B) Model of ATX with <b>9</b> highlighting possible interactions. (C) Shift observed when 4-Cl substituted <b>18</b> is docked (yellow) vs 6-Cl substituted <b>9</b> (colored by atom type). Docked using GOLD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and viewed using Discovery Studio Visualizer<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0012.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Enzyme kinetic studies using compounds <b>9</b>, <b>28</b>, <b>47</b>, and <b>51</b>. Compound <b>9</b>: α = 0.8.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0013.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQQ">5LQQ</a>) vs docking model of <b>51</b> with ATX. Cocrystal structure of <b>51</b> (colored by atom type) overlaid with docking model of <b>51</b> (yellow). Docked using GOLD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and viewed using Discovery Studio Visualizer<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/medium/jm-2016-01597w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0014.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Crystallographic data of <b>51</b> with ATX. (A) <b>51</b> bound within the tunnel, remote from the catalytic site. (B) Stick and ball model of <b>51</b>. (C) Ligand display for interaction and analysis (LIDIA) graph of <b>51</b>. Model and LIDIA graph built using COOT.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Images created using CCP4MG.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-2/acs.jmedchem.6b01597/20170120/images/large/jm-2016-01597w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01597&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i127">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Strackes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krutzsch, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unsworth, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arestad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cioce, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, L. A.</span><span> </span><span class="NLM_article-title">Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=2524-2529&author=M.+L.+Strackesauthor=H.+C.+Krutzschauthor=E.+J.+Unsworthauthor=A.+Arestadauthor=V.+Cioceauthor=E.+Schiffmannauthor=L.+A.+Liotta&title=Identification%2C+purification%2C+and+partial+sequence+analysis+of+autotaxin%2C+a+novel+motility-stimulating+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrackes%26aufirst%3DM.%2BL.%26aulast%3DKrutzsch%26aufirst%3DH.%2BC.%26aulast%3DUnsworth%26aufirst%3DE.%2BJ.%26aulast%3DArestad%26aufirst%3DA.%26aulast%3DCioce%26aufirst%3DV.%26aulast%3DSchiffmann%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26atitle%3DIdentification%252C%2520purification%252C%2520and%2520partial%2520sequence%2520analysis%2520of%2520autotaxin%252C%2520a%2520novel%2520motility-stimulating%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D2524%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tokumura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuzawa, K.</span><span> </span><span class="NLM_article-title">Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">39436</span><span class="NLM_x">–</span> <span class="NLM_lpage">39442</span><span class="refDoi"> DOI: 10.1074/jbc.M205623200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1074%2Fjbc.M205623200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=12176993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVeit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=39436-39442&author=A.+Tokumuraauthor=E.+Majimaauthor=Y.+Kariyaauthor=K.+Tominagaauthor=K.+Kogureauthor=K.+Yasudaauthor=K.+Fukuzawa&title=Identification+of+human+plasma+lysophospholipase+D%2C+a+lysophosphatidic+acid-producing+enzyme%2C+as+autotaxin%2C+a+multifunctional+phosphodiesterase&doi=10.1074%2Fjbc.M205623200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase</span></div><div class="casAuthors">Tokumura, Akira; Majima, Eiji; Kariya, Yuko; Tominaga, Kyoko; Kogure, Kentaro; Yasuda, Katsuhiko; Fukuzawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">39436-39442</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We purified human plasma lysophospholipase D that produces physiol. active lysophosphatidic acid and showed that it is a sol. form of autotaxin, an ecto-nucleotide pyrophosphatase/phosphodiesterase, originally found as a tumor cell motility-stimulating factor.  Its lower Km value for a lysophosphatidylcholine than that for a synthetic substrate of nucleotide suggests that lysophosphatidylcholine is a more likely physiol. substrate for autotaxin and that its predicted physiol. and pathophysiol. functions could be mediated by its activity to produce lysophosphate acid, an intercellular mediator.  Recombinant autotaxin was found to have lysophospholipase D activity; its substrate specificity and metal ion requirement were the same as those of the purified plasma enzyme.  The activity of lysophospholipase D for exogenous lysophosphatidylcholine in human serum was found to increase in normal pregnant women at the third trimester of pregnancy and to a higher extent in patients in threatened preterm delivery, suggesting its roles in induction of parturition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTHkH4G7jBw7Vg90H21EOLACvtfcHk0lh0bb-tfuqaew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVeit7k%253D&md5=e9074bb4026cd1349670dafb7e580276</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205623200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205623200%26sid%3Dliteratum%253Aachs%26aulast%3DTokumura%26aufirst%3DA.%26aulast%3DMajima%26aufirst%3DE.%26aulast%3DKariya%26aufirst%3DY.%26aulast%3DTominaga%26aufirst%3DK.%26aulast%3DKogure%26aufirst%3DK.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DFukuzawa%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520human%2520plasma%2520lysophospholipase%2520D%252C%2520a%2520lysophosphatidic%2520acid-producing%2520enzyme%252C%2520as%2520autotaxin%252C%2520a%2520multifunctional%2520phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D39436%26epage%3D39442%26doi%3D10.1074%2Fjbc.M205623200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span><span class="refDoi"> DOI: 10.1194/jlr.R046458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1194%2Fjlr.R046458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=24643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1192-1214&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=J.+Chun&title=LPA+receptor+signaling%3A+pharmacology%2C+physiology%2C+and+pathophysiology&doi=10.1194%2Fjlr.R046458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1214</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biol. actions and demonstrates medicinal relevance.  LPA's functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors.  These receptors are named LPA1-6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs.  LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies.  These studies have revealed physiol. and pathophysiol. influences on virtually every organ system and developmental stage of an organism.  These include the nervous, cardiovascular, reproductive, and pulmonary systems.  Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity.  These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7Ll3PB1oubVg90H21EOLACvtfcHk0lh0bb-tfuqaew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK&md5=77271408ffda2fab00e7e0a0f32540d9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046458%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptor%2520signaling%253A%2520pharmacology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1192%26epage%3D1214%26doi%3D10.1194%2Fjlr.R046458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mutoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Insights into the pharmacological relevance of lysophospholipid receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01622.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1111%2Fj.1476-5381.2011.01622.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21838759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=829-844&author=T.+Mutohauthor=R.+Riveraauthor=J.+Chun&title=Insights+into+the+pharmacological+relevance+of+lysophospholipid+receptors&doi=10.1111%2Fj.1476-5381.2011.01622.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the pharmacological relevance of lysophospholipid receptors</span></div><div class="casAuthors">Mutoh, Tetsuji; Rivera, Richard; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">829-844</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery of lysophospholipid (LP) 7-transmembrane, G protein-coupled receptors (GPCRs) that began in the 1990s, together with research into the functional roles of the major LPs known as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), have opened new research avenues into their biol. processes and mechanisms.  Major examples of LP signaling effects include embryogenesis, nervous system development, vascular development, uterine implantation, immune cell trafficking, and inflammatory reactions.  LP signaling also influences the pathophysiol. of many diseases including cancer, autoimmune and inflammatory diseases, which indicate that LP receptors may be attractive targets for pharmacol. therapies.  A key example of such a therapeutic agent is the S1P receptor modulator FTY720, which upon phosphorylation and continued drug exposure, acts as an S1P receptor functional antagonist.  This compd. (also known as fingolimod or Gilenya) has recently been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.  Continued basic and translational research on LP signaling should provide novel insights into both basic biol. mechanisms, as well as novel therapeutic approaches to combat a range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qOGwbmBPirVg90H21EOLACvtfcHk0lh0bb-tfuqaew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D&md5=cf240e202ccfa00c40366f7309e36b78</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01622.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01622.x%26sid%3Dliteratum%253Aachs%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520the%2520pharmacological%2520relevance%2520of%2520lysophospholipid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D829%26epage%3D844%26doi%3D10.1111%2Fj.1476-5381.2011.01622.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Nam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMarlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stracke, M. L.</span><span> </span><span class="NLM_article-title">Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">6938</span><span class="NLM_x">–</span> <span class="NLM_lpage">6944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=6938-6944&author=S.+W.+Namauthor=T.+Clairauthor=Y.+S.+Kimauthor=A.+McMarlinauthor=E.+Schiffmannauthor=L.+A.+Liottaauthor=M.+L.+Stracke&title=Autotaxin+%28NPP-2%29%2C+a+metastasis-enhancing+motogen%2C+is+an+angiogenic+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DS.%2BW.%26aulast%3DClair%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DMcMarlin%26aufirst%3DA.%26aulast%3DSchiffmann%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26aulast%3DStracke%26aufirst%3DM.%2BL.%26atitle%3DAutotaxin%2520%2528NPP-2%2529%252C%2520a%2520metastasis-enhancing%2520motogen%252C%2520is%2520an%2520angiogenic%2520factor%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D6938%26epage%3D6944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Zahednasab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harirchian, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesbah-Namin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siroos, B.</span><span> </span><span class="NLM_article-title">Increased autotaxin activity in multiple sclerosis</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.jneuroim.2014.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2Fj.jneuroim.2014.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=24984830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOnt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2014&pages=120-123&author=H.+Zahednasabauthor=M.+Baloodauthor=M.+H.+Harirchianauthor=S.+A.+Mesbah-Naminauthor=N.+Rahimianauthor=B.+Siroos&title=Increased+autotaxin+activity+in+multiple+sclerosis&doi=10.1016%2Fj.jneuroim.2014.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Increased autotaxin activity in multiple sclerosis</span></div><div class="casAuthors">Zahednasab, Hamid; Balood, Mohammad; Harirchian, Mohammad Hossein; Mesbah-Namin, Seyed Alireza; Rahimian, Nasrin; Siroos, Bahaadin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">120-123</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is an enzyme producing lysophosphatidic acid (LPA) from lysophosphatidyl choline (LPC) and it is up-regulated in inflammatory conditions such as various cancers, arthritis and multiple sclerosis (MS).  Numerous studies have shown that the LPA signaling gives rise to angiogenesis, mitosis, cell proliferation and cytokine secretion.  On the one hand, an increasing body of evidence suggests that blockade of ATX has anti-inflammatory properties in a variety of diseases.  The aim of this study was to measure the enzyme activity of ATX in cerebrospinal fluid (CSF) and serum of patients with MS using an enzymic photometric method.  Twenty definite relapsing remitting MS patients along with 20 patients with other neurol. diseases (OND) were recruited.  The results showed that ATX activity was significantly higher (p value < 0.0001) in MS patients than those patients diagnosed with OND.  It is possible that inhibition of the ATX may decrease the rate of MS relapses/progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbfShx57e7pLVg90H21EOLACvtfcHk0liiuIsmCbr8bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOnt7zJ&md5=d57f6b3275da21ef7fd248a0b1b30e6c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2014.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2014.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DZahednasab%26aufirst%3DH.%26aulast%3DBalood%26aufirst%3DM.%26aulast%3DHarirchian%26aufirst%3DM.%2BH.%26aulast%3DMesbah-Namin%26aufirst%3DS.%2BA.%26aulast%3DRahimian%26aufirst%3DN.%26aulast%3DSiroos%26aufirst%3DB.%26atitle%3DIncreased%2520autotaxin%2520activity%2520in%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2014%26volume%3D273%26spage%3D120%26epage%3D123%26doi%3D10.1016%2Fj.jneuroim.2014.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gotoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami-Murofushi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G. J.</span><span> </span><span class="NLM_article-title">Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1042/BST20110608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1042%2FBST20110608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=22260662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=31-36&author=M.+Gotohauthor=Y.+Fujiwaraauthor=J.+Yueauthor=J.+Liuauthor=S.+Leeauthor=J.+Fellsauthor=A.+Uchiyamaauthor=K.+Murakami-Murofushiauthor=S.+Kennelauthor=J.+Wallauthor=R.+Patilauthor=R.+Gupteauthor=L.+Balazsauthor=D.+D.+Millerauthor=G.+J.+Tigyi&title=Controlling+cancer+through+the+autotaxin-lysophosphatidic+acid+receptor+axis&doi=10.1042%2FBST20110608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis</span></div><div class="casAuthors">Gotoh, Mari; Fujiwara, Yuko; Yue, Junming; Liu, Jianxiong; Lee, Sue Chin; Fells, James; Uchiyama, Ayako; Murakami-Murofushi, Kimiko; Kennel, Stephen; Wall, Jonathan; Patil, Renukadevi; Gupte, Renuka; Balazs, Louisa; Miller, Duane D.; Tigyi, Gabor J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-36</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  LPA (lysophosphatidic acid, 1-acyl-2-hydroxy-sn-glycero-3-phosphate), is a growth factor-like lipid mediator that regulates many cellular functions, many of which are unique to malignantly transformed cells.  The simple chem. structure of LPA and its profound effects in cancer cells has attracted the attention of the cancer therapeutics field and drives the development of therapeutics based on the LPA scaffold.  In biol. fluids, LPA is generated by ATX (autotaxin), a lysophospholipase D that cleaves the choline/serine headgroup from lysophosphatidylcholine and lysophosphatidylserine to generate LPA.  In the present article, we review some of the key findings that make the ATX-LPA signalling axis an emerging target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVq4fS9k_amrVg90H21EOLACvtfcHk0liiuIsmCbr8bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtbc%253D&md5=d6f36a7963badbd37ea18887afe9f0a0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2FBST20110608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110608%26sid%3Dliteratum%253Aachs%26aulast%3DGotoh%26aufirst%3DM.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DUchiyama%26aufirst%3DA.%26aulast%3DMurakami-Murofushi%26aufirst%3DK.%26aulast%3DKennel%26aufirst%3DS.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DGupte%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DTigyi%26aufirst%3DG.%2BJ.%26atitle%3DControlling%2520cancer%2520through%2520the%2520autotaxin-lysophosphatidic%2520acid%2520receptor%2520axis%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D31%26epage%3D36%26doi%3D10.1042%2FBST20110608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCamera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Shah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nm1685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak&doi=10.1038%2Fnm1685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0lia5MQQiuapDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D45%26epage%3D54%26doi%3D10.1038%2Fnm1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kanda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, S.</span><span> </span><span class="NLM_article-title">Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1038/ni1573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fni1573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=18327261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlGms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=415-423&author=H.+Kandaauthor=R.+Newtonauthor=R.+Kleinauthor=Y.+Moritaauthor=M.+Gunnauthor=S.+Rosen&title=Autotaxin%2C+an+ectoenzyme+that+produces+lysophosphatidic+acid%2C+promotes+the+entry+of+lymphocytes+into+secondary+lymphoid+organs&doi=10.1038%2Fni1573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs</span></div><div class="casAuthors">Kanda, Hidenobu; Newton, Rebecca; Klein, Russell; Morita, Yuka; Gunn, Michael D.; Rosen, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-423</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The extracellular lysophospholipase D autotaxin (ATX) and its product, lysophosphatidic acid, have diverse functions in development and cancer, but little is known about their functions in the immune system.  Here we found that ATX had high expression in the high endothelial venules of lymphoid organs and was secreted.  Chemokine-activated lymphocytes expressed receptors with enhanced affinity for ATX, which provides a mechanism for targeting the secreted ATX to lymphocytes undergoing recruitment.  Lysophosphatidic acid induced chemokinesis in T cells.  I.v. injection of enzymically inactive ATX attenuated the homing of T cells to lymphoid tissues, probably through competition with endogenous ATX and exertion of a dominant neg. effect.  These results support the idea of a new and general step in the homing cascade in which the ectoenzyme ATX facilitates the entry of lymphocytes into lymphoid organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq39VaRyMTpqrVg90H21EOLACvtfcHk0lia5MQQiuapDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlGms7c%253D&md5=a9b09e0b4ca5e80504bc2c25162b620e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fni1573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1573%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DGunn%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DS.%26atitle%3DAutotaxin%252C%2520an%2520ectoenzyme%2520that%2520produces%2520lysophosphatidic%2520acid%252C%2520promotes%2520the%2520entry%2520of%2520lymphocytes%2520into%2520secondary%2520lymphoid%2520organs%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D415%26epage%3D423%26doi%3D10.1038%2Fni1573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Awada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grès, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre d’Hellencourt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdon, E.</span><span> </span><span class="NLM_article-title">Autotaxin protects microglial cells against oxidative stress</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2Fj.freeradbiomed.2011.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=22155714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=516-526&author=R.+Awadaauthor=P.+Rondeauauthor=S.+Gr%C3%A8sauthor=J.+S.+Saulnier-Blacheauthor=C.+Lefebvre+d%E2%80%99Hellencourtauthor=E.+Bourdon&title=Autotaxin+protects+microglial+cells+against+oxidative+stress&doi=10.1016%2Fj.freeradbiomed.2011.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin protects microglial cells against oxidative stress</span></div><div class="casAuthors">Awada, Rana; Rondeau, Philippe; Gres, Sandra; Saulnier-Blache, Jean Sebastien; Lefebvre d'Hellencourt, Christian; Bourdon, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-526</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxidative stress occurs when antioxidant defenses are overwhelmed by oxygen-reactive species and can lead to cellular damage, as seen in several neurodegenerative disorders.  Microglia are specialized cells in the central nervous system that act as the first and main form of active immune defense in the response to pathol. events.  Autotaxin (ATX) plays an important role in the modulation of crit. cellular functions, through its enzymic prodn. of lysophosphatidic acid (LPA).  In this study, we investigated the potential role of ATX in the response of microglial cells to oxidative stress.  We show that treatment of a microglial BV2 cell line with hydrogen peroxide (H2O2) stimulates ATX expression and LPA prodn.  Stable overexpression of ATX inhibits microglial activation (CD11b expression) and protects against H2O2-treatment-induced cellular damage.  This protective effect of ATX was partially reduced in the presence of the LPA-receptor antagonist Ki16425.  ATX overexpression was also assocd. with a redn. in intracellular ROS formation, carbonylated protein accumulation, proteasomal activity, and catalase expression.  Our results suggest that up-regulation of ATX expression in microglia could be a mechanism for protection against oxidative stress, thereby reducing inflammation in the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL6Bqivi85ULVg90H21EOLACvtfcHk0lia5MQQiuapDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVygtg%253D%253D&md5=9962485b2cc9f6e2a2b9d551909708c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DAwada%26aufirst%3DR.%26aulast%3DRondeau%26aufirst%3DP.%26aulast%3DGr%25C3%25A8s%26aufirst%3DS.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DLefebvre%2Bd%25E2%2580%2599Hellencourt%26aufirst%3DC.%26aulast%3DBourdon%26aufirst%3DE.%26atitle%3DAutotaxin%2520protects%2520microglial%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D516%26epage%3D526%26doi%3D10.1016%2Fj.freeradbiomed.2011.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J. B.</span><span> </span><span class="NLM_article-title">Development of autotaxin inhibitors: an overview of the patent and primary literature</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5604</span><span class="NLM_x">–</span> <span class="NLM_lpage">5621</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5604-5621&author=D.+Castagnaauthor=D.+C.+Buddauthor=S.+J.+F.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+B.+Watson&title=Development+of+autotaxin+inhibitors%3A+an+overview+of+the+patent+and+primary+literature&doi=10.1021%2Facs.jmedchem.5b01599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature</span></div><div class="casAuthors">Castagna, Diana; Budd, David C.; MacDonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5604-5621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others.  As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities.  This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clin. trial data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzWQadusHW7Vg90H21EOLACvtfcHk0lia5MQQiuapDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D&md5=68ca29436fd3b0a1728a9a52fbaf2cb0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01599%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%2BB.%26atitle%3DDevelopment%2520of%2520autotaxin%2520inhibitors%253A%2520an%2520overview%2520of%2520the%2520patent%2520and%2520primary%2520literature%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5604%26epage%3D5621%26doi%3D10.1021%2Facs.jmedchem.5b01599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Chemical evolution of autotaxin inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span><span class="refDoi"> DOI: 10.1021/cr2003213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2003213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=2593-2603&author=H.+M.+H.+G.+Albersauthor=H.+Ovaa&title=Chemical+evolution+of+autotaxin+inhibitors&doi=10.1021%2Fcr2003213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr2003213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2003213%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DChemical%2520evolution%2520of%2520autotaxin%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D2593%26epage%3D2603%26doi%3D10.1021%2Fcr2003213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchinson, J. H.; Lonergan, D.; Huang, F.; Rowbottom, M.; Calderon, I.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitor compounds</span>. (PharmAkea, Inc.). International Patent Application WO2015/048301 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+H.+Hutchinson&author=D.+Lonergan&author=F.+Huang&author=M.+Rowbottom&author=I.+Calderon&title=Autotaxin+inhibitor+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DAutotaxin%2520inhibitor%2520compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelzer, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1124/mol.115.100404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fmol.115.100404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=26371182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=982-992&author=A.+J.+Steinauthor=G.+Bainauthor=P.+Prodanovichauthor=A.+M.+Santiniauthor=J.+Darlingtonauthor=N.+M.+Stelzerauthor=R.+S.+Sidhuauthor=J.+Schaubauthor=L.+Gouletauthor=D.+Lonerganauthor=I.+Calderonauthor=J.+F.+Evansauthor=J.+H.+Hutchinson&title=Structural+basis+for+inhibition+of+human+autotaxin+by+four+potent+compounds+with+distinct+modes+of+binding&doi=10.1124%2Fmol.115.100404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span></div><div class="casAuthors">Stein, Adam J.; Bain, Gretchen; Prodanovich, Pat; Santini, Angelina M.; Darlington, Janice; Stelzer, Nina M. P.; Sidhu, Ranjinder S.; Schaub, Jeffrey; Goulet, Lance; Lonergan, Dave; Calderon, Imelda; Evans, Jilly F.; Hutchinson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-992</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA).  LPA is a bioactive phospholipid that regulates diverse biol. processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of Gprotein-coupled receptors.  The ATXLPA pathway has been implicated in many pathol. conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain.  Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases.  Mouse and rat ATX have been crystd. previously with LPA or small-mol. inhibitors bound.  Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors.  We demonstrate that the mechanism of inhibition of each compd. reflects its unique interactions with human ATX.  Our studies may provide a basis for the rational design of novel ATX inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8334n30PQrLVg90H21EOLACvtfcHk0lilGw20SWQscg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D&md5=f847e18cf228207349d21c449abdb039</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100404%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DStelzer%26aufirst%3DN.%2BM.%26aulast%3DSidhu%26aufirst%3DR.%2BS.%26aulast%3DSchaub%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520human%2520autotaxin%2520by%2520four%2520potent%2520compounds%2520with%2520distinct%2520modes%2520of%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D982%26epage%3D992%26doi%3D10.1124%2Fmol.115.100404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Prestwich, G.; Tigyi, G.; Jiang, G.; Zhang, G.; Gajewiak, J.; Zhang, H.; Xu, X.</span><span> </span><span class="NLM_article-title">α-Chloro and α-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof</span>. WO2008157361A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Prestwich&author=G.+Tigyi&author=G.+Jiang&author=G.+Zhang&author=J.+Gajewiak&author=H.+Zhang&author=X.+Xu&title=%CE%B1-Chloro+and+%CE%B1-bromo+phosphonate+analogs+of+lysophosphatidic+acid+and+methods+of+making+and+using+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrestwich%26aufirst%3DG.%26atitle%3D%25CE%25B1-Chloro%2520and%2520%25CE%25B1-bromo%2520phosphonate%2520analogs%2520of%2520lysophosphatidic%2520acid%2520and%2520methods%2520of%2520making%2520and%2520using%2520thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajewiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration <i>in vitro</i> and causes tumor regression <i>in vivo</i></span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">5441</span><span class="NLM_x">–</span> <span class="NLM_lpage">5449</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-0302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1158%2F0008-5472.CAN-09-0302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=19509223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=5441-5449&author=H.+Zhangauthor=X.+Xuauthor=J.+Gajewiakauthor=R.+Tsukaharaauthor=Y.+Fujiwaraauthor=J.+Liuauthor=J.+I.+Fellsauthor=D.+Peryginauthor=A.+L.+Parrillauthor=G.+Tigyiauthor=G.+D.+Prestwich&title=Dual+activity+lysophosphatidic+acid+receptor+pan-antagonist%2Fautotaxin+inhibitor+reduces+breast+cancer+cell+migration+in+vitro+and+causes+tumor+regression+in+vivo&doi=10.1158%2F0008-5472.CAN-09-0302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo</span></div><div class="casAuthors">Zhang, Honglu; Xu, Xiaoyu; Gajewiak, Joanna; Tsukahara, Ryoko; Fujiwara, Yuko; Liu, Jianxiong; Fells, James I.; Perygin, Donna; Parrill, Abby L.; Tigyi, Gabor; Prestwich, Glenn D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5441-5449</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Signal transduction modifiers that modulate the lysophosphatidic acid (LPA) pathway have potential as anticancer agents.  Herein, we describe metabolically stabilized LPA analogs that reduce cell migration and invasion and cause regression of orthotopic breast tumors in vivo.  Two diastereoisomeric α-bromophosphonates (BrP-LPA) were synthesized, and the pharmacol. was detd. for five LPA G protein-coupled receptors (GPCRs).  The syn and anti diastereomers of BrP-LPA are pan-LPA GPCR antagonists and are also nanomolar inhibitors of the lysophospholipase D activity of autotaxin, the dominant biosynthetic source of LPA.  Computational models correctly predicted the diastereoselectivity of antagonism for three GPCR isoforms.  The anti isomer of BrP-LPA was more effective than syn isomer in reducing migration of MDA-MB-231 cells, and the anti isomer was superior in reducing invasion of these cells.  Finally, orthotopic breast cancer xenografts were established in nude mice by injection of MB-231 cells in an in situ cross-linkable extracellular matrix.  After 2 wk, mice were treated with the BrP-LPA alone (10 mg/kg), Taxol alone (10 mg/kg), or Taxol followed by BrP-LPA.  All treatments significantly reduced tumor burden, and BrP-LPA was superior to Taxol in reducing blood vessel d. in tumors.  Moreover, both the anti- and syn-BrP-LPA significantly reduced tumors at 3 mg/kg. [Cancer Res 2009;69(13):5441-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMJ8_lQcWDqLVg90H21EOLACvtfcHk0lilGw20SWQscg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrg%253D&md5=18f67a14de05b9f0d0666315665a47c1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-0302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-0302%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DPerygin%26aufirst%3DD.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DDual%2520activity%2520lysophosphatidic%2520acid%2520receptor%2520pan-antagonist%252Fautotaxin%2520inhibitor%2520reduces%2520breast%2520cancer%2520cell%2520migration%2520in%2520vitro%2520and%2520causes%2520tumor%2520regression%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D5441%26epage%3D5449%26doi%3D10.1158%2F0008-5472.CAN-09-0302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulharat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradère, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Try, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giganti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beucher-Gaudin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonchampt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J. A.</span><span> </span><span class="NLM_article-title">S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span><span class="refDoi"> DOI: 10.1124/jpet.108.141911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fjpet.108.141911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=18755937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=809-819&author=G.+Ferryauthor=N.+Moulharatauthor=J.+P.+Prad%C3%A8reauthor=P.+Desosauthor=A.+Tryauthor=A.+Gentonauthor=A.+Gigantiauthor=M.+Beucher-Gaudinauthor=M.+Lonchamptauthor=M.+Bertrandauthor=J.+S.+Saulnier-Blacheauthor=G.+C.+Tuckerauthor=A.+Cordiauthor=J.+A.+Boutin&title=S32826%2C+a+nanomolar+inhibitor+of+autotaxin%3A+discovery%2C+synthesis+and+applications+as+a+pharmacological+tool&doi=10.1124%2Fjpet.108.141911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool</span></div><div class="casAuthors">Ferry, Gilles; Moulharat, Natacha; Pradere, Jean-Philippe; Desos, Patrice; Try, Anne; Genton, Annie; Giganti, Adeline; Beucher-Gaudin, Monique; Lonchampt, Michel; Bertrand, Marc; Saulnier-Blache, Jean-Sebastien; Tucker, Gordon C.; Cordi, Alex; Boutin, Jean A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">809-819</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin catalyzes the transformation of lyso-phosphatidylcholine to lyso-phosphatidic acid (LPA).  LPA is a phospholipid possessing a large panel of activity, in particular as a motility factor or as a growth signal, through its G-protein coupled seven transmembrane receptors.  Indirect evidence strongly suggests that autotaxin is the main, if not the only source of circulating LPA.  Because of its central role in pathol. conditions, such as oncol. and diabetes/obesity, the biochem. properties of autotaxin has attracted a lot of attention, but confirmation of its role in pathol. remains elusive.  One way to validate and/or confirm its central role, is to find potent and selective inhibitors.  A systematic screening of several thousand compds. using a colorimetric assay and taking advantage of the phosphodiesterase activity of autotaxin that requires the enzymic site for LPA generation, led to the discovery of a potent nanomolar inhibitor, [4-(tetradecanoylamino)benzyl]phosphonic acid (S32826).  This compd. was inhibitory toward the various autotaxin isoforms, using an assay measuring the [14C]lyso-phosphatidylcholine conversion into [14C]LPA.  We also evaluated the activity of S32826 in cellular models of diabesity and oncol.  Nevertheless, the poor in vivo stability and/or bioavailability of the compd. did not permit to use it in animals.  S32826 is the first reported inhibitor of autotaxin with an IC50 in the nanomolar range that can be used to validate the role of autotaxin in various pathologies in cellular models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojxROGoeQsO7Vg90H21EOLACvtfcHk0li2NsmJ9aLtdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvF&md5=812d4ceacdeeb8426ad995b3e1519407</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.141911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.141911%26sid%3Dliteratum%253Aachs%26aulast%3DFerry%26aufirst%3DG.%26aulast%3DMoulharat%26aufirst%3DN.%26aulast%3DPrad%25C3%25A8re%26aufirst%3DJ.%2BP.%26aulast%3DDesos%26aufirst%3DP.%26aulast%3DTry%26aufirst%3DA.%26aulast%3DGenton%26aufirst%3DA.%26aulast%3DGiganti%26aufirst%3DA.%26aulast%3DBeucher-Gaudin%26aufirst%3DM.%26aulast%3DLonchampt%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DM.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DTucker%26aufirst%3DG.%2BC.%26aulast%3DCordi%26aufirst%3DA.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26atitle%3DS32826%252C%2520a%2520nanomolar%2520inhibitor%2520of%2520autotaxin%253A%2520discovery%252C%2520synthesis%2520and%2520applications%2520as%2520a%2520pharmacological%2520tool%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D809%26epage%3D819%26doi%3D10.1124%2Fjpet.108.141911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5098</span><span class="NLM_x">–</span> <span class="NLM_lpage">5101</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2Fj.bmcl.2011.03.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5098-5101&author=G.+Jiangauthor=D.+Madanauthor=G.+D.+Prestwich&title=Aromatic+phosphonates+inhibit+the+lysophospholipase+D+activity+of+autotaxin&doi=10.1016%2Fj.bmcl.2011.03.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMadan%26aufirst%3DD.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DAromatic%2520phosphonates%2520inhibit%2520the%2520lysophospholipase%2520D%2520activity%2520of%2520autotaxin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5098%26epage%3D5101%26doi%3D10.1016%2Fj.bmcl.2011.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gierse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw-Pierce, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovskiy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wene, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J.</span><span> </span><span class="NLM_article-title">A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1124/jpet.110.165845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fjpet.110.165845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20392816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Klur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=310-317&author=J.+Gierseauthor=A.+Thorarensenauthor=K.+Belteyauthor=E.+Bradshaw-Pierceauthor=L.+Cortes-Burgosauthor=T.+Hallauthor=A.+Johnstonauthor=M.+Murphyauthor=O.+Nemirovskiyauthor=S.+Ogawaauthor=L.+Peggauthor=M.+Pelcauthor=M.+Prinsenauthor=M.+Schnuteauthor=J.+Wendlingauthor=S.+Weneauthor=R.+Weinbergauthor=A.+Wittwerauthor=B.+Zweifelauthor=J.+Masferrer&title=A+novel+autotaxin+inhibitor+reduces+lysophosphatidic+acid+levels+in+plasma+and+the+site+of+inflammation&doi=10.1124%2Fjpet.110.165845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation</span></div><div class="casAuthors">Gierse, James; Thorarensen, Atli; Beltey, Konstantine; Bradshaw-Pierce, Erica; Cortes-Burgos, Luz; Hall, Troii; Johnston, Amy; Murphy, Michael; Nemirovskiy, Olga; Ogawa, Shinji; Pegg, Lyle; Pelc, Matthew; Prinsen, Michael; Schnute, Mark; Wendling, Jay; Wene, Steven; Weinberg, Robin; Wittwer, Arthur; Zweifel, Ben; Masferrer, Jaime</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">310-317</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin is the enzyme responsible for the prodn. of lysophosphatidic acid (LPA) from lysophosphatidyl choline (LPC), and it is up-regulated in many inflammatory conditions, including but not limited to cancer, arthritis, and multiple sclerosis.  LPA signaling causes angiogenesis, mitosis, cell proliferation, and cytokine secretion.  Inhibition of autotaxin may have anti-inflammatory properties in a variety of diseases; however, this hypothesis has not been tested pharmacol. because of the lack of potent inhibitors.  Here, we report the development of a potent autotaxin inhibitor, PF-8380 [6-(3-(piperazin-1-yl)propanoyl)benzo[d]oxazol-2(3H)-one] with an IC50 of 2.8 nM in isolated enzyme assay and 101 nM in human whole blood.  PF-8380 has adequate oral bioavailability and exposures required for in vivo testing of autotaxin inhibition.  Autotaxin's role in producing LPA in plasma and at the site of inflammation was tested in a rat air pouch model.  The specific inhibitor PF-8380, dosed orally at 30 mg/kg, provided >95% redn. in both plasma and air pouch LPA within 3 h, indicating autotaxin is a major source of LPA during inflammation.  At 30 mg/kg PF-8380 reduced inflammatory hyperalgesia with the same efficacy as 30 mg/kg naproxen.  Inhibition of plasma autotaxin activity correlated with inhibition of autotaxin at the site of inflammation and in ex vivo whole blood.  Furthermore, a close pharmacokinetic/pharmacodynamic relationship was obsd., which suggests that LPA is rapidly formed and degraded in vivo.  PF-8380 can serve as a tool compd. for elucidating LPA's role in inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmRNc2Hmsy67Vg90H21EOLACvtfcHk0li2NsmJ9aLtdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Klur8%253D&md5=ee20fe2e5906e24646dc5e28b6023e9c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.165845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.165845%26sid%3Dliteratum%253Aachs%26aulast%3DGierse%26aufirst%3DJ.%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DBeltey%26aufirst%3DK.%26aulast%3DBradshaw-Pierce%26aufirst%3DE.%26aulast%3DCortes-Burgos%26aufirst%3DL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DJohnston%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DM.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DPegg%26aufirst%3DL.%26aulast%3DPelc%26aufirst%3DM.%26aulast%3DPrinsen%26aufirst%3DM.%26aulast%3DSchnute%26aufirst%3DM.%26aulast%3DWendling%26aufirst%3DJ.%26aulast%3DWene%26aufirst%3DS.%26aulast%3DWeinberg%26aufirst%3DR.%26aulast%3DWittwer%26aufirst%3DA.%26aulast%3DZweifel%26aufirst%3DB.%26aulast%3DMasferrer%26aufirst%3DJ.%26atitle%3DA%2520novel%2520autotaxin%2520inhibitor%2520reduces%2520lysophosphatidic%2520acid%2520levels%2520in%2520plasma%2520and%2520the%2520site%2520of%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D310%26epage%3D317%26doi%3D10.1124%2Fjpet.110.165845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tilburg, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Discovery and optimization of boronic acid based inhibitors of autotaxin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4958</span><span class="NLM_x">–</span> <span class="NLM_lpage">4967</span><span class="refDoi"> DOI: 10.1021/jm1005012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4958-4967&author=H.+M.+H.+G.+Albersauthor=L.+A.+van+Meeterenauthor=D.+A.+Eganauthor=E.+W.+van+Tilburgauthor=W.+H.+Moolenaarauthor=H.+Ovaa&title=Discovery+and+optimization+of+boronic+acid+based+inhibitors+of+autotaxin&doi=10.1021%2Fjm1005012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm1005012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005012%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DEgan%26aufirst%3DD.%2BA.%26aulast%3Dvan%2BTilburg%26aufirst%3DE.%2BW.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520boronic%2520acid%2520based%2520inhibitors%2520of%2520autotaxin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4958%26epage%3D4967%26doi%3D10.1021%2Fjm1005012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchinson, J. H.; Parr, T. A.; Roppe, J. R.; Stock, N. S.; Volkots, D.</span><span> </span><span class="NLM_article-title">Heterocyclic autotaxin inhibitors and uses thereof</span>. (Amira Pharmaceuticals, Inc.). International Patent Application WO/2012/024620-A2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+H.+Hutchinson&author=T.+A.+Parr&author=J.+R.+Roppe&author=N.+S.+Stock&author=D.+Volkots&title=Heterocyclic+autotaxin+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DHeterocyclic%2520autotaxin%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roppe, J. R.; Parr, T. A.; Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Heterocyclic autotaxin inhibitors and uses thereof</span>. (Amira Pharmaceuticals, Inc.). International Patent Application WO/2012/166415-A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Roppe&author=T.+A.+Parr&author=J.+H.+Hutchinson&title=Heterocyclic+autotaxin+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoppe%26aufirst%3DJ.%2BR.%26atitle%3DHeterocyclic%2520autotaxin%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roppe, J. R.; Parr, T. A.; Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Heterocyclic autotaxin inhibitors and uses thereof</span>. (Amira Pharmaceuticals, Inc.). United States Patent Application US/2013/029948-A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Roppe&author=T.+A.+Parr&author=J.+H.+Hutchinson&title=Heterocyclic+autotaxin+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoppe%26aufirst%3DJ.%2BR.%26atitle%3DHeterocyclic%2520autotaxin%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trost, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godwin, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G.</span><span> </span><span class="NLM_article-title">Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">433</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0076-6879(07)33001-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2FS0076-6879%2807%2933001-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2007&pages=1-25&author=M.+Murphauthor=T.+Tanakaauthor=J.+Pangauthor=E.+Felixauthor=S.+Liuauthor=R.+Trostauthor=A.+K.+Godwinauthor=R.+Newmanauthor=G.+Mills&title=Liquid+chromatography+mass+spectrometry+for+quantifying+plasma+lysophospholipids%3A+potential+biomarkers+for+cancer+diagnosis&doi=10.1016%2FS0076-6879%2807%2933001-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2807%2933001-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252807%252933001-2%26sid%3Dliteratum%253Aachs%26aulast%3DMurph%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DFelix%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DTrost%26aufirst%3DR.%26aulast%3DGodwin%26aufirst%3DA.%2BK.%26aulast%3DNewman%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DG.%26atitle%3DLiquid%2520chromatography%2520mass%2520spectrometry%2520for%2520quantifying%2520plasma%2520lysophospholipids%253A%2520potential%2520biomarkers%2520for%2520cancer%2520diagnosis%26jtitle%3DMethods%2520Enzymol.%26date%3D2007%26volume%3D433%26spage%3D1%26epage%3D25%26doi%3D10.1016%2FS0076-6879%2807%2933001-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Umezu-Goto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1083/jcb.200204026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1083%2Fjcb.200204026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=12119361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Shsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2002&pages=227-233&author=M.+Umezu-Gotoauthor=Y.+Kishiauthor=A.+Tairaauthor=K.+Hamaauthor=N.+Dohmaeauthor=K.+Takioauthor=T.+Yamoriauthor=G.+B.+Millsauthor=K.+Inoueauthor=J.+Aokiauthor=H.+Arai&title=Autotaxin+has+lysophospholipase+D+activity+leading+to+tumor+cell+growth+and+motility+by+lysophosphatidic+acid+production&doi=10.1083%2Fjcb.200204026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production</span></div><div class="casAuthors">Umezu-Goto, Makiko; Kishi, Yasuhiro; Taira, Akitsu; Hama, Kotaro; Dohmae, Naoshi; Takio, Koji; Yamori, Takao; Mills, Gordon B.; Inoue, Keizo; Aoki, Junken; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-233</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a tumor cell motility-stimulating factor, originally isolated from melanoma cell supernatants.  ATX had been proposed to mediate its effects through 5'-nucleotide pyrophosphatase and phosphodiesterase activities.  However, the ATX substrate mediating the increase in cellular motility remains to be identified.  Here, we demonstrated that lysophospholipase D (lysoPLD) purified from fetal bovine serum, which catalyzes the prodn. of the bioactive phospholipid mediator, lysophosphatidic acid (LPA), from lysophosphatidylcholine (LPC), is identical to ATX.  The Km value of ATX for LPC was 25-fold lower than that for the synthetic nucleoside substrate, p-nitrophenyl-tri-monophosphate.  LPA mediates multiple biol. functions including cytoskeletal reorganization, chemotaxis, and cell growth through activation of specific G protein-coupled receptors.  Recombinant ATX, particularly in the presence of LPC, dramatically increased chemotaxis and proliferation of multiple different cell lines.  Moreover, we demonstrate that several cancer cell lines release significant amts. of LPC, a substrate for ATX, into the culture medium.  The demonstration that ATX and lysoPLD are identical suggests that autocrine or paracrine prodn. of LPA contributes to tumor cell motility, survival, and proliferation.  It also provides potential novel targets for therapy of pathophysiol. states including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrvee1BK52h7Vg90H21EOLACvtfcHk0lhiNk_w0nmMkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Shsrg%253D&md5=8c091eeb8d9f6da65b0aa75ad7db4011</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200204026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200204026%26sid%3Dliteratum%253Aachs%26aulast%3DUmezu-Goto%26aufirst%3DM.%26aulast%3DKishi%26aufirst%3DY.%26aulast%3DTaira%26aufirst%3DA.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DTakio%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DAutotaxin%2520has%2520lysophospholipase%2520D%2520activity%2520leading%2520to%2520tumor%2520cell%2520growth%2520and%2520motility%2520by%2520lysophosphatidic%2520acid%2520production%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D158%26spage%3D227%26epage%3D233%26doi%3D10.1083%2Fjcb.200204026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Imamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuti, Y.</span><span> </span><span class="NLM_article-title">Enzymatic determination of phospholipase D activity with choline oxidase</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1093/oxfordjournals.jbchem.a131960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1093%2Foxfordjournals.jbchem.a131960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=641031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVOru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1978&pages=677-680&author=S.+Imamuraauthor=Y.+Horiuti&title=Enzymatic+determination+of+phospholipase+D+activity+with+choline+oxidase&doi=10.1093%2Foxfordjournals.jbchem.a131960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic determination of phospholipase D activity with choline oxidase</span></div><div class="casAuthors">Imamura, Shigeyuki; Horiuti, Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">677-80</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">An enzymic method was developed for the assay of phospholipase D from cabbage leaves using choline oxidase from Arthrobacter globiformis cells.  The method was based on the estn. of choline by a series of enzymic reactions after ending the phospholipase D reaction.  The amt. of choline was proportional to the amt. of resulting quinoneimine dye with an absorbance max. at 500 nm.  The phospholipase D reaction (choline liberation) was carried out at pH 5.5 in the presence of Ca2+ and ended by adding EDTA in concd. Tris-HCl buffer, pH 8, to give a final pH of around 8.  The initial rate of the phospholipase D reaction was proportional to the enzyme concn. over the absorbance change range of 0-0.25 (equiv. to 0-21 μM choline) under the optimal reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbuEFRvRtu4LVg90H21EOLACvtfcHk0lhiNk_w0nmMkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVOru7c%253D&md5=3558ef83a0d48c699d6f4578c3a1aab0</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a131960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a131960%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DHoriuti%26aufirst%3DY.%26atitle%3DEnzymatic%2520determination%2520of%2520phospholipase%2520D%2520activity%2520with%2520choline%2520oxidase%26jtitle%3DJ.%2520Biochem.%26date%3D1978%26volume%3D83%26spage%3D677%26epage%3D680%26doi%3D10.1093%2Foxfordjournals.jbchem.a131960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gijsbers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, M.</span><span> </span><span class="NLM_article-title">The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">538</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00133-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1016%2FS0014-5793%2803%2900133-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=538&publication_year=2003&pages=60-64&author=R.+Gijsbersauthor=J.+Aokiauthor=H.+Araiauthor=M.+Bollen&title=The+hydrolysis+of+lysophospholipids+and+nucleotides+by+autotaxin+%28NPP2%29+involves+a+single+catalytic+site&doi=10.1016%2FS0014-5793%2803%2900133-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900133-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900133-9%26sid%3Dliteratum%253Aachs%26aulast%3DGijsbers%26aufirst%3DR.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DThe%2520hydrolysis%2520of%2520lysophospholipids%2520and%2520nucleotides%2520by%2520autotaxin%2520%2528NPP2%2529%2520involves%2520a%2520single%2520catalytic%2520site%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D538%26spage%3D60%26epage%3D64%26doi%3D10.1016%2FS0014-5793%2803%2900133-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of an enzyme-cleavable sensor molecule for phosphodiesterase activity based on fluorescence resonance energy transfer</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1021/ja011251q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja011251q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Wgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=1653-1657&author=H.+Takakusaauthor=K.+Kikuchiauthor=Y.+Uranoauthor=S.+Sakamotoauthor=K.+Yamaguchiauthor=T.+Nagano&title=Design+and+synthesis+of+an+enzyme-cleavable+sensor+molecule+for+phosphodiesterase+activity+based+on+fluorescence+resonance+energy+transfer&doi=10.1021%2Fja011251q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of an Enzyme-Cleavable Sensor Molecule for Phosphodiesterase Activity Based on Fluorescence Resonance Energy Transfer</span></div><div class="casAuthors">Takakusa, Hideo; Kikuchi, Kazuya; Urano, Yasuteru; Sakamoto, Shigeru; Yamaguchi, Kentaro; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1653-1657</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ratiometric measurement is a technique that can provide precise data and even quant. detection.  To carry out ratiometric measurements, it is necessary that the sensor mol. exhibits a large shift in its emission or excitation spectrum after reaction with the target mol.  Fluorescence resonance energy transfer (FRET) is one mechanism used to obtain a large spectral shift.  In this study, our aim was to develop a ratiometric fluorescent sensor mol. for phosphodiesterase activity based on FRET.  We designed and synthesized CPF4 with a coumarin donor, a fluorescein acceptor, and two Ph linkers having the phosphodiester moiety interposed between them.  In the emission spectrum of CPF4 in aq. buffer excited at 370 nm, the emission of the coumarin donor was strongly quenched and the emission of the fluorescein acceptor was obsd.  This emission spectrum demonstrates that energy transfer from the coumarin donor to the fluorescein acceptor proceeds efficiently.  Addn. of a phosphodiesterase to an aq. soln. of CPF4 resulted in an increase in the donor fluorescence and a decrease in the acceptor fluorescence.  CPF4 exhibited a large shift in its emission spectrum after the hydrolysis of the phosphodiester group by the enzyme.  This large shift of the emission spectrum indicates that ratiometric measurements can be made by using CPF4.  The method described in this paper for designing enzyme-cleavable sensor mols. based on FRET should be readily applicable to other hydrolytic enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF7A_cE3st8LVg90H21EOLACvtfcHk0lhSVqayQrXAnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Wgsw%253D%253D&md5=9542a153a4ca8d9b6c975a410b8cae11</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja011251q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja011251q%26sid%3Dliteratum%253Aachs%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520enzyme-cleavable%2520sensor%2520molecule%2520for%2520phosphodiesterase%2520activity%2520based%2520on%2520fluorescence%2520resonance%2520energy%2520transfer%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D1653%26epage%3D1657%26doi%3D10.1021%2Fja011251q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ferguson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G.</span><span> </span><span class="NLM_article-title">Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span><span class="refDoi"> DOI: 10.1021/ol060414i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol060414i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2023-2026&author=C.+Fergusonauthor=C.+Bigmanauthor=R.+Richardsonauthor=L.+A.+van+Meeterenauthor=W.+H.+Moolenaarauthor=G.+Prestwich&title=Fluorogenic+phospholipid+substrate+to+detect+lysophospholipase+D%2Fautotaxin+activity&doi=10.1021%2Fol060414i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fol060414i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol060414i%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DC.%26aulast%3DBigman%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DR.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPrestwich%26aufirst%3DG.%26atitle%3DFluorogenic%2520phospholipid%2520substrate%2520to%2520detect%2520lysophospholipase%2520D%252Fautotaxin%2520activity%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2023%26epage%3D2026%26doi%3D10.1021%2Fol060414i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kawaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span> </span><span class="NLM_article-title">Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1721</span><span class="refDoi"> DOI: 10.1021/cb400150c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400150c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1713-1721&author=M.+Kawaguchiauthor=T.+Okabeauthor=S.+Okudairaauthor=H.+Nishimasuauthor=R.+Ishitaniauthor=H.+Kojimaauthor=O.+Nurekiauthor=J.+Aokiauthor=T.+Nagano&title=Screening+and+X-ray+crystal+structure-based+optimization+of+autotaxin+%28ENPP2%29+inhibitors%2C+using+a+newly+developed+fluorescence+probe&doi=10.1021%2Fcb400150c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and X-ray Crystal Structure-based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Okabe, Takayoshi; Okudaira, Shinichi; Nishimasu, Hiroshi; Ishitani, Ryuichiro; Kojima, Hirotatsu; Nureki, Osamu; Aoki, Junken; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1713-1721</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), was originally identified as a tumor cell autocrine motility factor and is identical to plasma lysophospholipase D, which is the predominant contributor to lysophosphatidic acid (LPA) prodn. from lysophospholipids.  ATX is therefore considered to regulate the physiol. and pathol. roles of LPA, including angiogenesis, lymphocyte trafficking, tissue fibrosis, and cancer cell invasion and metastasis.  Thus, it is a potential therapeutic target.  Here, the authors first developed a sensitive and specific ATX fluorescence probe, TG-mTMP, and used it to screen ATX inhibitors in a large chem. library.  This probe, which is superior to previously available probes FS-3 and CPF4 in terms of sensitivity or specificity, enabled the authors to identify several novel ATX inhibitor scaffolds.  The authors solved the crystal structures of ATX complexes with the hit compds. at high resoln. (1.75-1.95 Å) and used this information to guide optimization of the structure of a selected inhibitor.  The optimized compds., 3BoA and its derivs., exhibited potent ATX-inhibitory activity both in vitro and in vivo.  These inhibitors are expected to be useful tools to understand the roles of ATX in vitro and in vivo and may also be candidate anti-ATX therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-DjhUd2uXULVg90H21EOLACvtfcHk0lhSVqayQrXAnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D&md5=fdd7e4fcad2cda139edb17673fc4c829</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb400150c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400150c%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DNureki%26aufirst%3DO.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DScreening%2520and%2520X-ray%2520crystal%2520structure-based%2520optimization%2520of%2520autotaxin%2520%2528ENPP2%2529%2520inhibitors%252C%2520using%2520a%2520newly%2520developed%2520fluorescence%2520probe%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1713%26epage%3D1721%26doi%3D10.1021%2Fcb400150c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">North, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanjala, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, T. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span> </span><span class="NLM_article-title">Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3105</span><span class="refDoi"> DOI: 10.1021/jm901718z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901718z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3095-3105&author=E.+J.+Northauthor=A.+L.+Howardauthor=I.+W.+Wanjalaauthor=T.+C.+T.+Phamauthor=D.+L.+Bakerauthor=A.+L.+Parrill&title=Pharmacophore+development+and+application+toward+the+identification+of+novel%2C+small-molecule+autotaxin+inhibitors&doi=10.1021%2Fjm901718z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901718z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901718z%26sid%3Dliteratum%253Aachs%26aulast%3DNorth%26aufirst%3DE.%2BJ.%26aulast%3DHoward%26aufirst%3DA.%2BL.%26aulast%3DWanjala%26aufirst%3DI.%2BW.%26aulast%3DPham%26aufirst%3DT.%2BC.%2BT.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26atitle%3DPharmacophore%2520development%2520and%2520application%2520toward%2520the%2520identification%2520of%2520novel%252C%2520small-molecule%2520autotaxin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3095%26epage%3D3105%26doi%3D10.1021%2Fjm901718z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><div class="note"><p class="first last">GVK Biosciences Private Limited, Plot No. 28 A, IDA, Nacharam, Hyderabad 500076, India.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GVK+Biosciences+Private+Limited%2C+Plot+No.+28+A%2C+IDA%2C+Nacharam%2C+Hyderabad+500076%2C+India."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papoian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span><span class="refDoi"> DOI: 10.1124/mol.113.087080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1124%2Fmol.113.087080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=415-424&author=J.+I.+Fellsauthor=S.+C.+Leeauthor=Y.+Fujiwaraauthor=D.+D.+Normanauthor=K.+G.+Limauthor=R.+Tsukaharaauthor=J.+Liuauthor=R.+Patilauthor=D.+D.+Millerauthor=R.+J.+Kirbyauthor=S.+Nelsonauthor=W.+Seibelauthor=R.+Papoianauthor=A.+L.+Parrillauthor=D.+L.+Bakerauthor=R.+Bittmanauthor=G.+Tigyi&title=Hits+of+a+high-throughput+screen+identify+the+hydrophobic+pocket+of+autotaxin%2Flysophospholipase+D+as+an+inhibitory+surface&doi=10.1124%2Fmol.113.087080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087080%26sid%3Dliteratum%253Aachs%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DNorman%26aufirst%3DD.%2BD.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DKirby%26aufirst%3DR.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DSeibel%26aufirst%3DW.%26aulast%3DPapoian%26aufirst%3DR.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DHits%2520of%2520a%2520high-throughput%2520screen%2520identify%2520the%2520hydrophobic%2520pocket%2520of%2520autotaxin%252Flysophospholipase%2520D%2520as%2520an%2520inhibitory%2520surface%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D415%26epage%3D424%26doi%3D10.1124%2Fmol.113.087080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papoian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span><span class="refDoi"> DOI: 10.1111/febs.12674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1111%2Ffebs.12674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=1017-1028&author=J.+I.+Fellsauthor=S.+C.+Leeauthor=D.+D.+Normanauthor=R.+Tsukaharaauthor=R.+J.+Kirbyauthor=S.+Nelsonauthor=W.+Seibelauthor=R.+Papoianauthor=R.+Patilauthor=D.+D.+Millerauthor=A.+L.+Parrillauthor=T.+C.+Phamauthor=D.+L.+Bakerauthor=R.+Bittmanauthor=G.+Tigyi&title=Targeting+the+hydrophobic+pocket+of+autotaxin+with+virtual+screening+of+inhibitors+identifies+a+common+aromatic+sulfonamide+structural+motif&doi=10.1111%2Ffebs.12674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12674%26sid%3Dliteratum%253Aachs%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DNorman%26aufirst%3DD.%2BD.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DR.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DSeibel%26aufirst%3DW.%26aulast%3DPapoian%26aufirst%3DR.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DPham%26aufirst%3DT.%2BC.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DTargeting%2520the%2520hydrophobic%2520pocket%2520of%2520autotaxin%2520with%2520virtual%2520screening%2520of%2520inhibitors%2520identifies%2520a%2520common%2520aromatic%2520sulfonamide%2520structural%2520motif%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26spage%3D1017%26epage%3D1028%26doi%3D10.1111%2Ffebs.12674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulkerson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeijl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasiem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Structural basis of substrate discrimination and integrin binding by autotaxin</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1038/nsmb.1980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fnsmb.1980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21240271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=198-204&author=J.+Hausmannauthor=S.+Kamtekarauthor=E.+Christodoulouauthor=J.+E.+Dayauthor=T.+Wuauthor=Z.+Fulkersonauthor=H.+M.+Albersauthor=L.+A.+van+Meeterenauthor=A.+J.+Houbenauthor=L.+van+Zeijlauthor=S.+Jansenauthor=M.+Andriesauthor=T.+Hallauthor=L.+E.+Peggauthor=T.+E.+Bensonauthor=M.+Kasiemauthor=K.+Harlosauthor=C.+W.+Kooiauthor=S.+S.+Smythauthor=H.+Ovaaauthor=M.+Bollenauthor=A.+J.+Morrisauthor=W.+H.+Moolenaarauthor=A.+Perrakis&title=Structural+basis+of+substrate+discrimination+and+integrin+binding+by+autotaxin&doi=10.1038%2Fnsmb.1980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of substrate discrimination and integrin binding by autotaxin</span></div><div class="casAuthors">Hausmann, Jens; Kamtekar, Satwik; Christodoulou, Evangelos; Day, Jacqueline E.; Wu, Tao; Fulkerson, Zachary; Albers, Harald M. H. G.; van Meeteren, Laurens A.; Houben, Anna J. S.; van Zeijl, Leonie; Jansen, Silvia; Andries, Maria; Hall, Troii; Pegg, Lyle E.; Benson, Timothy E.; Kasiem, Mobien; Harlos, Karl; Vander Kooi, Craig W.; Smyth, Susan S.; Ovaa, Huib; Bollen, Mathieu; Morris, Andrew J.; Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as ectonucleotide pyrophosphatase/phosphodiesterase-2, ENPP2) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types.  ATX-LPA signaling is involved in various pathologies including tumor progression and inflammation.  However, the mol. basis of substrate recognition and catalysis by ATX and the mechanism by which it interacts with target cells are unclear.  Here, we present the crystal structure of ATX, alone and in complex with a small-mol. inhibitor.  We have identified a hydrophobic lipid-binding pocket and mapped key residues for catalysis and selection between nucleotide and phospholipid substrates.  We have shown that ATX interacts with cell-surface integrins through its N-terminal somatomedin B-like domains, using an atypical mechanism.  Our results define determinants of substrate discrimination by the ENPP family, suggest how ATX promotes localized LPA signaling and suggest new approaches for targeting ATX with small-mol. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fkNlSRtsTbVg90H21EOLACvtfcHk0ljmuH_51zT6dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D&md5=bc2ab613ace29ee008825cec69d65fce</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1980%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DFulkerson%26aufirst%3DZ.%26aulast%3DAlbers%26aufirst%3DH.%2BM.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DHouben%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BZeijl%26aufirst%3DL.%26aulast%3DJansen%26aufirst%3DS.%26aulast%3DAndries%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DPegg%26aufirst%3DL.%2BE.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DKasiem%26aufirst%3DM.%26aulast%3DHarlos%26aufirst%3DK.%26aulast%3DKooi%26aufirst%3DC.%2BW.%26aulast%3DSmyth%26aufirst%3DS.%2BS.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520substrate%2520discrimination%2520and%2520integrin%2520binding%2520by%2520autotaxin%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D198%26epage%3D204%26doi%3D10.1038%2Fnsmb.1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1038/nsmb.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fnsmb.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21240269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=205-212&author=H.+Nishimasuauthor=S.+Okudairaauthor=K.+Hamaauthor=E.+Miharaauthor=N.+Dohmaeauthor=A.+Inoueauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+structure+of+autotaxin+and+insight+into+GPCR+activation+by+lipid+mediators&doi=10.1038%2Fnsmb.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span></div><div class="casAuthors">Nishimasu, Hiroshi; Okudaira, Shinichi; Hama, Kotaro; Mihara, Emiko; Dohmae, Naoshi; Inoue, Asuka; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as Enpp2) is a secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine to generate lysophosphatidic acid (LPA), a lipid mediator that activates G protein-coupled receptors to evoke various cellular responses.  Here, we report the crystal structures of mouse ATX alone and in complex with LPAs with different acyl-chain lengths and saturations.  These structures reveal that the multidomain architecture helps to maintain the structural rigidity of the lipid-binding pocket, which accommodates the resp. LPA mols. in distinct conformations.  They indicate that a loop region in the catalytic domain is a major determinant for the substrate specificity of the Enpp family enzymes.  Furthermore, along with biochem. and biol. data, these structures suggest that the produced LPAs are delivered from the active site to cognate G protein-coupled receptors through a hydrophobic channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9dHNmB6yTbVg90H21EOLACvtfcHk0ljmuH_51zT6dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D&md5=f2f9ccaadf5c7de7bfd8431e5f954b2a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1998%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520structure%2520of%2520autotaxin%2520and%2520insight%2520into%2520GPCR%2520activation%2520by%2520lipid%2520mediators%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D205%26epage%3D212%26doi%3D10.1038%2Fnsmb.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Keune, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolenaars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidebrecht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunkara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matas-Rico, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Elferink, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11248</span><span class="refDoi"> DOI: 10.1038/ncomms11248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1038%2Fncomms11248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=27075612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11248&author=W.+Keuneauthor=J.+Hausmannauthor=R.+Bolierauthor=D.+Tolenaarsauthor=A.+Kremerauthor=T.+Heidebrechtauthor=R.+P.+Joostenauthor=M.+Sunkaraauthor=A.+J.+Morrisauthor=E.+Matas-Ricoauthor=W.+H.+Moolenaarauthor=R.+P.+Oude+Elferinkauthor=A.+Perrakis&title=Steroid+binding+to+Autotaxin+links+bile+salts+and+lysophosphatidic+acid+signalling&doi=10.1038%2Fncomms11248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span></div><div class="casAuthors">Keune, Willem-Jan; Hausmann, Jens; Bolier, Ruth; Tolenaars, Dagmar; Kremer, Andreas; Heidebrecht, Tatjana; Joosten, Robbie P.; Sunkara, Manjula; Morris, Andrew J.; Matas-Rico, Elisa; Moolenaar, Wouter H.; Oude Elferink, Ronald P.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11248</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX) generates the lipid mediator lysophosphatidic acid (LPA).  ATX-LPA signalling is involved in multiple biol. and pathophysiol. processes, including vasculogenesis, fibrosis, cholestatic pruritus and tumor progression.  ATX has a tripartite active site, combining a hydrophilic groove, a hydrophobic lipid-binding pocket and a tunnel of unclear function.  We present crystal structures of rat ATX bound to 7α-hydroxycholesterol and the bile salt tauroursodeoxycholate (TUDCA), showing how the tunnel selectively binds steroids.  A structure of ATX simultaneously harbouring TUDCA in the tunnel and LPA in the pocket, together with kinetic anal., reveals that bile salts act as partial non-competitive inhibitors of ATX, thereby attenuating LPA receptor activation.  This unexpected interplay between ATX-LPA signalling and select steroids, notably natural bile salts, provides a mol. basis for the emerging assocn. of ATX with disorders assocd. with increased circulating levels of bile salts.  Furthermore, our findings suggest potential clin. implications in the use of steroid drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3bO2RWT8ZrVg90H21EOLACvtfcHk0liJjk_2FvTrkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D&md5=29178b1c529c8c72ea6890fe32a66372</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms11248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11248%26sid%3Dliteratum%253Aachs%26aulast%3DKeune%26aufirst%3DW.%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DBolier%26aufirst%3DR.%26aulast%3DTolenaars%26aufirst%3DD.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DHeidebrecht%26aufirst%3DT.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DSunkara%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMatas-Rico%26aufirst%3DE.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DOude%2BElferink%26aufirst%3DR.%2BP.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DSteroid%2520binding%2520to%2520Autotaxin%2520links%2520bile%2520salts%2520and%2520lysophosphatidic%2520acid%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11248%26doi%3D10.1038%2Fncomms11248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Cole, J. C.; Nissink, J. W. M.; Taylor, R.</span> <span class="citation_source-book">Protein–Ligand Docking and Virtual Screening with GOLD</span>; <span class="NLM_series">Virtual Screening in Drug Discovery</span>; <span class="NLM_contrib-group">Shoichet, B.; Alvarez, J.</span>, Eds.; <span class="NLM_publisher-name">Taylor & Francis CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+C.+Cole&author=J.+W.+M.+Nissink&author=R.+Taylorauthor=B.+Shoichet&author=J.+Alvarez&title=Protein%E2%80%93Ligand+Docking+and+Virtual+Screening+with+GOLD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DJ.%2BC.%26btitle%3DProtein%25E2%2580%2593Ligand%2520Docking%2520and%2520Virtual%2520Screening%2520with%2520GOLD%26aulast%3DShoichet%26aufirst%3DB.%26pub%3DTaylor%2520%2526%2520Francis%2520CRC%2520Press%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span>Discovery Studio Modelling Environment, <span class="NLM_edition">release 4.5</span>; <span class="NLM_publisher-name">Dassault Systèmes BIOVIA</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discovery+Studio+Modelling+Environment%2C+release+4.5%3B+Dassault+Syst%C3%A8mes+BIOVIA%3A+San+Diego%2C+CA%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DDiscovery%2520Studio%2520Modelling%2520Environment%26pub%3DDassault%2520Syst%25C3%25A8mes%2520BIOVIA%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Brooks, H. B.; Geeganage, S.; Kahl, S. D.; Montrose, C.; Sittampalam, S.; Smith, M. C.; Weidner, J. R.</span><span> </span><span class="NLM_article-title">Basics of Enzymatic Assays for HTS</span>. In:  <span class="citation_source-book">Assay Guidance Manual</span>; <span class="NLM_contrib-group">Sittampalam, G. S.; Coussens, N. P.; Nelson, H.</span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span><a href="https://www.ncbi.nlm.nih.gov/books/NBK53196/" class="extLink">https://www.ncbi.nlm.nih.gov/books/NBK53196/</a> (accessed December 8, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=H.+B.+Brooks&author=S.+Geeganage&author=S.+D.+Kahl&author=C.+Montrose&author=S.+Sittampalam&author=M.+C.+Smith&author=J.+R.+Weidnerauthor=G.+S.+Sittampalam&author=N.+P.+Coussens&author=H.+Nelson&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DH.%2BB.%26atitle%3DBasics%2520of%2520Enzymatic%2520Assays%2520for%2520HTS%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruurs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goding, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">21155</span><span class="NLM_x">–</span> <span class="NLM_lpage">21161</span><span class="refDoi"> DOI: 10.1074/jbc.M413183200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1074%2Fjbc.M413183200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=21155-21161&author=L.+A.+van+Meeterenauthor=P.+Ruursauthor=E.+Christodoulouauthor=J.+W.+Godingauthor=H.+Takakusaauthor=K.+Kikuchiauthor=A.+Perrakisauthor=T.+Naganoauthor=W.+H.+Moolenaar&title=Inhibition+of+autotaxin+by+lysophosphatidic+acid+and+sphingosine+1-phosphate&doi=10.1074%2Fjbc.M413183200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413183200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413183200%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DRuurs%26aufirst%3DP.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DGoding%26aufirst%3DJ.%2BW.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DInhibition%2520of%2520autotaxin%2520by%2520lysophosphatidic%2520acid%2520and%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D21155%26epage%3D21161%26doi%3D10.1074%2Fjbc.M413183200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists</span>. <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>Chapter 3.2, p  <span class="NLM_fpage">53</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=53&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery%3A+A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%253A%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DWiley%26date%3D2005%26spage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liHJgSU9BGZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Potterton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M.</span><span> </span><span class="NLM_article-title">Developments in the CCP4 molecular-graphics project</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2288</span><span class="NLM_x">–</span> <span class="NLM_lpage">2294</span><span class="refDoi"> DOI: 10.1107/S0907444904023716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444904023716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=15572783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2288-2294&author=L.+Pottertonauthor=S.+McNicholasauthor=E.+Krissinelauthor=J.+Gruberauthor=K.+Cowtanauthor=P.+Emsleyauthor=G.+N.+Murshudovauthor=S.+Cohenauthor=A.+Perrakisauthor=M.+Noble&title=Developments+in+the+CCP4+molecular-graphics+project&doi=10.1107%2FS0907444904023716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in the CCP4 molecular-graphics project</span></div><div class="casAuthors">Potterton, Liz; McNicholas, Stuart; Krissinel, Eugene; Gruber, Jan; Cowtan, Kevin; Emsley, Paul; Murshudov, Garib N.; Cohen, Serge; Perrakis, Anastassis; Noble, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2288-2294</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Progress towards structure detn. that is both high-throughput and high-value is dependent on the development of integrated and automatic tools for electron-d. map interpretation and for the anal. of the resulting at. models.  Advances in map-interpretation algorithms are extending the resoln. regime in which fully automatic tools can work reliably, but at present human intervention is required to interpret poor regions of macromol. electron d., particularly where crystallog. data is only available to modest resoln. [for example, I/σ(I) < 2.0 for min. resoln. 2.5 Å].  In such cases, a set of manual and semi-manual model-building mol.-graphics tools is needed.  At the same time, converting the knowledge encapsulated in a mol. structure into understanding is dependent upon visualization tools, which must be able to communicate that understanding to others by both static and dynamic representations.  CCP4mg is a program designed to meet these needs in a way that is closely integrated with the ongoing development of CCP4 as a program suite suitable for both low- and high-intervention computational structural biol.  As well as providing a carefully designed user interface to advanced algorithms of model building and anal., CCP4mg is intended to present a graphical toolkit to developers of novel algorithms in these fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptPa3hk2BiOrVg90H21EOLACvtfcHk0liHJgSU9BGZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars7vN&md5=6bdc27bb8dc2d7c5ed37ef306e686001</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444904023716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904023716%26sid%3Dliteratum%253Aachs%26aulast%3DPotterton%26aufirst%3DL.%26aulast%3DMcNicholas%26aufirst%3DS.%26aulast%3DKrissinel%26aufirst%3DE.%26aulast%3DGruber%26aufirst%3DJ.%26aulast%3DCowtan%26aufirst%3DK.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DNoble%26aufirst%3DM.%26atitle%3DDevelopments%2520in%2520the%2520CCP4%2520molecular-graphics%2520project%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2288%26epage%3D2294%26doi%3D10.1107%2FS0907444904023716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Perrin, D. D.; Armarego, W. L. F.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_publisher-name">Pergamon Press</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">391</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=391&author=D.+D.+Perrin&author=W.+L.+F.+Armarego&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin%26aufirst%3DD.%2BD.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DPergamon%2520Press%26date%3D1988%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Huang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">7-Azaindolyl- and indolyl-functionalized starburst molecules with a 1,3,5-triazine or a benzene core – syntheses and luminescence</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1139/v06-022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1139%2Fv06-022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=477-485&author=W.+H.+Huangauthor=W.+L.+Jiaauthor=S.+Wang&title=7-Azaindolyl-+and+indolyl-functionalized+starburst+molecules+with+a+1%2C3%2C5-triazine+or+a+benzene+core+%E2%80%93+syntheses+and+luminescence&doi=10.1139%2Fv06-022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1139%2Fv06-022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv06-022%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BH.%26aulast%3DJia%26aufirst%3DW.%2BL.%26aulast%3DWang%26aufirst%3DS.%26atitle%3D7-Azaindolyl-%2520and%2520indolyl-functionalized%2520starburst%2520molecules%2520with%2520a%25201%252C3%252C5-triazine%2520or%2520a%2520benzene%2520core%2520%25E2%2580%2593%2520syntheses%2520and%2520luminescence%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D2006%26volume%3D84%26spage%3D477%26epage%3D485%26doi%3D10.1139%2Fv06-022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, B.</span><span> </span><span class="NLM_article-title">Sequence-specific association in aqueous media by integrating hydrogen bonding and dynamic covalent interactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">12628</span><span class="NLM_x">–</span> <span class="NLM_lpage">12629</span><span class="refDoi"> DOI: 10.1021/ja064515n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja064515n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=12628-12629&author=M.+Liauthor=K.+Yamatoauthor=J.+S.+Fergusonauthor=B.+Gong&title=Sequence-specific+association+in+aqueous+media+by+integrating+hydrogen+bonding+and+dynamic+covalent+interactions&doi=10.1021%2Fja064515n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja064515n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja064515n%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYamato%26aufirst%3DK.%26aulast%3DFerguson%26aufirst%3DJ.%2BS.%26aulast%3DGong%26aufirst%3DB.%26atitle%3DSequence-specific%2520association%2520in%2520aqueous%2520media%2520by%2520integrating%2520hydrogen%2520bonding%2520and%2520dynamic%2520covalent%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D12628%26epage%3D12629%26doi%3D10.1021%2Fja064515n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasiem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Mammalian cell expression, purification, crystallization and microcrystal data collection of autotaxin/ENPP2, a secreted mammalian glycoprotein</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span><span class="refDoi"> DOI: 10.1107/S1744309110032938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS1744309110032938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20823545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1130-1135&author=J.+Hausmannauthor=E.+Christodoulouauthor=M.+Kasiemauthor=V.+De+Marcoauthor=L.+A.+van+Meeterenauthor=W.+H.+Moolenaarauthor=D.+Axfordauthor=R.+L.+Owenauthor=G.+Evansauthor=A.+Perrakis&title=Mammalian+cell+expression%2C+purification%2C+crystallization+and+microcrystal+data+collection+of+autotaxin%2FENPP2%2C+a+secreted+mammalian+glycoprotein&doi=10.1107%2FS1744309110032938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian cell expression, purification, crystallization and microcrystal data collection of autotaxin/ENPP2, a secreted mammalian glycoprotein</span></div><div class="casAuthors">Hausmann, Jens; Christodoulou, Evangelos; Kasiem, Mobien; De Marco, Valeria; van Meeteren, Laurens A.; Moolenaar, Wouter H.; Axford, Danny; Owen, Robin L.; Evans, Gwyndaf; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1130-1135</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Autotaxin (ATX or ENPP2) is a secreted glycosylated mammalian enzyme that exhibits lysophospholipase D activity, hydrolyzing lysophosphatidylcholine to the signaling lipid, lysophosphatidic acid.  ATX is an ∼100 kDa multi-domain protein encompassing 2 N-terminal somatomedin B-like domains, a central catalytic phosphodiesterase domain, and a C-terminal nuclease-like domain.  Protocols for the efficient expression of ATX from stably transfected mammalian HEK293 cells in amts. sufficient for crystallog. studies are reported.  The purifn. resulted in protein that crystd. readily, but various attempts to grow crystals suitable in size for routine crystallog. structure detn. were not successful.  However, the available micrometer-thick plates diffracted x-rays beyond 2.0 Å resoln. and allowed the collection of complete diffraction data to ∼2.6 Å resoln.  The problems encountered and the current advantages and limitations of diffraction data collection from thin crystal plates are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohhtw5mdkwvLVg90H21EOLACvtfcHk0liHJgSU9BGZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamt7nI&md5=5cd367280e3ae14280b422ee78269235</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS1744309110032938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309110032938%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DKasiem%26aufirst%3DM.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DAxford%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DR.%2BL.%26aulast%3DEvans%26aufirst%3DG.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DMammalian%2520cell%2520expression%252C%2520purification%252C%2520crystallization%2520and%2520microcrystal%2520data%2520collection%2520of%2520autotaxin%252FENPP2%252C%2520a%2520secreted%2520mammalian%2520glycoprotein%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2010%26volume%3D66%26spage%3D1130%26epage%3D1135%26doi%3D10.1107%2FS1744309110032938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kabsch, W.</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kabsch%2C+W.Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+2010%2C+66%2C+125%E2%80%93132+10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lhnsGT4nni2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Evans, P. R.</span><span> </span><span class="NLM_article-title">An introduction to data reduction: space-group determination, scaling and intensity statistics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1107/S090744491003982X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS090744491003982X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21460446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=282-292&author=P.+R.+Evans&title=An+introduction+to+data+reduction%3A+space-group+determination%2C+scaling+and+intensity+statistics&doi=10.1107%2FS090744491003982X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An introduction to data reduction: Space-group determination, scaling and intensity statistics</span></div><div class="casAuthors">Evans, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">282-292</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  This paper presents an overview of how to run the CCP4 programs for data redn. (SCALA, POINTLESS and CTRUNCATE) through the CCP4 graphical interface ccp4i and points out some issues that need to be considered, together with a few examples.  It covers detn. of the point-group symmetry of the diffraction data (the Laue group), which is required for the subsequent scaling step, examn. of systematic absences, which in many cases will allow inference of the space group, putting multiple data sets on a common indexing system when there are alternatives, the scaling step itself, which produces a large set of data-quality indicators, estn. of |F| from intensity and finally examn. of intensity statistics to detect crystal pathologies such as twinning.  An appendix outlines the scoring schemes used by the program POINTLESS to assign probabilities to possible Laue and space groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEq8RhfQOW8LVg90H21EOLACvtfcHk0lhnsGT4nni2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D&md5=f425388a87744d721d324118d50e4f9a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS090744491003982X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491003982X%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26atitle%3DAn%2520introduction%2520to%2520data%2520reduction%253A%2520space-group%2520determination%252C%2520scaling%2520and%2520intensity%2520statistics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D282%26epage%3D292%26doi%3D10.1107%2FS090744491003982X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">McCoy, A.</span><span> </span><span class="NLM_article-title">Solving structures of protein complexes by molecular replacement with Phaser</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1107/S0907444906045975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444906045975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=17164524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=32-41&author=A.+McCoy&title=Solving+structures+of+protein+complexes+by+molecular+replacement+with+Phaser&doi=10.1107%2FS0907444906045975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Solving structures of protein complexes by molecular replacement with Phaser</span></div><div class="casAuthors">McCoy, Airlie J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Mol. replacement (MR) generally becomes more difficult as the no. of components in the asym. unit requiring sep. MR models (i.e. the dimensionality of the search) increases.  When the proportion of the total scattering contributed by each search component is small, the signal in the search for each component in isolation is weak or non-existent.  Maximum-likelihood MR functions enable complex asym. units to be built up from individual components with a 'tree search with pruning' approach.  This method, as implemented in the automated search procedure of the program Phaser, has been very successful in solving many previously intractable MR problems.  However, there are a no. of cases in which the automated search procedure of Phaser is suboptimal or encounters difficulties.  These include cases where there are a large no. of copies of the same component in the asym. unit or where the components of the asym. unit have greatly varying B factors.  Two case studies are presented to illustrate how Phaser can be used to best advantage in the std. 'automated MR' mode and two case studies are used to show how to modify the automated search strategy for problematic cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAvs9W8hQ3l7Vg90H21EOLACvtfcHk0lhnsGT4nni2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqu77F&md5=323a5297bdf622ebaf398a87c39dc794</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444906045975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906045975%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%26atitle%3DSolving%2520structures%2520of%2520protein%2520complexes%2520by%2520molecular%2520replacement%2520with%2520Phaser%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2007%26volume%3D63%26spage%3D32%26epage%3D41%26doi%3D10.1107%2FS0907444906045975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubák, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lgWoJUCNzRsMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Joosten, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">The PDB_REDO server for macromolecular structure model optimization</span> <span class="citation_source-journal">IUCrJ</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1107/S2052252514009324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1107%2FS2052252514009324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=25075342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=213-220&author=R.+P.+Joostenauthor=F.+Longauthor=G.+N.+Murshudovauthor=A.+Perrakis&title=The+PDB_REDO+server+for+macromolecular+structure+model+optimization&doi=10.1107%2FS2052252514009324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The PDBREDO server for macromolecular structure model optimization</span></div><div class="casAuthors">Joosten, Robbie P.; Long, Fei; Murshudov, Garib N.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">IUCrJ</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-220</span>CODEN:
                <span class="NLM_cas:coden">IUCRAJ</span>;
        ISSN:<span class="NLM_cas:issn">2052-2525</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The refinement and validation of a crystallog. structure model is the last step before the coordinates and the assocd. data are submitted to the Protein Data Bank (PDB).  The success of the refinement procedure is typically assessed by validating the models against geometrical criteria and the diffraction data, and is an important step in ensuring the quality of the PDB public archive [Read et al. (2011), Structure, 19, 1395-1412].  The PDBREDO procedure aims for 'constructive validation', aspiring to consistent and optimal refinement parameterization and pro-active model rebuilding, not only correcting errors but striving for optimal interpretation of the electron d.  A web server for PDBREDO has been implemented, allowing thorough, consistent and fully automated optimization of the refinement procedure in REFMAC and partial model rebuilding.  The goal of the web server is to help practicing crystallographers to improve their model prior to submission to the PDB.  For this, addnl. steps were implemented in the PDBREDO pipeline, both in the refinement procedure, e.g. testing of resoln. limits and k-fold cross-validation for small test sets, and as new validation criteria, e.g. the d.-fit metrics implemented in EDSTATS and ligand validation as implemented in YASARA.  Innovative ways to present the refinement and validation results to the user are also described, which together with auto-generated Coot scripts can guide users to subsequent model inspection and improvement.  It is demonstrated that using the server can lead to substantial improvement of structure models before they are submitted to the PDB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRplzNLO6ThbVg90H21EOLACvtfcHk0lgWoJUCNzRsMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnJ&md5=d7e448dc44857536ac5d71c1d92d5f10</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS2052252514009324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052252514009324%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DThe%2520PDB_REDO%2520server%2520for%2520macromolecular%2520structure%2520model%2520optimization%26jtitle%3DIUCrJ%26date%3D2014%26volume%3D1%26spage%3D213%26epage%3D220%26doi%3D10.1107%2FS2052252514009324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><div class="note"><p class="first last">For details of this assay, see:</p></div><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semaan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J. B.</span><span> </span><span class="NLM_article-title">Identification of a novel class of autotaxin inhibitors through cross-screening</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span><span class="refDoi"> DOI: 10.1039/C5MD00081E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;key=10.1039%2FC5MD00081E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1149-1155&author=D.+Castagnaauthor=E.+L.+Duffyauthor=D.+Semaanauthor=L.+C.+Youngauthor=J.+M.+Pritchardauthor=S.+J.+F.+MacDonaldauthor=D.+C.+Buddauthor=C.+Jamiesonauthor=A.+J.+B.+Watson&title=Identification+of+a+novel+class+of+autotaxin+inhibitors+through+cross-screening&doi=10.1039%2FC5MD00081E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1039%2FC5MD00081E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00081E%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DDuffy%26aufirst%3DE.%2BL.%26aulast%3DSemaan%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DL.%2BC.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%2BB.%26atitle%3DIdentification%2520of%2520a%2520novel%2520class%2520of%2520autotaxin%2520inhibitors%2520through%2520cross-screening%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1149%26epage%3D1155%26doi%3D10.1039%2FC5MD00081E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NKN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NKN','PDB','3NKN'); return false;">PDB: 3NKN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZG7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZG7','PDB','4ZG7'); return false;">PDB: 4ZG7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQQ','PDB','5LQQ'); return false;">PDB: 5LQQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XR9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XR9','PDB','2XR9'); return false;">PDB: 2XR9</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i123"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01597">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36642"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01597">10.1021/acs.jmedchem.6b01597</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental and analytical methods, characterization data, assay data, physicochemical data, molecular modeling data, crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_001.pdf">jm6b01597_si_001.pdf (31.91 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01597/suppl_file/jm6b01597_si_002.csv">jm6b01597_si_002.csv (4.58 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-2%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01597%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01597" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799215e8f9121e9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
